This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Intrahepatic Cholestasis of Pregnancy (ICP)
O15_ICP
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleonly females |
293145 |
2. Check conditionsNone |
293145 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3126 |
4. Check minimum number of eventsNone |
3126 |
5. Include endpointsNone |
3126 |
6. Filter based on genotype QC (FinnGen only) |
3003 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF3
- Parent code in ICD-10
- O26
- Name in latin
- Morbositates hepatis in graviditate, intra labores et/sive in puerperio
Similar endpoints
↥List of similar endpoints to
Intrahepatic Cholestasis of Pregnancy (ICP)
based on the number of shared cases.
Similar with more cases:
- Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls
- Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8
- Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls
- Pregnancy, childbirth and the puerperium
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3003 | 3003 | - |
| Unadjusted period prevalence (%) | 1.07 | 1.07 | - |
| Median age at first event (years) | 30.53 | 30.53 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3126
- Matched controls
- 31260
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A05AA02
ATC
ursodeoxycholic acid; oral
114.2
307.7
1076
143
6467A
ICD-9 Finland
Other complications of pregnancy, not elsewhere classified, Liver disorders in pregnancy[HEPATOSIS GRAVIDARUM]
+∞
307.7
733
*
O26.6
ICD-10 Finland
Liver disorders in pregnancy, childbirth and the puerperium
11179.8
307.7
2475
7
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
2.5
127.5
1374
7543
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.2
98.4
447
1560
O80.8
ICD-10 Finland
Other single spontaneous delivery
3.0
96.1
479
1762
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
2.5
93.3
776
3696
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
2.1
92.3
1734
11498
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
2.4
85.7
765
3744
W84
ICPC
Pregnancy high risk
2.9
73.9
382
1424
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
2.5
71.5
516
2276
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
2.0
71.1
1164
7137
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.5
69.9
513
2279
MAC10
NOMESCO Finland
Antepartum dilatation of cervical canal
3.3
66.2
263
839
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
2.2
63.2
687
3595
Z39.2
ICD-10 Finland
Routine postpartum follow-up
1.9
61.0
1065
6598
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
2.1
60.1
702
3770
SPAT1380
SPAT
Postpartum check-up
2.0
53.3
746
4255
SPAT1379
SPAT
Health check-up of pregnant person
1.9
53.1
853
5098
MAC01
NOMESCO Finland
Rupture of aminiotic membrane for induction of labor
3.4
52.4
196
601
O30.0
ICD-10 Finland
Twin pregnancy
3.8
52.2
165
452
O80.0
ICD-10 Finland
Spontaneous vertex delivery
1.8
51.7
1686
12457
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
1.8
47.2
1061
6991
SPAT1197
SPAT
Extensive health check-up of expecting family
1.8
45.9
933
5960
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
1.9
44.2
745
4482
O34.2
ICD-10 Finland
Maternal care due to uterine scar from previous surgery
2.2
44.2
446
2241
W78
ICPC
Pregnancy
1.7
43.6
1105
7498
XMA22
NOMESCO Finland
General examination of pregnant woman
2.1
42.7
451
2304
63900
ICD-8 Finland
Other toxaemias of pregnancy and the puerperium, Pruritus
16.5
42.7
36
22
O60
ICD-10 Finland
Preterm labour and delivery
2.8
40.8
213
791
Z32.1
ICD-10 Finland
Pregnancy confirmed
1.8
40.3
743
4580
MAC96
NOMESCO Finland
Other induction or advancement of labour
2.8
40.3
217
820
Z35.9
ICD-10 Finland
Supervision of high-risk pregnancy, unspecified
2.5
37.9
262
1119
MAX99
NOMESCO Finland
Assistance to normal delivery
1.8
35.7
682
4230
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
4.1
34.6
95
235
MAC40
NOMESCO Finland
Pharmacological induction or advancement of labor
2.7
34.0
185
702
O36.6
ICD-10 Finland
Maternal care for excessive fetal growth
2.3
33.9
274
1253
WX307
NOMESCO Finland
Obstetric epidural analgesia
1.8
33.6
634
3908
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
1.7
30.9
732
4796
MA2XE
NOMESCO Finland
Other obstetric ultrasound examination
1.9
30.4
462
2661
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.7
30.2
603
3765
O13
ICD-10 Finland
Gestational [pregnancy-induced] hypertension
2.0
28.7
323
1679
W29
ICPC
Pregnancy symptom/complaint other
2.3
28.6
220
983
O99.80
ICD-10 Finland
The fear of childbirth
1.9
27.6
382
2130
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
1.9
27.4
410
2345
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
2.6
27.4
168
677
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
1.6
26.8
707
4737
OAA12, ,
SPAT
2.0
26.7
324
1728
8811
FHL
Cesarean section
2.1
26.6
260
1281
WX321
NOMESCO Finland
Acute spinal anesthesia for delivery
2.0
26.0
289
1494
L29.9
ICD-10 Finland
Pruritus, unspecified
2.8
25.9
134
495
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
3.2
25.2
103
333
O82.0
ICD-10 Finland
Delivery by elective caesarean section
1.9
25.0
315
1700
MAA00
NOMESCO Finland
Amniocentesis
2.4
23.9
164
696
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
1.6
23.6
584
3836
OAA11, ,
SPAT
1.8
23.3
414
2488
S02
ICPC
Pruritus
2.5
21.8
145
607
OAA10, ,
SPAT
1.9
21.1
304
1713
ZXD05
NOMESCO Finland
Urgent procedure
1.5
20.8
986
7448
SPAT1196
SPAT
Monitoring of normal pregnancy
1.7
20.8
441
2777
MA3AE
NOMESCO Finland
Combined first trimester screening
1.7
20.7
393
2403
O82.10
ICD-10 Finland
Delivery by emergency caesarean section
1.7
20.4
374
2262
O14.9
ICD-10 Finland
Pre-eclampsia, unspecified
2.7
19.7
107
406
5742A
ICD-9 Finland
Cholelithiasis, Calculus of gallbladder without mention of cholecystitis[CHOLECYSTOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]
4.0
19.6
55
139
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
1.7
19.4
398
2482
ZXE00
NOMESCO Finland
One hour or less
1.4
19.3
1185
9366
W90
ICPC
Uncompl labour/delivery livebirth
1.7
18.2
340
2066
O84.0
ICD-10 Finland
Multiple delivery, all spontaneous
3.8
18.0
55
148
O26.88
ICD-10 Finland
Other specified pregnancy-related conditions
2.5
17.9
110
444
Z35.2
ICD-10 Finland
Supervision of pregnancy with other poor reproductive or obstetric history
2.3
17.9
142
643
63998
ICD-8 Finland
Other toxaemias of pregnancy and the puerperium, Alia definitae
20.2
17.7
26
13
K76.9
ICD-10 Finland
Liver disease, unspecified
3.6
17.1
56
158
Z35
ICD-10 Finland
Supervision of high-risk pregnancy
2.9
16.9
81
288
6510B
ICD-9 Finland
Multiple gestation, Twin pregnancy[GEMINI, SYNNYTYKSEN AIKANA]
4.2
16.5
44
107
W92
ICPC
Compl labour/ delivery livebirth
2.1
16.2
158
777
O28.8
ICD-10 Finland
Other abnormal findings on antenatal screening of mother
2.7
16.2
86
323
A10BX01
ATC
guar gum; oral
3.5
16.2
55
159
A02BC01
ATC
omeprazole; systemic
1.5
16.2
709
5232
O30.00
ICD-10 Finland
Twin pregnancy with separate amniotic and chorionic sacs
3.8
15.5
46
121
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
15.3
1294
10667
V230A
ICD-9 Finland
Supervision of high-risk pregnancy, Pregnancy with history of infertility
3.4
15.3
55
165
W85
ICPC
Gestational diabetes
1.7
15.3
284
1720
Z87.5
ICD-10 Finland
Personal history of complications of pregnancy, childbirth and the puerperium
2.7
15.1
80
300
O14.0
ICD-10 Finland
Mild to moderate pre-eclampsia
2.3
15.0
115
514
Z35.4
ICD-10 Finland
Supervision of pregnancy with grand multiparity
3.1
15.0
61
198
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
6.8
14.9
23
34
O72.2
ICD-10 Finland
Delayed and secondary postpartum haemorrhage
2.3
14.4
112
504
O21.9
ICD-10 Finland
Vomiting of pregnancy, unspecified
2.3
14.4
111
498
OAA41, ,
SPAT
2.0
14.2
160
829
Z3232
NOMESCO Finland
Midwife
1.5
14.2
516
3662
Z37.0
ICD-10 Finland
Single live birth
1.5
14.2
573
4153
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
14.0
344
2238
Z35.0
ICD-10 Finland
Supervision of pregnancy with history of infertility
1.9
13.9
177
956
O84.2
ICD-10 Finland
Multiple delivery, all by caesarean section
3.8
13.9
41
108
WX320
NOMESCO Finland
Spinalanesthesy
1.4
13.8
601
4413
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
2.3
13.7
103
457
O26.82
ICD-10 Finland
Exhaustion and fatigue pregnancy-related
2.0
13.7
154
799
O61.0
ICD-10 Finland
Failed medical induction of labour
2.6
13.6
77
300
6467X
ICD-9 Finland
Other complications of pregnancy, not elsewhere classified, Liver disorders in pregnancy[HEPATOPATHIA ALIA GRAVIDARUM]
+∞
13.5
13
*
O26.9
ICD-10 Finland
Pregnancy-related condition, unspecified
3.3
13.5
49
148
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
3.7
13.3
41
111
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
13.1
594
4391
K83.0
ICD-10 Finland
Cholangitis
4.3
13.1
33
77
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.4
12.5
570
4214
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.5
12.5
416
2896
O20.0
ICD-10 Finland
Threatened abortion
1.9
12.4
150
797
Z39.1
ICD-10 Finland
Care and examination of lactating mother
1.9
12.4
146
770
6488A
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Abnormal glucose tolerance
2.7
12.4
64
238
6510A
ICD-9 Finland
Multiple gestation, Twin pregnancy[GEMINI, RASKAUDEN AIKANA]
4.4
12.4
30
68
MAC98
NOMESCO Finland
Other induction of labor
4.6
12.3
29
64
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
2.1
12.2
114
552
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
1.4
12.1
767
5995
SPAT1399
SPAT
Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.
1.6
12.0
257
1614
O98.4
ICD-10 Finland
Viral hepatitis complicating pregnancy, childbirth and the puerperium
10.1
12.0
23
23
6500B
ICD-9 Finland
Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]
1.4
12.0
671
5140
Z39.0
ICD-10 Finland
Care and examination immediately after delivery
2.5
11.9
74
302
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
2.4
11.8
80
340
O35.8
ICD-10 Finland
Maternal care for other (suspected) fetal abnormality and damage
2.0
11.6
120
605
SPAT1200
SPAT
Guidance for breast-feeding and breast care
1.8
11.5
163
912
O47
ICD-10 Finland
False labour
2.6
11.5
65
253
Z36.8
ICD-10 Finland
Other antenatal screening
2.0
11.4
127
657
6663
FHL
Cholecystectomy and cholangiography
4.0
11.2
31
78
O61.8
ICD-10 Finland
Other failed induction of labour
3.5
11.1
37
106
SPAT1357
SPAT
Monitoring of problem during pregnancy
1.8
11.1
161
909
O21.0
ICD-10 Finland
Mild hyperemesis gravidarum
2.4
10.9
74
315
W27
ICPC
Fear of complications of pregnancy
2.4
10.9
74
315
MBA00
NOMESCO Finland
Vacuum aspiration from uterus after delivery or abortion
2.0
10.8
122
634
6480A
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus
3.9
10.8
31
80
B18.2
ICD-10 Finland
Chronic viral hepatitis C
3.1
10.6
42
135
O20.9
ICD-10 Finland
Haemorrhage in early pregnancy, unspecified
1.8
10.5
169
985
B01AB04
ATC
dalteparin; parenteral
1.9
10.4
124
658
O72.1
ICD-10 Finland
Other immediate postpartum haemorrhage
1.8
10.2
143
798
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
10.2
1362
11754
SPAT1263
SPAT
Sampling
1.3
10.2
1201
10204
L29.8
ICD-10 Finland
Other pruritus
2.8
9.9
48
173
O26.0
ICD-10 Finland
Excessive weight gain in pregnancy
7.6
9.9
22
29
OAA70, ,
SPAT
1.9
9.9
122
655
W94
ICPC
Puerperal mastitis
2.6
9.8
55
214
O84.8
ICD-10 Finland
Other multiple delivery
4.4
9.8
24
55
O02.0
ICD-10 Finland
Blighted ovum and nonhydatidiform mole
1.7
9.5
172
1034
O99.0
ICD-10 Finland
Anaemia complicating pregnancy, childbirth and the puerperium
2.2
9.4
74
337
Z32.0
ICD-10 Finland
Pregnancy, not (yet) confirmed
1.8
9.3
149
867
WX234
NOMESCO Finland
Paracervical blockade
1.7
9.1
178
1093
SPAT1189
SPAT
Other ultrasound examination during pregnancy
1.6
9.1
186
1156
A10AC01
ATC
insulin (human); parenteral
1.7
9.1
171
1040
Z2221
NOMESCO Finland
Medical doctor
1.3
8.9
812
6646
G03DA04
ATC
progesterone; systemic, rectal, vaginal
1.7
8.8
142
828
6440B
ICD-9 Finland
Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS]
2.4
8.7
59
252
O32.1
ICD-10 Finland
Maternal care for breech presentation
1.5
8.5
239
1603
O26.7
ICD-10 Finland
Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium
2.2
8.5
70
325
O36.8
ICD-10 Finland
Maternal care for other specified fetal problems
1.9
8.4
101
538
R51.80
ICD-10 Finland
Headache
1.3
8.3
580
4570
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
8.2
918
7698
O02.1
ICD-10 Finland
Missed abortion
1.5
8.2
297
2099
W03
ICPC
Antepartum bleeding
2.4
8.2
54
228
O72.0
ICD-10 Finland
Third-stage haemorrhage
1.7
8.1
134
787
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
3.1
8.1
33
108
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.1
8.1
73
351
O36.9
ICD-10 Finland
Maternal care for fetal problem, unspecified
2.2
8.0
62
280
O03.9
ICD-10 Finland
Spontaneous abortion, Complete or unspecified, without complication
1.5
7.9
235
1594
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.4
7.9
333
2419
O35.1
ICD-10 Finland
Maternal care for (suspected) chromosomal abnormality in fetus
1.8
7.9
111
623
O36.5
ICD-10 Finland
Maternal care for poor fetal growth
1.7
7.8
149
911
J01DB01
ATC
cefalexin; oral
1.3
7.8
2531
23908
O91.2
ICD-10 Finland
Nonpurulent mastitis associated with childbirth
2.1
7.8
74
364
G03GB02
ATC
clomifene; oral
1.8
7.7
104
576
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
7.7
1017
8688
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
2.3
7.5
52
224
MBA03
NOMESCO Finland
Curettage of uterus after delivery or abortion
1.7
7.5
146
898
SPAT1246
SPAT
Screening of depression or other psychiatric problem
1.5
7.4
203
1355
L04AX01
ATC
azathioprine; systemic
1.8
7.4
114
658
6440A
ICD-9 Finland
Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS IMMINENS]
2.0
7.2
72
360
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
1.8
7.2
109
625
Z30.1
ICD-10 Finland
Insertion of (intrauterine) contraceptive device
1.3
7.2
762
6329
O40
ICD-10 Finland
Polyhydramnios
2.1
7.1
66
322
Z37.2
ICD-10 Finland
Twins, both liveborn
3.4
7.0
24
71
N81.6
ICD-10 Finland
Rectocele
1.6
6.9
159
1019
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
6.9
241
1690
K80.1
ICD-10 Finland
Calculus of gallbladder with other cholecystitis
2.2
6.9
55
253
K50.0
ICD-10 Finland
Crohn disease of small intestine
2.3
6.9
50
221
K30
ICD-10 Finland
Functional dyspepsia
1.4
6.9
348
2609
O75.7
ICD-10 Finland
Vaginal delivery following previous caesarean section
3.3
6.8
25
77
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
6.8
1158
10135
O03.4
ICD-10 Finland
Spontaneous abortion, Incomplete, without complication
1.7
6.7
122
737
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.5
6.7
22
63
SPAT1307
SPAT
Psychosocial counselling and guidance
1.4
6.7
258
1844
O81.4
ICD-10 Finland
Vacuum extractor delivery
1.4
6.7
321
2384
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.2
6.7
1278
11311
TQW30
NOMESCO Finland
Acupuncture
2.6
6.6
36
139
SPAT1373
SPAT
Combined screening in early pregnancy
1.8
6.6
96
545
O86.0
ICD-10 Finland
Infection of obstetric surgical wound
2.2
6.6
50
225
O98.8
ICD-10 Finland
Other maternal infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium
7.8
6.6
14
18
W99
ICPC
Disorder of pregn/delivery other
2.8
6.5
30
106
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
1.8
6.4
85
469
SPAT1391
SPAT
Counselling and guidance related to family situation
2.0
6.4
64
321
6567A
ICD-9 Finland
Other foetal and placental problems affecting management of mother, Other placental conditions[CONDITIO PLACENTAE ALIA, RASKAUDEN AIKANA]
70.0
6.4
7
*
O46.9
ICD-10 Finland
Antepartum haemorrhage, unspecified
1.8
6.4
93
528
P01AB01
ATC
metronidazole; oral, rectal
1.2
6.4
1278
11340
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.4
6.4
231
1634
Z22.5
ICD-10 Finland
Carrier of viral hepatitis
11.0
6.3
11
10
J01DA01
ATC
[U] cefalexin
1.2
6.3
1798
16506
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.2
6.3
995
8624
SPAT1375
SPAT
Structural ultrasound screening, weeks 18+0-21+6
2.0
6.3
63
317
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
2.7
6.3
31
114
SPAT1190
SPAT
Insertion or removal of intrauterine contraceptive device
1.4
6.3
324
2436
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
1.9
6.2
75
402
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
7.0
6.2
14
20
Z34
ICD-10 Finland
Supervision of normal pregnancy
1.4
6.2
250
1803
O86.1
ICD-10 Finland
Other infection of genital tract following delivery
2.2
6.2
48
219
WX600
NOMESCO Finland
Single shot through catheter
1.8
6.1
86
484
W05
ICPC
Pregnancy vomiting/nausea
2.0
6.1
64
327
1413
FHL
Laparoscopy and other therapeutic procedure
1.9
6.1
69
362
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
2.7
6.1
30
110
O83.8
ICD-10 Finland
Other specified assisted single delivery
3.8
6.1
18
48
G02BA03
ATC
plastic IUD with progestogen
1.3
6.0
666
5547
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Obstetrics / Gynecology
16 [38004461]
16 [38004461]
4.9e-01
2.2e+00
3.0e+00
8.7e+00
3.7e+00
7.4e-01
7.5e-01
cases:54.07%
controls:41.84%
cases:65.71%
controls:17.94%
cases:41.31%
controls:3.46%
cases:89.09%
controls:0.13%
cases:60.00%
controls:3.50%
cases:31.22%
controls:17.78%
cases:60.26%
controls:41.74%
1547
11825
1314
16440
1880
5071
981
23194
1182
977
1679
27288
2549
38
312
28227
1716
989
1144
27257
883
4958
1945
22928
1604
10889
1058
15201
Bile acid [Moles/volume] in Serum --fasting
35562-8 [3034274]
35562-8 [3034274]
9.3e-01
2.6e+00
6.8e+00
1.0e+50
—
3.5e+00
3.0e+00
cases:1.82%
controls:0.72%
cases:2.83%
controls:0.21%
cases:17.76%
controls:0.02%
cases:7.38%
controls:0.00%
—
—
cases:6.58%
controls:0.22%
cases:11.61%
controls:0.67%
52
204
2809
28061
81
60
2780
28205
508
7
2353
28258
211
0
2650
28265
—
186
61
2642
27825
309
176
2353
25914
Inpatient Hospital
21 [8717]
21 [8717]
1.9e-01
-3.5e-01
1.5e+00
7.0e+00
5.6e+00
8.1e-01
7.5e-01
cases:44.11%
controls:39.57%
cases:9.33%
controls:12.73%
cases:5.80%
controls:1.37%
cases:35.55%
controls:0.05%
cases:79.16%
controls:1.42%
cases:24.50%
controls:12.63%
cases:55.97%
controls:37.58%
1262
11185
1599
17080
267
3599
2594
24666
166
388
2695
27877
1017
14
1844
28251
2264
402
596
27844
693
3522
2135
24364
1490
9804
1172
16286
Emergency Room Visit
ER [9203]
ER [9203]
3.4e-01
9.7e-01
2.5e+00
7.3e+00
3.1e+00
5.1e-01
6.0e-01
cases:35.44%
controls:28.06%
cases:23.17%
controls:10.27%
cases:14.23%
controls:1.28%
cases:31.28%
controls:0.03%
cases:22.52%
controls:1.23%
cases:15.63%
controls:10.06%
cases:43.88%
controls:29.92%
1014
7932
1847
20333
663
2903
2198
25362
407
363
2454
27902
895
9
1966
28256
644
348
2216
27898
442
2804
2386
25082
1168
7806
1494
18284
Twin pregnancy
O30.0 [45563076]
O30.0 [45563076]
-2.6e-01
3.7e+00
5.2e+00
1.0e+50
4.5e+00
1.8e+00
5.1e-01
cases:0.24%
controls:0.32%
cases:3.77%
controls:0.10%
cases:3.88%
controls:0.02%
cases:3.22%
controls:0.00%
cases:3.32%
controls:0.04%
cases:0.99%
controls:0.16%
cases:0.83%
controls:0.50%
7
90
2854
28175
108
27
2753
28238
111
6
2750
28259
92
0
2769
28265
95
11
2765
28235
28
46
2800
27840
22
130
2640
25960
Health check-up of pregnant person
SPAT1379 [2001700479]
SPAT1379 [2001700479]
2.9e-01
2.2e+00
3.1e+00
3.3e+00
2.9e+00
1.5e+00
6.9e-01
cases:7.06%
controls:5.37%
cases:18.25%
controls:2.50%
cases:15.31%
controls:0.80%
cases:1.01%
controls:0.04%
cases:13.22%
controls:0.84%
cases:8.98%
controls:2.17%
cases:10.03%
controls:5.28%
202
1518
2659
26747
522
707
2339
27558
438
227
2423
28038
29
11
2832
28254
378
236
2482
28010
254
605
2574
27281
267
1377
2395
24713
Outpatient Hospital
22 [8756]
22 [8756]
2.4e-01
-2.9e-01
1.1e+00
6.9e+00
3.7e+00
6.9e-01
5.1e-01
cases:26.11%
controls:21.80%
cases:5.10%
controls:6.71%
cases:2.27%
controls:0.76%
cases:15.03%
controls:0.02%
cases:24.37%
controls:0.80%
cases:12.45%
controls:6.63%
cases:33.85%
controls:23.59%
747
6162
2114
22103
146
1897
2715
26368
65
215
2796
28050
430
5
2431
28260
697
225
2163
28021
352
1848
2476
26038
901
6154
1761
19936
Pregnancy
W78 [2002001269]
W78 [2002001269]
2.3e-01
2.3e+00
3.0e+00
3.3e+00
2.5e+00
1.2e+00
6.4e-01
cases:9.26%
controls:7.47%
cases:28.94%
controls:4.03%
cases:23.28%
controls:1.48%
cases:2.52%
controls:0.10%
cases:15.80%
controls:1.55%
cases:11.92%
controls:4.09%
cases:15.70%
controls:8.97%
265
2111
2596
26154
828
1140
2033
27125
666
419
2195
27846
72
27
2789
28238
452
437
2408
27809
337
1141
2491
26745
418
2340
2244
23750
Diabetes mellitus arising in pregnancy
O24.4 [45543922]
O24.4 [45543922]
1.5e-01
2.1e+00
4.0e+00
—
4.2e+00
1.4e+00
8.1e-01
cases:3.53%
controls:3.04%
cases:7.79%
controls:1.02%
cases:9.96%
controls:0.21%
—
—
cases:12.24%
controls:0.21%
cases:4.63%
controls:1.14%
cases:7.81%
controls:3.65%
101
859
2760
27406
223
289
2638
27976
285
58
2576
28207
—
350
59
2510
28187
131
319
2697
27567
208
952
2454
25138
Supervision of other high-risk pregnancies
Z35.8 [45552076]
Z35.8 [45552076]
5.5e-02
2.1e+00
4.0e+00
1.0e+50
4.1e+00
1.0e+00
1.0e+00
cases:3.18%
controls:3.01%
cases:7.44%
controls:0.97%
cases:6.57%
controls:0.13%
cases:2.97%
controls:0.00%
cases:6.75%
controls:0.12%
cases:2.79%
controls:1.00%
cases:9.43%
controls:3.52%
91
852
2770
27413
213
275
2648
27990
188
36
2673
28229
85
0
2776
28265
193
35
2667
28211
79
278
2749
27608
251
919
2411
25171
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
MA2AE [2001306829]
MA2AE [2001306829]
2.8e-01
2.3e+00
3.7e+00
—
4.2e+00
8.2e-01
9.3e-01
cases:8.63%
controls:6.66%
cases:17.93%
controls:2.23%
cases:14.23%
controls:0.41%
—
—
cases:16.75%
controls:0.31%
cases:5.66%
controls:2.56%
cases:17.69%
controls:7.84%
247
1883
2614
26382
513
631
2348
27634
407
116
2454
28149
—
479
88
2381
28158
160
715
2668
27171
471
2046
2191
24044
Pregnancy high risk
W84 [2002001275]
W84 [2002001275]
-1.1e-01
2.3e+00
3.6e+00
—
3.4e+00
1.7e+00
1.1e+00
cases:1.05%
controls:1.17%
cases:4.61%
controls:0.48%
cases:4.09%
controls:0.11%
—
—
cases:4.13%
controls:0.15%
cases:2.79%
controls:0.50%
cases:4.28%
controls:1.51%
30
331
2831
27934
132
137
2729
28128
117
32
2744
28233
—
118
41
2742
28205
79
139
2749
27747
114
394
2548
25696
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
4.2e-02
8.0e-02
2.9e+00
5.5e+00
2.8e+00
5.7e-01
3.4e-01
cases:13.84%
controls:13.35%
cases:8.91%
controls:8.29%
cases:19.40%
controls:1.37%
cases:10.87%
controls:0.05%
cases:18.57%
controls:1.31%
cases:13.79%
controls:8.30%
cases:25.77%
controls:19.82%
396
3773
2465
24492
255
2342
2606
25923
555
388
2306
27877
311
14
2550
28251
531
369
2329
27877
390
2315
2438
25571
686
5172
1976
20918
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
49178-7 [3048929]
1.8e-01
1.1e+00
4.6e+00
1.0e+50
4.9e+00
-3.2e-01
1.3e+00
cases:0.87%
controls:0.73%
cases:0.56%
controls:0.19%
cases:1.75%
controls:0.02%
cases:1.85%
controls:0.00%
cases:4.02%
controls:0.03%
cases:0.18%
controls:0.24%
cases:2.29%
controls:0.61%
25
206
2836
28059
16
54
2845
28211
50
5
2811
28260
53
0
2808
28265
115
9
2745
28237
5
68
2823
27818
61
160
2601
25930
The fear of childbirth
O99.80 [2000503219]
O99.80 [2000503219]
3.0e-01
2.0e+00
3.7e+00
1.0e+50
4.0e+00
1.2e+00
8.9e-01
cases:1.82%
controls:1.35%
cases:3.32%
controls:0.45%
cases:3.39%
controls:0.08%
cases:2.38%
controls:0.00%
cases:4.23%
controls:0.08%
cases:1.94%
controls:0.60%
cases:4.40%
controls:1.85%
52
382
2809
27883
95
126
2766
28139
97
24
2764
28241
68
0
2793
28265
121
22
2739
28224
55
167
2773
27719
117
482
2545
25608
ursodeoxycholic acid; oral
A05AA02 [21600513]
A05AA02 [21600513]
2.8e+00
3.0e+00
—
1.0e+50
—
—
6.0e+00
cases:0.45%
controls:0.03%
cases:0.56%
controls:0.03%
—
—
cases:13.46%
controls:0.00%
—
—
—
—
cases:9.58%
controls:0.03%
13
8
2848
28257
16
8
2845
28257
—
385
0
2476
28265
—
—
255
7
2407
26083
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
1.8e-02
3.1e-01
2.3e+00
4.5e+00
2.8e+00
1.0e+00
6.6e-01
cases:3.64%
controls:3.57%
cases:2.27%
controls:1.68%
cases:2.34%
controls:0.24%
cases:1.57%
controls:0.02%
cases:4.09%
controls:0.25%
cases:4.31%
controls:1.57%
cases:8.56%
controls:4.63%
104
1010
2757
27255
65
474
2796
27791
67
67
2794
28198
45
5
2816
28260
117
71
2743
28175
122
437
2706
27449
228
1209
2434
24881
Detailed ultrasound examination of fetus including color doppler method
MA2DE [2001306835]
MA2DE [2001306835]
8.6e-03
2.0e+00
3.5e+00
—
4.0e+00
9.2e-01
7.6e-01
cases:3.46%
controls:3.43%
cases:7.69%
controls:1.13%
cases:6.92%
controls:0.22%
—
—
cases:8.04%
controls:0.16%
cases:2.90%
controls:1.18%
cases:8.53%
controls:4.20%
99
970
2762
27295
220
318
2641
27947
198
61
2663
28204
—
230
45
2630
28201
82
328
2746
27558
227
1095
2435
24995
Cholangitis
K83.0 [45552955]
K83.0 [45552955]
2.4e+00
2.4e+00
—
—
—
2.9e+00
3.3e+00
cases:0.24%
controls:0.02%
cases:0.24%
controls:0.02%
—
—
—
—
—
—
cases:0.39%
controls:0.02%
cases:0.53%
controls:0.02%
7
6
2854
28259
7
6
2854
28259
—
—
—
11
6
2817
27880
14
5
2648
26085
Other specified pregnancy-related conditions
O26.88 [2000503211]
O26.88 [2000503211]
3.3e-01
2.2e+00
3.6e+00
1.0e+50
3.8e+00
1.5e+00
7.5e-01
cases:0.45%
controls:0.33%
cases:0.77%
controls:0.08%
cases:0.63%
controls:0.02%
cases:0.38%
controls:0.00%
cases:0.91%
controls:0.02%
cases:0.50%
controls:0.11%
cases:0.90%
controls:0.43%
13
92
2848
28173
22
24
2839
28241
18
5
2843
28260
11
0
2850
28265
26
6
2834
28240
14
31
2814
27855
24
112
2638
25978
Gestational diabetes
W85 [2002001276]
W85 [2002001276]
-3.9e-02
2.4e+00
4.0e+00
—
3.0e+00
9.1e-01
6.6e-01
cases:1.05%
controls:1.09%
cases:4.58%
controls:0.43%
cases:3.15%
controls:0.06%
—
—
cases:1.36%
controls:0.07%
cases:1.27%
controls:0.52%
cases:2.85%
controls:1.50%
30
308
2831
27957
131
121
2730
28144
90
17
2771
28248
—
39
19
2821
28227
36
144
2792
27742
76
391
2586
25699
Outpatient Visit
OP [9202]
OP [9202]
1.6e-01
1.2e+00
1.7e+00
4.8e+00
2.2e+00
3.8e-01
4.7e-01
cases:60.15%
controls:56.20%
cases:63.68%
controls:33.97%
cases:31.63%
controls:7.73%
cases:33.83%
controls:0.43%
cases:44.76%
controls:8.05%
cases:43.03%
controls:34.05%
cases:74.46%
controls:64.57%
1721
15885
1140
12380
1822
9602
1039
18663
905
2185
1956
26080
968
121
1893
28144
1280
2273
1580
25973
1217
9496
1611
18390
1982
16846
680
9244
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
O99.3 [45606675]
O99.3 [45606675]
-1.5e-01
2.4e+00
3.3e+00
1.0e+50
3.9e+00
1.3e+00
5.6e-01
cases:0.49%
controls:0.57%
cases:1.57%
controls:0.15%
cases:1.01%
controls:0.04%
cases:1.05%
controls:0.00%
cases:1.54%
controls:0.03%
cases:0.64%
controls:0.18%
cases:1.09%
controls:0.62%
14
161
2847
28104
45
41
2816
28224
29
11
2832
28254
30
0
2831
28265
44
9
2816
28237
18
49
2810
27837
29
163
2633
25927
False labour before 37 completed weeks of gestation
O47.0 [45582556]
O47.0 [45582556]
3.1e-01
2.4e+00
3.8e+00
—
3.7e+00
4.1e-01
9.1e-01
cases:4.16%
controls:3.09%
cases:9.40%
controls:0.97%
cases:5.31%
controls:0.12%
—
—
cases:3.85%
controls:0.10%
cases:1.52%
controls:1.01%
cases:8.04%
controls:3.39%
119
872
2742
27393
269
275
2592
27990
152
34
2709
28231
—
110
28
2750
28218
43
283
2785
27603
214
885
2448
25205
labetalol; oral, parenteral
C07AG01 [21601699]
C07AG01 [21601699]
8.0e-01
1.4e+00
3.7e+00
1.0e+50
3.4e+00
1.5e+00
-6.9e-02
cases:1.12%
controls:0.51%
cases:0.77%
controls:0.19%
cases:0.87%
controls:0.02%
cases:0.21%
controls:0.00%
cases:1.43%
controls:0.05%
cases:1.10%
controls:0.26%
cases:0.83%
controls:0.89%
32
143
2829
28122
22
55
2839
28210
25
6
2836
28259
6
0
2855
28265
41
14
2819
28232
31
72
2797
27814
22
231
2640
25859
Planned health check-up monitoring, health check-up performed based on individual need
SPAT1317 [2001700418]
SPAT1317 [2001700418]
3.6e-01
2.0e+00
3.1e+00
—
2.9e+00
1.3e+00
8.7e-01
cases:4.09%
controls:2.88%
cases:5.49%
controls:0.82%
cases:2.10%
controls:0.10%
—
—
cases:1.64%
controls:0.09%
cases:2.79%
controls:0.80%
cases:5.97%
controls:2.59%
117
815
2744
27450
157
231
2704
28034
60
28
2801
28237
—
47
25
2813
28221
79
224
2749
27662
159
675
2503
25415
Antenatal screening for malformation
717800004 [36713462]
717800004 [36713462]
2.3e-01
3.0e+00
6.8e-01
3.6e+00
2.2e+00
-1.4e-01
7.1e-01
cases:13.67%
controls:11.21%
cases:47.54%
controls:4.46%
cases:1.22%
controls:0.63%
cases:1.05%
controls:0.03%
cases:5.87%
controls:0.72%
cases:3.93%
controls:4.50%
cases:24.68%
controls:13.89%
391
3169
2470
25096
1360
1261
1501
27004
35
177
2826
28088
30
8
2831
28257
168
203
2692
28043
111
1255
2717
26631
657
3625
2005
22465
azathioprine; oral, parenteral
L04AX01 [21603927]
L04AX01 [21603927]
1.5e+00
1.8e+00
1.9e+00
—
2.1e+00
1.7e+00
1.3e+00
cases:1.85%
controls:0.42%
cases:1.71%
controls:0.29%
cases:0.45%
controls:0.07%
—
—
cases:0.66%
controls:0.08%
cases:1.56%
controls:0.30%
cases:1.95%
controls:0.52%
53
119
2808
28146
49
82
2812
28183
13
19
2848
28246
—
19
24
2841
28222
44
84
2784
27802
52
135
2610
25955
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
-9.5e-02
8.2e-02
2.3e+00
4.0e+00
2.5e+00
8.6e-01
5.0e-01
cases:2.80%
controls:3.07%
cases:1.50%
controls:1.39%
cases:1.75%
controls:0.17%
cases:0.98%
controls:0.02%
cases:2.27%
controls:0.19%
cases:3.04%
controls:1.31%
cases:6.76%
controls:4.22%
80
867
2781
27398
43
392
2818
27873
50
49
2811
28216
28
5
2833
28260
65
55
2795
28191
86
364
2742
27522
180
1100
2482
24990
Gestational [pregnancy-induced] hypertension
O13 [45539091]
O13 [45539091]
3.6e-01
4.9e-01
3.9e+00
1.0e+50
4.9e+00
1.3e+00
3.5e-01
cases:1.89%
controls:1.33%
cases:0.59%
controls:0.36%
cases:2.13%
controls:0.04%
cases:3.46%
controls:0.00%
cases:4.23%
controls:0.03%
cases:1.56%
controls:0.43%
cases:2.18%
controls:1.54%
54
375
2807
27890
17
103
2844
28162
61
12
2800
28253
99
0
2762
28265
121
9
2739
28237
44
121
2784
27765
58
403
2604
25687
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
O99.2 [45534321]
O99.2 [45534321]
-1.9e-01
2.1e+00
3.1e+00
1.0e+50
3.7e+00
1.2e+00
4.8e-01
cases:0.38%
controls:0.46%
cases:1.33%
controls:0.16%
cases:0.87%
controls:0.04%
cases:0.87%
controls:0.00%
cases:1.26%
controls:0.03%
cases:0.67%
controls:0.20%
cases:1.13%
controls:0.70%
11
131
2850
28134
38
46
2823
28219
25
11
2836
28254
25
0
2836
28265
36
9
2824
28237
19
56
2809
27830
30
182
2632
25908
Supervision of pregnancy with history of infertility
Z35.0 [45600322]
Z35.0 [45600322]
7.4e-01
2.8e+00
3.4e+00
—
3.1e+00
3.4e-01
4.9e-02
cases:1.29%
controls:0.62%
cases:3.70%
controls:0.23%
cases:0.77%
controls:0.02%
—
—
cases:0.45%
controls:0.02%
cases:0.39%
controls:0.28%
cases:0.90%
controls:0.86%
37
176
2824
28089
106
64
2755
28201
22
7
2839
28258
—
13
6
2847
28240
11
77
2817
27809
24
224
2638
25866
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
1.0e-01
1.6e+00
2.1e+00
3.9e+00
2.0e+00
1.4e-01
3.8e-01
cases:11.08%
controls:10.09%
cases:19.92%
controls:4.69%
cases:5.42%
controls:0.67%
cases:1.19%
controls:0.02%
cases:4.37%
controls:0.63%
cases:5.16%
controls:4.53%
cases:16.87%
controls:12.17%
317
2853
2544
25412
570
1326
2291
26939
155
188
2706
28077
34
7
2827
28258
125
178
2735
28068
146
1263
2682
26623
449
3174
2213
22916
General examination of pregnant woman
XMA22 [2001306916]
XMA22 [2001306916]
2.0e-02
1.6e+00
3.4e+00
—
3.8e+00
6.9e-01
4.7e-01
cases:2.10%
controls:2.06%
cases:3.39%
controls:0.70%
cases:2.87%
controls:0.10%
—
—
cases:4.09%
controls:0.09%
cases:1.49%
controls:0.75%
cases:4.58%
controls:2.92%
60
581
2801
27684
97
197
2764
28068
82
28
2779
28237
—
117
26
2743
28220
42
209
2786
27677
122
763
2540
25327
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
1.2e-01
1.5e+00
2.0e+00
4.2e+00
1.9e+00
1.1e-01
3.5e-01
cases:10.94%
controls:9.85%
cases:18.21%
controls:4.79%
cases:5.14%
controls:0.71%
cases:1.19%
controls:0.02%
cases:4.20%
controls:0.67%
cases:5.16%
controls:4.65%
cases:16.45%
controls:12.16%
313
2783
2548
25482
521
1355
2340
26910
147
200
2714
28065
34
5
2827
28260
120
188
2740
28058
146
1297
2682
26589
438
3172
2224
22918
Personal history of complications of pregnancy, childbirth and the puerperium
Z87.5 [45600366]
Z87.5 [45600366]
3.1e-01
1.6e+00
3.4e+00
1.0e+50
3.2e+00
1.4e+00
1.7e+00
cases:0.28%
controls:0.21%
cases:0.45%
controls:0.09%
cases:0.52%
controls:0.02%
cases:0.49%
controls:0.00%
cases:0.59%
controls:0.02%
cases:0.28%
controls:0.07%
cases:1.20%
controls:0.21%
8
58
2853
28207
13
26
2848
28239
15
5
2846
28260
14
0
2847
28265
17
7
2843
28239
8
19
2820
27867
32
56
2630
26034
Treatment-related counselling outside office
SPAT1249 [2001700350]
SPAT1249 [2001700350]
2.3e-02
1.1e+00
2.1e+00
4.2e+00
1.6e+00
4.3e-01
3.9e-01
cases:6.64%
controls:6.50%
cases:7.55%
controls:2.64%
cases:3.29%
controls:0.44%
cases:1.15%
controls:0.02%
cases:1.82%
controls:0.37%
cases:3.61%
controls:2.37%
cases:9.50%
controls:6.63%
190
1837
2671
26428
216
747
2645
27518
94
123
2767
28142
33
5
2828
28260
52
104
2808
28142
102
660
2726
27226
253
1729
2409
24361
Other abnormal findings on antenatal screening of mother
O28.8 [45548729]
O28.8 [45548729]
4.8e-01
1.5e+00
3.2e+00
—
3.9e+00
8.4e-01
1.0e+00
cases:0.52%
controls:0.33%
cases:0.52%
controls:0.12%
cases:0.45%
controls:0.02%
—
—
cases:0.91%
controls:0.02%
cases:0.28%
controls:0.12%
cases:0.98%
controls:0.36%
15
92
2846
28173
15
34
2846
28231
13
5
2848
28260
—
26
5
2834
28241
8
34
2820
27852
26
94
2636
25996
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
3.8e-01
1.4e+00
2.9e+00
—
3.2e+00
9.4e-01
8.2e-01
cases:5.42%
controls:3.76%
cases:4.30%
controls:1.14%
cases:3.70%
controls:0.21%
—
—
cases:4.86%
controls:0.20%
cases:3.01%
controls:1.19%
cases:7.18%
controls:3.29%
155
1064
2706
27201
123
321
2738
27944
106
60
2755
28205
—
139
57
2721
28189
85
332
2743
27554
191
858
2471
25232
Maternal care for other (suspected) fetal abnormality and damage
O35.8 [45572816]
O35.8 [45572816]
3.6e-02
2.1e+00
3.2e+00
1.0e+50
3.4e+00
8.0e-01
7.9e-01
cases:0.52%
controls:0.51%
cases:1.47%
controls:0.17%
cases:0.52%
controls:0.02%
cases:0.38%
controls:0.00%
cases:0.66%
controls:0.02%
cases:0.32%
controls:0.14%
cases:1.24%
controls:0.57%
15
143
2846
28122
42
49
2819
28216
15
6
2846
28259
11
0
2850
28265
19
6
2841
28240
9
40
2819
27846
33
148
2629
25942
Maternal care due to uterine scar from previous surgery
O34.2 [45572805]
O34.2 [45572805]
-6.3e-01
1.1e+00
2.8e+00
—
3.5e+00
9.4e-01
1.2e+00
cases:0.84%
controls:1.57%
cases:1.92%
controls:0.65%
cases:2.10%
controls:0.12%
—
—
cases:4.34%
controls:0.14%
cases:1.77%
controls:0.70%
cases:8.30%
controls:2.63%
24
443
2837
27822
55
184
2806
28081
60
35
2801
28230
—
124
39
2736
28207
50
194
2778
27692
221
685
2441
25405
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
O99.89 [2000503220]
O99.89 [2000503220]
7.5e-01
2.7e+00
3.8e+00
—
—
1.3e+00
1.1e+00
cases:0.87%
controls:0.41%
cases:1.61%
controls:0.11%
cases:0.91%
controls:0.02%
—
—
—
—
cases:0.60%
controls:0.16%
cases:1.54%
controls:0.52%
25
117
2836
28148
46
32
2815
28233
26
6
2835
28259
—
—
17
46
2811
27840
41
136
2621
25954
Twin pregnancy with separate amniotic and chorionic sacs
O30.00 [2000503212]
O30.00 [2000503212]
—
3.6e+00
3.9e+00
1.0e+50
—
2.0e+00
9.6e-01
—
—
cases:1.01%
controls:0.03%
cases:1.01%
controls:0.02%
cases:0.87%
controls:0.00%
—
—
cases:0.25%
controls:0.03%
cases:0.30%
controls:0.11%
—
29
8
2832
28257
29
6
2832
28259
25
0
2836
28265
—
7
9
2821
27877
8
30
2654
26060
Supervision of high-risk pregnancy, unspecified
Z35.9 [45576148]
Z35.9 [45576148]
3.2e-02
2.0e+00
3.3e+00
1.0e+50
3.1e+00
3.0e-01
1.0e+00
cases:0.73%
controls:0.71%
cases:2.31%
controls:0.31%
cases:1.57%
controls:0.06%
cases:0.56%
controls:0.00%
cases:1.47%
controls:0.07%
cases:0.50%
controls:0.37%
cases:2.74%
controls:1.02%
21
201
2840
28064
66
87
2795
28178
45
16
2816
28249
16
0
2845
28265
42
19
2818
28227
14
102
2814
27784
73
266
2589
25824
Exhaustion and fatigue pregnancy-related
O26.82 [2000503207]
O26.82 [2000503207]
2.2e-01
2.0e+00
2.9e+00
1.0e+50
3.5e+00
9.8e-01
1.1e+00
cases:0.56%
controls:0.45%
cases:1.26%
controls:0.17%
cases:0.49%
controls:0.03%
cases:0.21%
controls:0.00%
cases:0.56%
controls:0.02%
cases:0.39%
controls:0.15%
cases:1.65%
controls:0.56%
16
127
2845
28138
36
47
2825
28218
14
8
2847
28257
6
0
2855
28265
16
5
2844
28241
11
41
2817
27845
44
147
2618
25943
Supervision of normal pregnancy, unspecified
Z34.9 [45566420]
Z34.9 [45566420]
3.7e-01
1.6e+00
3.7e+00
—
3.1e+00
1.7e-01
7.0e-01
cases:5.52%
controls:3.88%
cases:6.15%
controls:1.33%
cases:5.91%
controls:0.16%
—
—
cases:4.09%
controls:0.19%
cases:1.56%
controls:1.32%
cases:7.96%
controls:4.10%
158
1096
2703
27169
176
375
2685
27890
169
46
2692
28219
—
117
54
2743
28192
44
368
2784
27518
212
1070
2450
25020
Anaemia complicating pregnancy, childbirth and the puerperium
O99.0 [45587397]
O99.0 [45587397]
2.8e-01
1.9e+00
3.3e+00
—
2.9e+00
5.3e-01
1.1e+00
cases:0.28%
controls:0.21%
cases:0.42%
controls:0.06%
cases:0.49%
controls:0.02%
—
—
cases:0.45%
controls:0.02%
cases:0.18%
controls:0.10%
cases:0.83%
controls:0.28%
8
60
2853
28205
12
17
2849
28248
14
5
2847
28260
—
13
7
2847
28239
5
29
2823
27857
22
74
2640
26016
Maternal and Fetal Medicine
OMOP4821963 [45756780]
OMOP4821963 [45756780]
-7.9e-02
1.5e+00
2.9e+00
—
3.5e+00
9.2e-01
3.3e-01
cases:2.87%
controls:3.10%
cases:6.22%
controls:1.41%
cases:4.86%
controls:0.28%
—
—
cases:7.45%
controls:0.24%
cases:3.25%
controls:1.32%
cases:5.52%
controls:4.03%
82
875
2779
27390
178
398
2683
27867
139
79
2722
28186
—
213
68
2647
28178
92
367
2736
27519
147
1051
2515
25039
Midwife
Z3232 [2001311563]
Z3232 [2001311563]
3.2e-01
2.3e+00
2.5e+00
—
2.8e+00
6.1e-01
9.4e-01
cases:3.67%
controls:2.68%
cases:8.74%
controls:0.92%
cases:1.43%
controls:0.12%
—
—
cases:2.17%
controls:0.13%
cases:1.52%
controls:0.84%
cases:6.39%
controls:2.61%
105
758
2756
27507
250
261
2611
28004
41
33
2820
28232
—
62
38
2798
28208
43
233
2785
27653
170
680
2492
25410
Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium
O10.0 [45601777]
O10.0 [45601777]
-1.3e-01
2.2e+00
3.5e+00
1.0e+50
3.5e+00
1.1e+00
3.5e-01
cases:0.35%
controls:0.40%
cases:1.08%
controls:0.13%
cases:1.01%
controls:0.03%
cases:0.77%
controls:0.00%
cases:0.94%
controls:0.03%
cases:0.39%
controls:0.14%
cases:0.71%
controls:0.50%
10
113
2851
28152
31
36
2830
28229
29
9
2832
28256
22
0
2839
28265
27
8
2833
28238
11
38
2817
27848
19
131
2643
25959
Monitoring of normal pregnancy
SPAT1196 [2001700297]
SPAT1196 [2001700297]
2.1e-02
1.9e+00
2.8e+00
—
2.7e+00
1.6e+00
2.8e-01
cases:2.52%
controls:2.47%
cases:5.98%
controls:0.91%
cases:4.72%
controls:0.30%
—
—
cases:4.27%
controls:0.31%
cases:4.60%
controls:0.95%
cases:3.76%
controls:2.87%
72
697
2789
27568
171
256
2690
28009
135
86
2726
28179
—
122
88
2738
28158
130
265
2698
27621
100
748
2562
25342
Monitoring of problem during pregnancy
SPAT1357 [2001700458]
SPAT1357 [2001700458]
-1.7e-01
1.9e+00
3.9e+00
1.0e+50
3.1e+00
4.4e-01
3.5e-01
cases:0.66%
controls:0.79%
cases:1.57%
controls:0.23%
cases:1.01%
controls:0.02%
cases:0.31%
controls:0.00%
cases:0.70%
controls:0.03%
cases:0.32%
controls:0.20%
cases:1.24%
controls:0.88%
19
223
2842
28042
45
65
2816
28200
29
6
2832
28259
9
0
2852
28265
20
9
2840
28237
9
57
2819
27829
33
229
2629
25861
Maternal care for excessive fetal growth
O36.6 [45543983]
O36.6 [45543983]
1.5e-02
4.4e-01
3.3e+00
1.0e+50
4.1e+00
8.9e-01
5.5e-01
cases:1.33%
controls:1.31%
cases:0.70%
controls:0.45%
cases:1.57%
controls:0.06%
cases:1.71%
controls:0.00%
cases:3.36%
controls:0.06%
cases:1.03%
controls:0.42%
cases:2.74%
controls:1.61%
38
370
2823
27895
20
128
2841
28137
45
16
2816
28249
49
0
2812
28265
96
16
2764
28230
29
118
2799
27768
73
419
2589
25671
Supervision of other normal pregnancy
Z34.8 [45537628]
Z34.8 [45537628]
-2.4e-02
1.8e+00
3.2e+00
—
2.9e+00
2.1e-01
9.4e-01
cases:5.14%
controls:5.26%
cases:10.80%
controls:1.98%
cases:7.03%
controls:0.30%
—
—
cases:5.63%
controls:0.33%
cases:2.62%
controls:2.13%
cases:16.12%
controls:6.99%
147
1486
2714
26779
309
559
2552
27706
201
86
2660
28179
—
161
93
2699
28153
74
595
2754
27291
429
1823
2233
24267
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
16128-1 [3017143]
4.2e-01
1.1e+00
3.1e+00
1.0e+50
3.7e+00
-4.3e-01
5.2e-01
cases:4.09%
controls:2.73%
cases:2.90%
controls:1.00%
cases:1.75%
controls:0.08%
cases:1.78%
controls:0.00%
cases:3.78%
controls:0.10%
cases:0.53%
controls:0.81%
cases:4.40%
controls:2.65%
117
772
2744
27493
83
283
2778
27982
50
23
2811
28242
51
0
2810
28265
108
28
2752
28218
15
226
2813
27660
117
691
2545
25399
Detailed morfological ultrasound examination of fetus
MA2HE [2001306836]
MA2HE [2001306836]
1.9e-01
2.7e+00
2.7e+00
—
2.7e+00
-1.8e-02
6.7e-01
cases:8.11%
controls:6.80%
cases:24.08%
controls:2.09%
cases:3.01%
controls:0.21%
—
—
cases:4.20%
controls:0.29%
cases:2.16%
controls:2.19%
cases:14.20%
controls:7.84%
232
1921
2629
26344
689
590
2172
27675
86
59
2775
28206
—
120
82
2740
28164
61
612
2767
27274
378
2045
2284
24045
Telehealth
OMOP5556618 [722455]
OMOP5556618 [722455]
-8.3e-02
8.0e-01
1.9e+00
4.1e+00
1.4e+00
2.6e-01
1.9e-01
cases:15.73%
controls:16.85%
cases:13.95%
controls:6.79%
cases:7.41%
controls:1.19%
cases:2.55%
controls:0.04%
cases:4.69%
controls:1.18%
cases:8.56%
controls:6.71%
cases:18.93%
controls:16.22%
450
4764
2411
23501
399
1919
2462
26346
212
337
2649
27928
73
12
2788
28253
134
333
2726
27913
242
1872
2586
26014
504
4233
2158
21857
Pregnancy symptom/complaint other
W29 [2002001222]
W29 [2002001222]
3.2e-01
2.5e+00
3.6e+00
—
2.6e+00
3.7e-02
5.5e-01
cases:1.08%
controls:0.79%
cases:3.46%
controls:0.28%
cases:1.71%
controls:0.05%
—
—
cases:0.45%
controls:0.04%
cases:0.28%
controls:0.27%
cases:1.54%
controls:0.90%
31
224
2830
28041
99
79
2762
28186
49
14
2812
28251
—
13
10
2847
28236
8
76
2820
27810
41
234
2621
25856
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
6.7e-02
4.5e-01
1.6e+00
4.5e+00
2.1e+00
1.7e-01
1.3e-01
cases:16.88%
controls:15.96%
cases:14.99%
controls:10.11%
cases:7.13%
controls:1.60%
cases:4.30%
controls:0.05%
cases:11.68%
controls:1.55%
cases:11.56%
controls:9.94%
cases:24.42%
controls:22.17%
483
4511
2378
23754
429
2859
2432
25406
204
453
2657
27812
123
14
2738
28251
334
437
2526
27809
327
2773
2501
25113
650
5785
2012
20305
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
-7.2e-02
4.5e-01
1.1e+00
4.0e+00
2.0e+00
4.2e-01
4.5e-01
cases:4.19%
controls:4.49%
cases:4.79%
controls:3.11%
cases:2.10%
controls:0.73%
cases:1.75%
controls:0.03%
cases:4.09%
controls:0.57%
cases:4.49%
controls:2.99%
cases:8.90%
controls:5.86%
120
1270
2741
26995
137
879
2724
27386
60
207
2801
28058
50
9
2811
28256
117
162
2743
28084
127
834
2701
27052
237
1528
2425
24562
Other obstetric ultrasound examination
MA2XE [2001306838]
MA2XE [2001306838]
3.3e-01
2.2e+00
2.9e+00
—
2.8e+00
5.3e-01
5.3e-01
cases:2.69%
controls:1.95%
cases:5.77%
controls:0.71%
cases:1.96%
controls:0.11%
—
—
cases:2.20%
controls:0.14%
cases:1.13%
controls:0.67%
cases:4.66%
controls:2.79%
77
550
2784
27715
165
200
2696
28065
56
31
2805
28234
—
63
39
2797
28207
32
187
2796
27699
124
729
2538
25361
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
-1.1e-02
4.7e-01
1.4e+00
4.4e+00
2.1e+00
2.0e-01
1.3e-01
cases:12.69%
controls:12.81%
cases:13.81%
controls:9.13%
cases:7.13%
controls:1.87%
cases:5.35%
controls:0.07%
cases:12.97%
controls:1.81%
cases:11.07%
controls:9.22%
cases:20.70%
controls:18.59%
363
3620
2498
24645
395
2581
2466
25684
204
529
2657
27736
153
20
2708
28245
371
511
2489
27735
313
2570
2515
25316
551
4849
2111
21241
Supervision of pregnancy with other poor reproductive or obstetric history
Z35.2 [45585822]
Z35.2 [45585822]
-6.7e-01
2.0e+00
2.5e+00
1.0e+50
2.9e+00
7.8e-01
9.3e-01
cases:0.24%
controls:0.48%
cases:1.36%
controls:0.19%
cases:0.38%
controls:0.03%
cases:0.42%
controls:0.00%
cases:0.56%
controls:0.03%
cases:0.39%
controls:0.18%
cases:1.77%
controls:0.70%
7
135
2854
28130
39
53
2822
28212
11
9
2850
28256
12
0
2849
28265
16
9
2844
28237
11
50
2817
27836
47
183
2615
25907
Examination and observation for other specified reasons
Z04.8 [45552063]
Z04.8 [45552063]
3.8e-02
8.9e-01
1.9e+00
—
3.9e+00
9.6e-01
5.9e-01
cases:1.01%
controls:0.98%
cases:0.63%
controls:0.26%
cases:0.28%
controls:0.04%
—
—
cases:1.22%
controls:0.02%
cases:0.81%
controls:0.31%
cases:1.99%
controls:1.12%
29
276
2832
27989
18
73
2843
28192
8
12
2853
28253
—
35
7
2825
28239
23
87
2805
27799
53
291
2609
25799
Maternal care for breech presentation
O32.1 [45606580]
O32.1 [45606580]
1.3e-01
1.7e-01
3.3e+00
1.0e+50
3.9e+00
1.0e+00
3.1e-01
cases:1.33%
controls:1.17%
cases:0.42%
controls:0.35%
cases:1.26%
controls:0.05%
cases:1.54%
controls:0.00%
cases:2.38%
controls:0.05%
cases:1.06%
controls:0.39%
cases:1.88%
controls:1.39%
38
330
2823
27935
12
100
2849
28165
36
13
2825
28252
44
0
2817
28265
68
14
2792
28232
30
109
2798
27777
50
362
2612
25728
Microorganisms panel - Urine sediment
58435-9 [40761536]
58435-9 [40761536]
3.6e-01
1.7e+00
2.8e+00
—
2.8e+00
6.1e-01
8.4e-01
cases:1.89%
controls:1.33%
cases:2.69%
controls:0.51%
cases:0.84%
controls:0.05%
—
—
cases:0.73%
controls:0.05%
cases:0.92%
controls:0.50%
cases:2.63%
controls:1.15%
54
375
2807
27890
77
143
2784
28122
24
14
2837
28251
—
21
13
2839
28233
26
140
2802
27746
70
301
2592
25789
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
14804-9 [3022250]
2.6e-01
4.7e-01
2.6e+00
—
4.5e+00
1.1e+00
4.6e-01
cases:0.66%
controls:0.51%
cases:0.35%
controls:0.22%
cases:0.52%
controls:0.04%
—
—
cases:2.13%
controls:0.02%
cases:0.57%
controls:0.20%
cases:1.09%
controls:0.69%
19
145
2842
28120
10
62
2851
28203
15
11
2846
28254
—
61
7
2799
28239
16
55
2812
27831
29
180
2633
25910
Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.
SPAT1399 [2001700499]
SPAT1399 [2001700499]
3.2e-01
2.3e+00
3.1e+00
—
2.8e+00
—
4.4e-01
cases:2.06%
controls:1.51%
cases:3.43%
controls:0.36%
cases:1.05%
controls:0.05%
—
—
cases:0.45%
controls:0.03%
—
—
cases:1.73%
controls:1.12%
59
427
2802
27838
98
103
2763
28162
30
14
2831
28251
—
13
8
2847
28238
—
46
293
2616
25797
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
4.1e-03
4.1e-01
1.4e+00
4.2e+00
2.0e+00
1.2e-01
9.4e-02
cases:18.70%
controls:18.64%
cases:19.78%
controls:14.01%
cases:10.49%
controls:2.76%
cases:6.85%
controls:0.11%
cases:17.38%
controls:2.67%
cases:15.74%
controls:14.22%
cases:29.04%
controls:27.14%
535
5268
2326
22997
566
3959
2295
24306
300
780
2561
27485
196
31
2665
28234
497
755
2363
27491
445
3966
2383
23920
773
7081
1889
19009
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
5.0e-03
4.1e-01
1.4e+00
4.2e+00
2.0e+00
1.2e-01
9.7e-02
cases:18.70%
controls:18.62%
cases:19.78%
controls:14.02%
cases:10.49%
controls:2.76%
cases:6.85%
controls:0.11%
cases:17.38%
controls:2.68%
cases:15.74%
controls:14.22%
cases:29.08%
controls:27.12%
535
5264
2326
23001
566
3963
2295
24302
300
780
2561
27485
196
31
2665
28234
497
756
2363
27490
445
3965
2383
23921
774
7076
1888
19014
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
8.3e-03
4.1e-01
1.4e+00
4.2e+00
2.0e+00
1.2e-01
9.4e-02
cases:18.70%
controls:18.57%
cases:19.71%
controls:14.01%
cases:10.49%
controls:2.76%
cases:6.85%
controls:0.11%
cases:17.38%
controls:2.67%
cases:15.70%
controls:14.19%
cases:29.00%
controls:27.11%
535
5250
2326
23015
564
3959
2297
24306
300
779
2561
27486
196
31
2665
28234
497
755
2363
27491
444
3956
2384
23930
772
7072
1890
19018
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
4.1e-03
4.1e-01
1.4e+00
4.2e+00
2.0e+00
1.2e-01
9.6e-02
cases:18.70%
controls:18.64%
cases:19.78%
controls:14.03%
cases:10.49%
controls:2.77%
cases:6.85%
controls:0.11%
cases:17.38%
controls:2.68%
cases:15.74%
controls:14.24%
cases:29.08%
controls:27.14%
535
5268
2326
22997
566
3965
2295
24300
300
782
2561
27483
196
31
2665
28234
497
757
2363
27489
445
3971
2383
23915
774
7082
1888
19008
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
4.3e-03
4.1e-01
1.4e+00
4.2e+00
2.0e+00
1.2e-01
9.5e-02
cases:18.70%
controls:18.63%
cases:19.78%
controls:14.02%
cases:10.49%
controls:2.77%
cases:6.85%
controls:0.11%
cases:17.34%
controls:2.68%
cases:15.74%
controls:14.24%
cases:29.08%
controls:27.16%
535
5267
2326
22998
566
3964
2295
24301
300
782
2561
27483
196
31
2665
28234
496
757
2364
27489
445
3972
2383
23914
774
7085
1888
19005
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
2.4e-03
4.3e-01
1.4e+00
4.2e+00
2.0e+00
1.2e-01
9.0e-02
cases:18.73%
controls:18.70%
cases:20.10%
controls:14.05%
cases:10.56%
controls:2.77%
cases:6.85%
controls:0.11%
cases:17.41%
controls:2.68%
cases:15.77%
controls:14.28%
cases:29.04%
controls:27.23%
536
5285
2325
22980
575
3972
2286
24293
302
784
2559
27481
196
32
2665
28233
498
757
2362
27489
446
3983
2382
23903
773
7104
1889
18986
Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
584-3 [3020321]
584-3 [3020321]
1.1e-01
3.2e-01
3.9e+00
1.0e+50
3.3e+00
2.2e-01
7.5e-01
cases:2.27%
controls:2.05%
cases:0.98%
controls:0.71%
cases:4.51%
controls:0.09%
cases:0.56%
controls:0.00%
cases:2.48%
controls:0.09%
cases:0.92%
controls:0.74%
cases:4.58%
controls:2.22%
65
579
2796
27686
28
202
2833
28063
129
26
2732
28239
16
0
2845
28265
71
26
2789
28220
26
206
2802
27680
122
580
2540
25510
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
1.1e-02
4.1e-01
1.4e+00
4.1e+00
2.0e+00
1.2e-01
9.9e-02
cases:18.80%
controls:18.64%
cases:19.78%
controls:14.06%
cases:10.52%
controls:2.79%
cases:6.85%
controls:0.12%
cases:17.38%
controls:2.70%
cases:15.81%
controls:14.25%
cases:29.19%
controls:27.19%
538
5269
2323
22996
566
3973
2295
24292
301
789
2560
27476
196
33
2665
28232
497
762
2363
27484
447
3975
2381
23911
777
7094
1885
18996
Antenatal classes
SPAT1195 [2001700296]
SPAT1195 [2001700296]
3.1e-01
1.9e+00
3.7e+00
—
2.4e+00
6.8e-01
—
cases:1.33%
controls:0.97%
cases:1.82%
controls:0.28%
cases:1.64%
controls:0.04%
—
—
cases:0.42%
controls:0.04%
cases:0.46%
controls:0.23%
—
—
38
275
2823
27990
52
79
2809
28186
47
12
2814
28253
—
12
11
2848
28235
13
65
2815
27821
—
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
2.2e-02
9.7e-01
2.3e+00
—
3.5e+00
1.1e+00
2.3e-01
cases:1.68%
controls:1.64%
cases:1.47%
controls:0.56%
cases:0.94%
controls:0.09%
—
—
cases:2.69%
controls:0.08%
cases:1.87%
controls:0.61%
cases:2.97%
controls:2.36%
48
464
2813
27801
42
159
2819
28106
27
26
2834
28239
—
77
24
2783
28222
53
171
2775
27715
79
616
2583
25474
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5195-3 [3019284]
3.0e-01
2.3e+00
2.0e+00
—
2.8e+00
-1.8e-01
5.8e-01
cases:8.60%
controls:6.49%
cases:21.32%
controls:2.61%
cases:1.82%
controls:0.26%
—
—
cases:3.50%
controls:0.23%
cases:1.87%
controls:2.23%
cases:12.25%
controls:7.27%
246
1835
2615
26430
610
739
2251
27526
52
73
2809
28192
—
100
65
2760
28181
53
622
2775
27264
326
1898
2336
24192
False labour, unspecified
O47.9 [45597011]
O47.9 [45597011]
-3.0e-02
1.7e+00
3.1e+00
—
3.1e+00
—
5.8e-01
cases:0.38%
controls:0.40%
cases:0.91%
controls:0.16%
cases:0.63%
controls:0.03%
—
—
cases:0.52%
controls:0.02%
—
—
cases:0.75%
controls:0.42%
11
112
2850
28153
26
46
2835
28219
18
8
2843
28257
—
15
7
2845
28239
—
20
110
2642
25980
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
29760-6 [3005772]
-1.9e-01
6.7e-01
2.1e+00
—
3.1e+00
1.6e+00
1.0e+00
cases:0.63%
controls:0.76%
cases:0.52%
controls:0.27%
cases:0.42%
controls:0.05%
—
—
cases:0.98%
controls:0.05%
cases:1.17%
controls:0.23%
cases:2.40%
controls:0.90%
18
214
2843
28051
15
76
2846
28189
12
15
2849
28250
—
28
13
2832
28233
33
65
2795
27821
64
234
2598
25856
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
O99.6 [45572910]
O99.6 [45572910]
8.7e-01
3.4e+00
—
1.0e+50
—
2.2e+00
2.2e+00
cases:0.42%
controls:0.18%
cases:1.22%
controls:0.04%
—
—
cases:0.94%
controls:0.00%
—
—
cases:0.57%
controls:0.06%
cases:1.24%
controls:0.14%
12
50
2849
28215
35
12
2826
28253
—
27
0
2834
28265
—
16
18
2812
27868
33
37
2629
26053
Supervision of high-risk pregnancy
Z35 [45756076]
Z35 [45756076]
—
1.8e+00
2.8e+00
—
—
1.5e+00
1.5e+00
—
—
cases:0.49%
controls:0.08%
cases:0.35%
controls:0.02%
—
—
—
—
cases:0.32%
controls:0.07%
cases:1.09%
controls:0.24%
—
14
24
2847
28241
10
6
2851
28259
—
—
9
20
2819
27866
29
63
2633
26027
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
6.9e-03
6.1e-02
1.4e+00
3.5e+00
1.6e+00
5.8e-01
4.6e-01
cases:6.64%
controls:6.60%
cases:4.02%
controls:3.79%
cases:2.38%
controls:0.60%
cases:0.91%
controls:0.03%
cases:2.76%
controls:0.57%
cases:6.33%
controls:3.63%
cases:13.64%
controls:9.03%
190
1865
2671
26400
115
1071
2746
27194
68
169
2793
28096
26
8
2835
28257
79
161
2781
28085
179
1013
2649
26873
363
2355
2299
23735
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
-2.1e-02
3.2e-01
1.5e+00
4.0e+00
1.5e+00
1.3e-01
4.2e-02
cases:21.99%
controls:22.35%
cases:26.53%
controls:20.71%
cases:23.80%
controls:6.22%
cases:13.70%
controls:0.30%
cases:22.52%
controls:5.92%
cases:23.30%
controls:21.07%
cases:32.57%
controls:31.65%
629
6318
2232
21947
759
5854
2102
22411
681
1758
2180
26507
392
85
2469
28180
644
1673
2216
26573
659
5876
2169
22010
867
8258
1795
17832
Calculus of gallbladder without cholecystitis
K80.2 [45552951]
K80.2 [45552951]
9.3e-01
6.5e-01
1.5e+00
—
2.4e+00
2.4e+00
1.6e+00
cases:1.43%
controls:0.57%
cases:0.38%
controls:0.20%
cases:0.17%
controls:0.04%
—
—
cases:0.42%
controls:0.04%
cases:1.87%
controls:0.16%
cases:4.06%
controls:0.85%
41
162
2820
28103
11
57
2850
28208
5
11
2856
28254
—
12
11
2848
28235
53
46
2775
27840
108
222
2554
25868
hydroxyzine; oral, parenteral
N05BB01 [21604590]
N05BB01 [21604590]
2.3e-01
-2.9e-01
3.0e+00
—
3.5e+00
-5.7e-01
7.3e-01
cases:2.17%
controls:1.73%
cases:0.45%
controls:0.61%
cases:1.75%
controls:0.08%
—
—
cases:3.43%
controls:0.11%
cases:0.39%
controls:0.69%
cases:3.83%
controls:1.89%
62
490
2799
27775
13
172
2848
28093
50
24
2811
28241
—
98
31
2762
28215
11
192
2817
27694
102
492
2560
25598
Diabetes mellitus in pregnancy, unspecified
O24.9 [45539107]
O24.9 [45539107]
-3.2e-01
6.3e-01
3.4e+00
1.0e+50
3.8e+00
6.2e-01
4.4e-02
cases:0.45%
controls:0.62%
cases:0.42%
controls:0.22%
cases:0.87%
controls:0.03%
cases:0.80%
controls:0.00%
cases:1.26%
controls:0.03%
cases:0.42%
controls:0.23%
cases:1.09%
controls:1.04%
13
176
2848
28089
12
63
2849
28202
25
8
2836
28257
23
0
2838
28265
36
8
2824
28238
12
64
2816
27822
29
272
2633
25818
Visit based on need for special support
SPAT1389 [2001700489]
SPAT1389 [2001700489]
-2.0e-01
1.7e+00
2.8e+00
—
2.6e+00
1.2e+00
-1.3e-01
cases:0.49%
controls:0.60%
cases:0.80%
controls:0.14%
cases:0.45%
controls:0.03%
—
—
cases:0.24%
controls:0.02%
cases:0.39%
controls:0.11%
cases:0.34%
controls:0.38%
14
169
2847
28096
23
40
2838
28225
13
8
2848
28257
—
7
5
2853
28241
11
32
2817
27854
9
100
2653
25990
Other induction or advancement of labour
MAC96 [2001306874]
MAC96 [2001306874]
-4.2e-01
-1.0e+50
-1.0e+50
1.0e+50
4.8e+00
1.6e+00
8.0e-01
cases:0.52%
controls:0.80%
cases:0.00%
controls:0.17%
cases:0.00%
controls:0.03%
cases:1.05%
controls:0.00%
cases:2.45%
controls:0.02%
cases:0.81%
controls:0.17%
cases:1.84%
controls:0.84%
15
225
2846
28040
0
49
2861
28216
0
8
2861
28257
30
0
2831
28265
70
6
2790
28240
23
47
2805
27839
49
218
2613
25872
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
-4.9e-02
2.7e-01
1.2e+00
3.9e+00
1.8e+00
-7.5e-02
4.7e-03
cases:13.63%
controls:14.22%
cases:12.48%
controls:9.85%
cases:5.94%
controls:1.86%
cases:3.95%
controls:0.08%
cases:9.97%
controls:1.81%
cases:9.26%
controls:9.92%
cases:20.89%
controls:20.81%
390
4019
2471
24246
357
2784
2504
25481
170
526
2691
27739
113
24
2748
28241
285
512
2575
27734
262
2766
2566
25120
556
5429
2106
20661
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
OMOP4821986 [45756756]
3.5e-02
1.1e+00
2.1e+00
—
2.6e+00
1.4e+00
9.4e-01
cases:0.84%
controls:0.81%
cases:0.49%
controls:0.17%
cases:0.42%
controls:0.05%
—
—
cases:0.45%
controls:0.04%
cases:0.46%
controls:0.11%
cases:0.53%
controls:0.21%
24
229
2837
28036
14
47
2847
28218
12
15
2849
28250
—
13
10
2847
28236
13
31
2815
27855
14
54
2648
26036
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
1.2e-01
1.8e+00
1.7e+00
—
3.2e+00
3.1e-01
4.5e-01
cases:6.64%
controls:5.92%
cases:14.05%
controls:2.71%
cases:1.96%
controls:0.37%
—
—
cases:6.78%
controls:0.29%
cases:3.43%
controls:2.53%
cases:10.93%
controls:7.28%
190
1672
2671
26593
402
765
2459
27500
56
104
2805
28161
—
194
83
2666
28163
97
705
2731
27181
291
1899
2371
24191
Gynecological ultrasound examination as part of clinical examination
LX1AE [2001306815]
LX1AE [2001306815]
7.0e-01
1.4e+00
1.5e+00
—
2.2e+00
9.1e-01
4.5e-01
cases:3.95%
controls:1.99%
cases:3.08%
controls:0.80%
cases:0.35%
controls:0.08%
—
—
cases:0.70%
controls:0.08%
cases:2.02%
controls:0.82%
cases:3.83%
controls:2.48%
113
563
2748
27702
88
226
2773
28039
10
23
2851
28242
—
20
22
2840
28224
57
230
2771
27656
102
648
2560
25442
Health maint/preventive medicine
A98 [2002000231]
A98 [2002000231]
4.7e-03
4.4e-01
1.4e+00
2.7e+00
1.8e+00
6.2e-01
1.4e-01
cases:22.79%
controls:22.71%
cases:21.04%
controls:14.64%
cases:10.42%
controls:2.70%
cases:1.68%
controls:0.11%
cases:14.02%
controls:2.75%
cases:25.21%
controls:15.35%
cases:34.15%
controls:31.10%
652
6418
2209
21847
602
4137
2259
24128
298
762
2563
27503
48
31
2813
28234
401
776
2459
27470
713
4280
2115
23606
909
8115
1753
17975
Supervision of normal first pregnancy
Z34.0 [45595500]
Z34.0 [45595500]
4.6e-01
2.0e+00
3.2e+00
—
2.9e+00
1.0e-02
-1.6e+00
cases:7.65%
controls:4.97%
cases:10.07%
controls:1.47%
cases:6.15%
controls:0.28%
—
—
cases:4.09%
controls:0.23%
cases:1.49%
controls:1.47%
cases:0.98%
controls:4.86%
219
1404
2642
26861
288
416
2573
27849
176
78
2685
28187
—
117
64
2743
28182
42
410
2786
27476
26
1267
2636
24823
Urine culture
117010004 [4024509]
117010004 [4024509]
—
2.2e+00
2.4e+00
—
2.3e+00
—
5.3e-01
—
—
cases:0.87%
controls:0.10%
cases:0.24%
controls:0.02%
—
—
cases:0.21%
controls:0.02%
—
—
cases:0.83%
controls:0.49%
—
25
28
2836
28237
7
6
2854
28259
—
6
6
2854
28240
—
22
127
2640
25963
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
-1.2e-01
6.9e-01
1.8e+00
2.7e+00
1.7e+00
1.5e-01
1.7e-01
cases:6.05%
controls:6.79%
cases:4.02%
controls:2.06%
cases:1.78%
controls:0.29%
cases:0.42%
controls:0.03%
cases:1.92%
controls:0.36%
cases:2.37%
controls:2.05%
cases:7.66%
controls:6.56%
173
1920
2688
26345
115
581
2746
27684
51
82
2810
28183
12
8
2849
28257
55
101
2805
28145
67
571
2761
27315
204
1711
2458
24379
Pregnancy confirmed
Z32.1 [45566418]
Z32.1 [45566418]
3.7e-01
2.5e+00
1.3e+00
1.0e+50
2.0e+00
2.8e-01
6.9e-01
cases:5.03%
controls:3.53%
cases:13.46%
controls:1.26%
cases:0.56%
controls:0.15%
cases:0.35%
controls:0.00%
cases:1.15%
controls:0.15%
cases:1.66%
controls:1.26%
cases:7.66%
controls:4.00%
144
998
2717
27267
385
355
2476
27910
16
43
2845
28222
10
0
2851
28265
33
43
2827
28203
47
351
2781
27535
204
1044
2458
25046
Preterm labour and delivery
O60 [45539187]
O60 [45539187]
1.5e-01
-1.0e+50
-1.0e+50
1.0e+50
4.6e+00
1.3e+00
9.5e-01
cases:0.87%
controls:0.75%
cases:0.00%
controls:0.22%
cases:0.00%
controls:0.03%
cases:0.91%
controls:0.00%
cases:2.87%
controls:0.03%
cases:0.78%
controls:0.22%
cases:2.25%
controls:0.89%
25
213
2836
28052
0
63
2861
28202
0
9
2861
28256
26
0
2835
28265
82
8
2778
28238
22
60
2806
27826
60
231
2602
25859
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2465-3 [3005719]
2.7e-01
6.1e-01
2.2e+00
—
2.4e+00
1.3e+00
1.1e+00
cases:0.77%
controls:0.59%
cases:0.38%
controls:0.21%
cases:0.24%
controls:0.03%
—
—
cases:0.42%
controls:0.04%
cases:0.85%
controls:0.24%
cases:1.88%
controls:0.66%
22
166
2839
28099
11
59
2850
28206
7
8
2854
28257
—
12
11
2848
28235
24
66
2804
27820
50
173
2612
25917
ABO and Rh group [Type] in Blood
882-1 [3003694]
882-1 [3003694]
1.5e-01
2.2e+00
2.1e+00
—
2.0e+00
-1.1e-01
5.9e-01
cases:6.96%
controls:6.04%
cases:18.63%
controls:2.36%
cases:2.41%
controls:0.31%
—
—
cases:1.61%
controls:0.23%
cases:1.80%
controls:2.00%
cases:11.01%
controls:6.39%
199
1706
2662
26559
533
668
2328
27597
69
89
2792
28176
—
46
64
2814
28182
51
558
2777
27328
293
1668
2369
24422
Antenatal screening for fetal growth retardation
717801000 [36713463]
717801000 [36713463]
-1.2e+00
1.0e+00
2.9e+00
1.0e+50
2.9e+00
-1.4e-02
-3.4e-01
cases:0.21%
controls:0.66%
cases:0.49%
controls:0.17%
cases:0.49%
controls:0.03%
cases:0.56%
controls:0.00%
cases:0.52%
controls:0.03%
cases:0.18%
controls:0.18%
cases:0.60%
controls:0.84%
6
187
2855
28078
14
49
2847
28216
14
8
2847
28257
16
0
2845
28265
15
8
2845
28238
5
50
2823
27836
16
219
2646
25871
Obstetric epidural analgesia
WX307 [2001310797]
WX307 [2001310797]
5.7e-01
—
—
—
4.4e+00
1.2e+00
5.9e-01
cases:5.03%
controls:2.92%
—
—
—
—
—
—
cases:7.94%
controls:0.10%
cases:3.08%
controls:0.96%
cases:5.45%
controls:3.09%
144
825
2717
27440
—
—
—
227
29
2633
28217
87
268
2741
27618
145
806
2517
25284
Maternal care for poor fetal growth
O36.5 [45592238]
O36.5 [45592238]
7.9e-02
8.3e-01
3.0e+00
1.0e+50
3.8e+00
4.6e-01
4.9e-01
cases:0.77%
controls:0.71%
cases:0.42%
controls:0.18%
cases:0.91%
controls:0.05%
cases:0.94%
controls:0.00%
cases:1.36%
controls:0.03%
cases:0.32%
controls:0.20%
cases:1.39%
controls:0.86%
22
201
2839
28064
12
52
2849
28213
26
13
2835
28252
27
0
2834
28265
39
9
2821
28237
9
56
2819
27830
37
224
2625
25866
Delayed and secondary postpartum haemorrhage
O72.2 [45597026]
O72.2 [45597026]
3.9e-01
-1.0e+50
-1.0e+50
—
3.9e+00
2.8e+00
4.8e-01
cases:0.59%
controls:0.40%
cases:0.00%
controls:0.11%
cases:0.00%
controls:0.02%
—
—
cases:1.05%
controls:0.02%
cases:1.24%
controls:0.08%
cases:0.71%
controls:0.44%
17
114
2844
28151
0
30
2861
28235
0
7
2861
28258
—
30
6
2830
28240
35
21
2793
27865
19
115
2643
25975
Chronic viral hepatitis C
B18.2 [45590846]
B18.2 [45590846]
1.1e+00
1.9e+00
—
1.0e+50
1.0e+50
2.5e+00
2.2e+00
cases:0.38%
controls:0.13%
cases:0.42%
controls:0.06%
—
—
cases:0.21%
controls:0.00%
cases:0.35%
controls:0.00%
cases:0.50%
controls:0.04%
cases:0.94%
controls:0.10%
11
36
2850
28229
12
18
2849
28247
—
6
0
2855
28265
10
0
2850
28246
14
11
2814
27875
25
27
2637
26063
Bacteria identified in Urine by Culture
630-4 [3026008]
630-4 [3026008]
9.9e-03
1.4e+00
2.1e+00
—
2.6e+00
-1.5e-01
3.1e-01
cases:3.43%
controls:3.39%
cases:4.86%
controls:1.25%
cases:1.19%
controls:0.14%
—
—
cases:1.15%
controls:0.08%
cases:1.10%
controls:1.27%
cases:5.11%
controls:3.79%
98
959
2763
27306
139
353
2722
27912
34
40
2827
28225
—
33
24
2827
28222
31
354
2797
27532
136
988
2526
25102
Left sided colitis
K51.5 [45533604]
K51.5 [45533604]
1.1e+00
1.1e+00
1.9e+00
—
1.2e+00
1.0e+00
1.2e+00
cases:0.87%
controls:0.29%
cases:0.66%
controls:0.22%
cases:0.31%
controls:0.05%
—
—
cases:0.28%
controls:0.08%
cases:0.71%
controls:0.25%
cases:1.28%
controls:0.38%
25
81
2836
28184
19
61
2842
28204
9
13
2852
28252
—
8
23
2852
28223
20
70
2808
27816
34
98
2628
25992
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
14933-6 [3026493]
1.8e-01
5.4e-01
2.8e+00
1.0e+50
3.6e+00
1.9e-01
3.3e-01
cases:1.36%
controls:1.15%
cases:0.70%
controls:0.41%
cases:1.33%
controls:0.08%
cases:1.15%
controls:0.00%
cases:1.96%
controls:0.06%
cases:0.67%
controls:0.56%
cases:2.37%
controls:1.71%
39
324
2822
27941
20
115
2841
28150
38
22
2823
28243
33
0
2828
28265
56
16
2804
28230
19
155
2809
27731
63
445
2599
25645
Fetal chromosomal abnormality screening
472825005 [43020943]
472825005 [43020943]
-1.2e-01
2.5e+00
5.3e-01
—
3.2e+00
1.2e-01
6.4e-01
cases:1.57%
controls:1.78%
cases:8.46%
controls:0.73%
cases:0.17%
controls:0.10%
—
—
cases:2.10%
controls:0.09%
cases:0.81%
controls:0.72%
cases:4.43%
controls:2.38%
45
502
2816
27763
242
207
2619
28058
5
29
2856
28236
—
60
25
2800
28221
23
201
2805
27685
118
620
2544
25470
Extensive health check-up of expecting family
SPAT1197 [2001700298]
SPAT1197 [2001700298]
2.0e-01
2.6e+00
2.0e+00
—
1.1e+00
-2.1e-01
6.2e-01
cases:7.10%
controls:5.86%
cases:20.13%
controls:1.86%
cases:1.54%
controls:0.20%
—
—
cases:0.66%
controls:0.23%
cases:1.34%
controls:1.65%
cases:10.07%
controls:5.69%
203
1657
2658
26608
576
527
2285
27738
44
57
2817
28208
—
19
65
2841
28181
38
459
2790
27427
268
1485
2394
24605
Assistance to normal delivery
MAX99 [2001306918]
MAX99 [2001306918]
1.5e-01
—
—
—
4.5e+00
9.8e-01
8.2e-01
cases:4.58%
controls:3.95%
—
—
—
—
—
—
cases:9.02%
controls:0.11%
cases:3.18%
controls:1.22%
cases:9.28%
controls:4.32%
131
1117
2730
27148
—
—
—
258
32
2602
28214
90
341
2738
27545
247
1126
2415
24964
Care and examination of lactating mother
Z39.1 [45595508]
Z39.1 [45595508]
1.1e-01
—
—
—
3.9e+00
2.4e+00
5.4e-01
cases:0.52%
controls:0.47%
—
—
—
—
—
—
cases:1.01%
controls:0.02%
cases:2.05%
controls:0.20%
cases:1.13%
controls:0.66%
15
133
2846
28132
—
—
—
29
6
2831
28240
58
55
2770
27831
30
172
2632
25918
Gastroenterology
10 [38004455]
10 [38004455]
5.8e-01
8.6e-01
1.5e+00
—
1.4e+00
1.1e+00
8.3e-01
cases:3.60%
controls:2.05%
cases:2.31%
controls:0.99%
cases:0.91%
controls:0.21%
—
—
cases:0.94%
controls:0.23%
cases:2.90%
controls:1.00%
cases:5.90%
controls:2.66%
103
580
2758
27685
66
279
2795
27986
26
59
2835
28206
—
27
66
2833
28180
82
280
2746
27606
157
693
2505
25397
Labour and delivery complicated by fetal heart rate anomaly
O68.0 [45548818]
O68.0 [45548818]
2.1e-01
—
—
—
5.1e+00
1.0e+00
-3.5e-01
cases:1.68%
controls:1.37%
—
—
—
—
—
—
cases:3.50%
controls:0.02%
cases:1.13%
controls:0.41%
cases:1.28%
controls:1.80%
48
386
2813
27879
—
—
—
100
6
2760
28240
32
113
2796
27773
34
469
2628
25621
Inpatient Visit
IP [9201]
IP [9201]
5.3e-02
-3.6e-03
1.7e+00
—
3.3e+00
4.3e-01
6.7e-01
cases:12.23%
controls:11.68%
cases:2.83%
controls:2.84%
cases:1.40%
controls:0.26%
—
—
cases:8.01%
controls:0.30%
cases:3.78%
controls:2.49%
cases:9.20%
controls:4.94%
350
3301
2511
24964
81
803
2780
27462
40
73
2821
28192
—
229
86
2631
28160
107
695
2721
27191
245
1288
2417
24802
omeprazole; oral, parenteral
A02BC01 [21600096]
A02BC01 [21600096]
3.9e-01
1.4e+00
2.4e+00
—
1.5e+00
1.6e-01
4.4e-01
cases:3.74%
controls:2.57%
cases:4.51%
controls:1.15%
cases:1.85%
controls:0.17%
—
—
cases:0.70%
controls:0.16%
cases:1.41%
controls:1.21%
cases:5.45%
controls:3.56%
107
726
2754
27539
129
324
2732
27941
53
47
2808
28218
—
20
46
2840
28200
40
338
2788
27548
145
929
2517
25161
Single live birth
Z37.0 [45571346]
Z37.0 [45571346]
1.6e-01
—
-1.0e+50
—
4.5e+00
9.4e-01
6.8e-01
cases:4.61%
controls:3.96%
—
—
cases:0.00%
controls:0.11%
—
—
cases:10.24%
controls:0.13%
cases:2.86%
controls:1.13%
cases:8.08%
controls:4.26%
132
1119
2729
27146
—
0
32
2861
28233
—
293
36
2567
28210
81
316
2747
27570
215
1111
2447
24979
Glucose tolerance 2 hours gestational panel - Serum or Plasma
81324-6 [21492888]
81324-6 [21492888]
2.6e-01
2.6e+00
2.8e+00
—
—
-2.3e-01
7.2e-01
cases:2.27%
controls:1.77%
cases:7.27%
controls:0.59%
cases:0.80%
controls:0.05%
—
—
—
—
cases:0.42%
controls:0.53%
cases:3.34%
controls:1.66%
65
499
2796
27766
208
167
2653
28098
23
14
2838
28251
—
—
12
149
2816
27737
89
433
2573
25657
Erythrocyte agglutination [Presence] in Blood
50670-9 [3029396]
50670-9 [3029396]
2.9e-01
2.1e+00
2.9e+00
—
—
8.6e-01
1.1e+00
cases:0.28%
controls:0.21%
cases:0.80%
controls:0.10%
cases:0.45%
controls:0.02%
—
—
—
—
cases:0.21%
controls:0.09%
cases:0.86%
controls:0.30%
8
59
2853
28206
23
28
2838
28237
13
7
2848
28258
—
—
6
25
2822
27861
23
78
2639
26012
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
-2.5e-02
2.5e-01
1.2e+00
3.2e+00
1.1e+00
2.3e-01
3.7e-02
cases:35.44%
controls:36.02%
cases:37.89%
controls:32.16%
cases:35.83%
controls:13.83%
cases:17.93%
controls:0.87%
cases:31.78%
controls:13.58%
cases:39.25%
controls:33.86%
cases:47.90%
controls:46.97%
1014
10180
1847
18085
1084
9091
1777
19174
1025
3909
1836
24356
513
245
2348
28020
909
3837
1951
24409
1110
9441
1718
18445
1275
12254
1387
13836
Spontaneous vertex delivery
O80.0 [45577661]
O80.0 [45577661]
2.2e-01
—
—
—
4.4e+00
6.8e-01
7.2e-01
cases:16.50%
controls:13.73%
—
—
—
—
—
—
cases:25.59%
controls:0.43%
cases:7.96%
controls:4.18%
cases:26.03%
controls:14.66%
472
3882
2389
24383
—
—
—
732
121
2128
28125
225
1167
2603
26719
693
3824
1969
22266
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
-2.6e-02
3.0e-01
1.6e+00
—
2.8e+00
9.9e-01
5.8e-01
cases:1.61%
controls:1.65%
cases:0.98%
controls:0.73%
cases:0.38%
controls:0.08%
—
—
cases:1.29%
controls:0.08%
cases:1.56%
controls:0.58%
cases:3.49%
controls:1.99%
46
466
2815
27799
28
206
2833
28059
11
23
2850
28242
—
37
22
2823
28224
44
163
2784
27723
93
520
2569
25570
Delivery by emergency caesarean section
O82.10 [2000503217]
O82.10 [2000503217]
2.5e-01
—
-1.0e+50
1.0e+50
4.6e+00
1.4e+00
5.9e-02
cases:2.41%
controls:1.90%
—
—
cases:0.00%
controls:0.03%
cases:2.34%
controls:0.00%
cases:5.73%
controls:0.06%
cases:1.98%
controls:0.51%
cases:2.52%
controls:2.38%
69
536
2792
27729
—
0
8
2861
28257
67
0
2794
28265
164
18
2696
28228
56
142
2772
27744
67
620
2595
25470
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
-2.8e-02
-3.2e-02
9.3e-01
3.7e+00
1.3e+00
-8.3e-02
7.8e-02
cases:11.01%
controls:11.29%
cases:6.54%
controls:6.73%
cases:2.27%
controls:0.91%
cases:0.98%
controls:0.02%
cases:3.39%
controls:0.93%
cases:6.15%
controls:6.65%
cases:17.81%
controls:16.69%
315
3190
2546
25075
187
1903
2674
26362
65
258
2796
28007
28
7
2833
28258
97
263
2763
27983
174
1855
2654
26031
474
4354
2188
21736
Supervision of normal pregnancy
Z34 [45566419]
Z34 [45566419]
1.4e-01
2.0e+00
3.2e+00
—
6.4e-01
-2.2e-02
7.4e-01
cases:1.78%
controls:1.55%
cases:3.57%
controls:0.48%
cases:1.47%
controls:0.06%
—
—
cases:0.17%
controls:0.09%
cases:0.46%
controls:0.47%
cases:3.19%
controls:1.55%
51
439
2810
27826
102
137
2759
28128
42
18
2819
28247
—
5
26
2855
28220
13
131
2815
27755
85
404
2577
25686
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
4.6e-01
-1.3e-01
—
1.0e+50
3.5e+00
1.2e+00
6.7e-01
cases:8.04%
controls:5.24%
cases:1.29%
controls:1.47%
—
—
cases:2.69%
controls:0.00%
cases:6.12%
controls:0.19%
cases:4.67%
controls:1.39%
cases:10.18%
controls:5.46%
230
1480
2631
26785
37
415
2824
27850
—
77
0
2784
28265
175
55
2685
28191
132
388
2696
27498
271
1425
2391
24665
Urgent procedure
ZXD05 [2001311386]
ZXD05 [2001311386]
3.7e-01
-6.0e-01
—
—
4.1e+00
1.0e+00
3.4e-01
cases:6.75%
controls:4.75%
cases:0.73%
controls:1.32%
—
—
—
—
cases:6.92%
controls:0.12%
cases:3.47%
controls:1.27%
cases:6.95%
controls:5.07%
193
1343
2668
26922
21
374
2840
27891
—
—
198
34
2662
28212
98
353
2730
27533
185
1323
2477
24767
Spinalanesthesia
WX320 [2001310799]
WX320 [2001310799]
8.8e-02
—
-1.0e+50
1.0e+50
4.3e+00
1.0e+00
5.0e-01
cases:1.68%
controls:1.54%
—
—
cases:0.00%
controls:0.05%
cases:0.94%
controls:0.00%
cases:3.53%
controls:0.05%
cases:1.63%
controls:0.58%
cases:3.61%
controls:2.21%
48
435
2813
27830
—
0
15
2861
28250
27
0
2834
28265
101
14
2759
28232
46
163
2782
27723
96
577
2566
25513
Amniocentesis
MAA00 [2001306845]
MAA00 [2001306845]
8.2e-02
2.0e+00
—
1.0e+50
3.8e+00
6.5e-01
2.1e-01
cases:0.66%
controls:0.61%
cases:1.43%
controls:0.20%
—
—
cases:0.80%
controls:0.00%
cases:0.80%
controls:0.02%
cases:0.39%
controls:0.20%
cases:1.28%
controls:1.03%
19
173
2842
28092
41
57
2820
28208
—
23
0
2838
28265
23
5
2837
28241
11
57
2817
27829
34
270
2628
25820
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
50949-7 [3029937]
9.7e-02
1.4e+00
2.0e+00
—
2.0e+00
6.3e-02
3.3e-01
cases:3.88%
controls:3.53%
cases:6.22%
controls:1.54%
cases:1.54%
controls:0.22%
—
—
cases:1.29%
controls:0.17%
cases:1.84%
controls:1.73%
cases:6.42%
controls:4.70%
111
999
2750
27266
178
435
2683
27830
44
62
2817
28203
—
37
48
2823
28198
52
482
2776
27404
171
1225
2491
24865
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
3.9e-02
3.0e-01
1.0e+00
2.7e+00
1.8e+00
1.4e-01
1.6e-01
cases:14.92%
controls:14.43%
cases:11.32%
controls:8.68%
cases:4.19%
controls:1.51%
cases:1.05%
controls:0.07%
cases:7.55%
controls:1.36%
cases:10.36%
controls:9.09%
cases:22.76%
controls:20.12%
427
4079
2434
24186
324
2454
2537
25811
120
427
2741
27838
30
21
2831
28244
216
385
2644
27861
293
2536
2535
25350
606
5250
2056
20840
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
-2.4e-02
-5.1e-03
9.1e-01
3.6e+00
1.3e+00
-6.7e-02
7.3e-02
cases:11.01%
controls:11.25%
cases:6.68%
controls:6.71%
cases:2.27%
controls:0.92%
cases:0.98%
controls:0.03%
cases:3.36%
controls:0.93%
cases:6.22%
controls:6.62%
cases:17.69%
controls:16.66%
315
3180
2546
25085
191
1896
2670
26369
65
261
2796
28004
28
8
2833
28257
96
264
2764
27982
176
1847
2652
26039
471
4346
2191
21744
Guidance for breast-feeding and breast care
SPAT1200 [2001700301]
SPAT1200 [2001700301]
2.1e-01
-1.2e-02
—
—
4.2e+00
1.5e+00
3.4e-01
cases:0.94%
controls:0.76%
cases:0.17%
controls:0.18%
—
—
—
—
cases:1.22%
controls:0.02%
cases:1.20%
controls:0.27%
cases:1.24%
controls:0.88%
27
216
2834
28049
5
50
2856
28215
—
—
35
5
2825
28241
34
74
2794
27812
33
230
2629
25860
Lower uterine segment caesarean section
MCA10 [2001306959]
MCA10 [2001306959]
1.0e-02
—
-1.0e+50
1.0e+50
4.4e+00
1.3e+00
2.7e-01
cases:4.02%
controls:3.98%
—
—
cases:0.00%
controls:0.09%
cases:5.03%
controls:0.00%
cases:9.27%
controls:0.12%
cases:4.24%
controls:1.22%
cases:6.80%
controls:5.27%
115
1125
2746
27140
—
0
26
2861
28239
144
0
2717
28265
265
34
2595
28212
120
339
2708
27547
181
1375
2481
24715
Other specified counselling
Z71.8 [45581061]
Z71.8 [45581061]
3.1e-02
8.1e-01
2.3e+00
—
2.6e+00
3.4e-01
1.3e-01
cases:3.43%
controls:3.33%
cases:3.29%
controls:1.49%
cases:2.17%
controls:0.22%
—
—
cases:3.08%
controls:0.24%
cases:2.30%
controls:1.65%
cases:5.90%
controls:5.23%
98
940
2763
27325
94
422
2767
27843
62
63
2799
28202
—
88
69
2772
28177
65
459
2763
27427
157
1365
2505
24725
Repeated or continuing anesthesia shots throug a catheter
WX602 [2001310813]
WX602 [2001310813]
5.4e-01
—
—
—
4.2e+00
8.8e-01
3.2e-01
cases:3.08%
controls:1.82%
—
—
—
—
—
—
cases:4.16%
controls:0.06%
cases:1.38%
controls:0.58%
cases:2.74%
controls:2.00%
88
514
2773
27751
—
—
—
119
18
2741
28228
39
161
2789
27725
73
523
2589
25567
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
48065-7 [3051714]
-1.4e-02
3.8e-01
2.3e+00
—
3.3e+00
1.9e-01
1.2e-01
cases:1.78%
controls:1.81%
cases:1.01%
controls:0.69%
cases:0.59%
controls:0.06%
—
—
cases:1.36%
controls:0.05%
cases:0.81%
controls:0.67%
cases:3.04%
controls:2.71%
51
511
2810
27754
29
196
2832
28069
17
17
2844
28248
—
39
14
2821
28232
23
187
2805
27699
81
707
2581
25383
Lumbar epidural anesthesia
WX306 [2001310796]
WX306 [2001310796]
8.7e-02
—
-1.0e+50
1.0e+50
4.5e+00
1.1e+00
1.3e-01
cases:1.89%
controls:1.73%
—
—
cases:0.00%
controls:0.04%
cases:1.68%
controls:0.00%
cases:3.53%
controls:0.04%
cases:1.49%
controls:0.51%
cases:2.37%
controls:2.08%
54
490
2807
27775
—
0
12
2861
28253
48
0
2813
28265
101
12
2759
28234
42
141
2786
27745
63
542
2599
25548
Obesity due to excess calories
E66.01 [2000501501]
E66.01 [2000501501]
3.4e-02
8.4e-01
2.0e+00
—
2.7e+00
4.9e-01
1.4e-01
cases:0.94%
controls:0.91%
cases:1.01%
controls:0.44%
cases:0.73%
controls:0.10%
—
—
cases:1.43%
controls:0.10%
cases:0.81%
controls:0.50%
cases:1.65%
controls:1.44%
27
258
2834
28007
29
125
2832
28140
21
28
2840
28237
—
41
28
2819
28218
23
140
2805
27746
44
376
2618
25714
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
6.8e-03
-6.4e-01
1.3e+00
—
3.7e+00
2.8e-01
4.6e-01
cases:2.83%
controls:2.81%
cases:0.70%
controls:1.32%
cases:0.52%
controls:0.14%
—
—
cases:5.17%
controls:0.14%
cases:2.02%
controls:1.52%
cases:7.10%
controls:4.58%
81
795
2780
27470
20
372
2841
27893
15
39
2846
28226
—
148
39
2712
28207
57
425
2771
27461
189
1196
2473
24894
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
1.0e-01
3.2e-01
1.5e+00
—
2.6e+00
6.6e-01
6.8e-01
cases:2.13%
controls:1.93%
cases:1.26%
controls:0.92%
cases:0.70%
controls:0.16%
—
—
cases:1.71%
controls:0.13%
cases:1.77%
controls:0.92%
cases:4.77%
controls:2.48%
61
546
2800
27719
36
260
2825
28005
20
44
2841
28221
—
49
37
2811
28209
50
257
2778
27629
127
647
2535
25443
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
2.9e-02
9.7e-01
2.0e+00
—
2.0e+00
1.7e-01
4.8e-01
cases:1.85%
controls:1.80%
cases:1.75%
controls:0.67%
cases:0.63%
controls:0.09%
—
—
cases:0.52%
controls:0.07%
cases:0.60%
controls:0.51%
cases:2.48%
controls:1.55%
53
509
2808
27756
50
189
2811
28076
18
25
2843
28240
—
15
20
2845
28226
17
141
2811
27745
66
404
2596
25686
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2472-9 [3028026]
2.6e-01
7.1e-01
—
—
2.8e+00
1.4e+00
1.2e+00
cases:0.52%
controls:0.40%
cases:0.28%
controls:0.14%
—
—
—
—
cases:0.28%
controls:0.02%
cases:0.71%
controls:0.17%
cases:1.47%
controls:0.44%
15
114
2846
28151
8
39
2853
28226
—
—
8
5
2852
28241
20
47
2808
27839
39
114
2623
25976
Obstructed labour due to incomplete rotation of fetal head
O64.0 [45606639]
O64.0 [45606639]
-2.4e-01
-1.0e+50
—
1.0e+50
4.2e+00
1.2e+00
-1.0e-01
cases:0.35%
controls:0.45%
cases:0.00%
controls:0.12%
—
—
cases:0.35%
controls:0.00%
cases:1.47%
controls:0.02%
cases:0.57%
controls:0.18%
cases:0.49%
controls:0.54%
10
126
2851
28139
0
35
2861
28230
—
10
0
2851
28265
42
6
2818
28240
16
50
2812
27836
13
141
2649
25949
Counselling, unspecified
Z71.9 [45561648]
Z71.9 [45561648]
9.4e-02
8.1e-01
2.4e+00
—
3.0e+00
2.0e-02
1.2e-01
cases:0.49%
controls:0.45%
cases:0.42%
controls:0.19%
cases:0.31%
controls:0.03%
—
—
cases:0.35%
controls:0.02%
cases:0.21%
controls:0.21%
cases:1.05%
controls:0.94%
14
126
2847
28139
12
53
2849
28212
9
8
2852
28257
—
10
5
2850
28241
6
58
2822
27828
28
244
2634
25846
Prolonged first stage (of labour)
O63.0 [45563158]
O63.0 [45563158]
2.1e-01
—
—
1.0e+50
3.8e+00
1.6e+00
-4.5e-01
cases:0.59%
controls:0.48%
—
—
—
—
cases:0.56%
controls:0.00%
cases:1.08%
controls:0.02%
cases:0.67%
controls:0.14%
cases:0.38%
controls:0.59%
17
136
2844
28129
—
—
16
0
2845
28265
31
7
2829
28239
19
38
2809
27848
10
153
2652
25937
Haemorrhage in early pregnancy, unspecified
O20.9 [45539094]
O20.9 [45539094]
7.9e-02
2.3e+00
—
—
2.4e+00
-1.1e-01
6.3e-01
cases:0.80%
controls:0.74%
cases:2.31%
controls:0.23%
—
—
—
—
cases:0.28%
controls:0.02%
cases:0.21%
controls:0.24%
cases:1.50%
controls:0.81%
23
210
2838
28055
66
66
2795
28199
—
—
8
7
2852
28239
6
66
2822
27820
40
211
2622
25879
Laparoscopic cholecystectomy
JKA21 [2001305294]
JKA21 [2001305294]
1.1e+00
3.9e-01
—
—
—
2.5e+00
1.7e+00
cases:1.26%
controls:0.42%
cases:0.21%
controls:0.14%
—
—
—
—
—
—
cases:1.49%
controls:0.12%
cases:3.83%
controls:0.73%
36
120
2825
28145
6
40
2855
28225
—
—
—
42
33
2786
27853
102
191
2560
25899
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
O99.1 [45563195]
O99.1 [45563195]
6.6e-01
2.6e+00
—
1.0e+50
—
1.6e+00
1.2e+00
cases:0.28%
controls:0.15%
cases:0.59%
controls:0.05%
—
—
cases:0.42%
controls:0.00%
—
—
cases:0.28%
controls:0.06%
cases:0.49%
controls:0.15%
8
41
2853
28224
17
13
2844
28252
—
12
0
2849
28265
—
8
16
2820
27870
13
40
2649
26050
Cholelithiasis, Calculus of gallbladder without mention of cholecystitis[CHOLECYSTOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]
5742A [2000404528]
5742A [2000404528]
1.4e+00
-1.0e+50
—
—
—
2.2e+00
3.1e+00
cases:0.31%
controls:0.08%
cases:0.00%
controls:0.02%
—
—
—
—
—
—
cases:0.28%
controls:0.03%
cases:0.53%
controls:0.02%
9
22
2852
28243
0
6
2861
28259
—
—
—
8
9
2820
27877
14
6
2648
26084
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
5.0e-01
2.0e-01
-1.0e+50
—
3.1e+00
1.1e+00
6.6e-01
cases:5.21%
controls:3.24%
cases:1.15%
controls:0.95%
cases:0.00%
controls:0.07%
—
—
cases:2.27%
controls:0.11%
cases:2.76%
controls:0.96%
cases:7.02%
controls:3.78%
149
915
2712
27350
33
268
2828
27997
0
19
2861
28246
—
65
31
2795
28215
78
269
2750
27617
187
985
2475
25105
Prolonged second stage (of labour)
O63.1 [45601878]
O63.1 [45601878]
2.6e-01
-1.0e+50
—
—
4.1e+00
1.2e+00
-5.1e-01
cases:1.05%
controls:0.81%
cases:0.00%
controls:0.24%
—
—
—
—
cases:2.03%
controls:0.04%
cases:0.81%
controls:0.26%
cases:0.53%
controls:0.87%
30
230
2831
28035
0
69
2861
28196
—
—
58
10
2802
28236
23
72
2805
27814
14
227
2648
25863
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
-7.9e-03
3.9e-03
9.1e-01
3.2e+00
1.1e+00
-1.5e-02
5.8e-02
cases:13.25%
controls:13.34%
cases:8.74%
controls:8.71%
cases:3.36%
controls:1.38%
cases:1.26%
controls:0.05%
cases:4.13%
controls:1.37%
cases:8.59%
controls:8.71%
cases:21.15%
controls:20.19%
379
3770
2482
24495
250
2461
2611
25804
96
391
2765
27874
36
15
2825
28250
118
387
2742
27859
243
2430
2585
25456
563
5268
2099
20822
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
7.2e-02
1.4e+00
2.0e+00
—
1.9e+00
-6.5e-02
1.7e-01
cases:5.94%
controls:5.55%
cases:10.38%
controls:2.83%
cases:2.76%
controls:0.40%
—
—
cases:2.34%
controls:0.37%
cases:2.86%
controls:3.05%
cases:10.63%
controls:9.11%
170
1569
2691
26696
297
799
2564
27466
79
113
2782
28152
—
67
104
2793
28142
81
851
2747
27035
283
2377
2379
23713
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
6.7e-02
1.4e+00
2.0e+00
—
1.8e+00
8.8e-04
1.8e-01
cases:6.08%
controls:5.71%
cases:10.56%
controls:2.89%
cases:2.90%
controls:0.42%
—
—
cases:2.41%
controls:0.39%
cases:3.11%
controls:3.11%
cases:10.93%
controls:9.33%
174
1614
2687
26651
302
818
2559
27447
83
119
2778
28146
—
69
110
2791
28136
88
867
2740
27019
291
2435
2371
23655
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus
6480A [2000405086]
6480A [2000405086]
-2.8e-01
2.3e+00
2.9e+00
1.0e+50
—
1.6e+00
—
cases:0.17%
controls:0.23%
cases:0.42%
controls:0.04%
cases:0.31%
controls:0.02%
cases:0.42%
controls:0.00%
—
—
cases:0.18%
controls:0.04%
—
—
5
65
2856
28200
12
12
2849
28253
9
5
2852
28260
12
0
2849
28265
—
5
10
2823
27876
—
Antenatal screening
243787009 [4087235]
243787009 [4087235]
3.0e-01
2.4e+00
1.4e+00
—
2.8e+00
6.2e-02
3.1e-01
cases:1.29%
controls:0.97%
cases:3.64%
controls:0.36%
cases:0.17%
controls:0.04%
—
—
cases:0.35%
controls:0.02%
cases:0.39%
controls:0.37%
cases:1.80%
controls:1.33%
37
273
2824
27992
104
101
2757
28164
5
12
2856
28253
—
10
6
2850
28240
11
102
2817
27784
48
347
2614
25743
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
6.7e-02
1.4e+00
2.0e+00
—
1.8e+00
-4.4e-02
2.0e-01
cases:6.01%
controls:5.65%
cases:10.63%
controls:2.88%
cases:2.80%
controls:0.41%
—
—
cases:2.34%
controls:0.39%
cases:3.01%
controls:3.14%
cases:11.08%
controls:9.23%
172
1596
2689
26669
304
815
2557
27450
80
115
2781
28150
—
67
111
2793
28135
85
875
2743
27011
295
2409
2367
23681
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
1.2e-01
-1.2e-01
1.0e+00
—
4.0e+00
6.7e-01
4.8e-01
cases:3.50%
controls:3.11%
cases:1.15%
controls:1.29%
cases:0.42%
controls:0.15%
—
—
cases:6.75%
controls:0.13%
cases:2.51%
controls:1.31%
cases:6.57%
controls:4.18%
100
878
2761
27387
33
366
2828
27899
12
43
2849
28222
—
193
38
2667
28208
71
364
2757
27522
175
1090
2487
25000
Antepartum haemorrhage, unspecified
O46.9 [45553575]
O46.9 [45553575]
-3.0e-03
1.7e+00
—
—
3.4e+00
—
4.4e-01
cases:0.38%
controls:0.39%
cases:0.73%
controls:0.13%
—
—
—
—
cases:0.52%
controls:0.02%
—
—
cases:0.60%
controls:0.39%
11
109
2850
28156
21
38
2840
28227
—
—
15
5
2845
28241
—
16
101
2646
25989
Repair of obstetric laceration of vagina
MBC10 [2001306946]
MBC10 [2001306946]
1.4e-01
-1.0e+50
-1.0e+50
1.0e+50
4.1e+00
1.0e+00
5.3e-01
cases:0.70%
controls:0.61%
cases:0.00%
controls:0.22%
cases:0.00%
controls:0.02%
cases:0.52%
controls:0.00%
cases:1.01%
controls:0.02%
cases:0.57%
controls:0.20%
cases:1.13%
controls:0.67%
20
172
2841
28093
0
62
2861
28203
0
5
2861
28260
15
0
2846
28265
29
5
2831
28241
16
57
2812
27829
30
174
2632
25916
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
5794-3 [3011397]
-2.3e-02
1.3e+00
2.0e+00
—
1.8e+00
-4.0e-01
-7.3e-02
cases:2.03%
controls:2.07%
cases:4.09%
controls:1.18%
cases:1.26%
controls:0.18%
—
—
cases:1.12%
controls:0.18%
cases:0.95%
controls:1.42%
cases:4.02%
controls:4.31%
58
586
2803
27679
117
333
2744
27932
36
50
2825
28215
—
32
52
2828
28194
27
396
2801
27490
107
1125
2555
24965
Manual removal of placenta from delivered uterus
MBA30 [2001306935]
MBA30 [2001306935]
-1.8e-01
—
-1.0e+50
1.0e+50
3.7e+00
1.3e+00
2.7e-02
cases:0.35%
controls:0.42%
—
—
cases:0.00%
controls:0.02%
cases:0.31%
controls:0.00%
cases:0.73%
controls:0.02%
cases:0.39%
controls:0.11%
cases:0.49%
controls:0.48%
10
118
2851
28147
—
0
7
2861
28258
9
0
2852
28265
21
5
2839
28241
11
30
2817
27856
13
124
2649
25966
Obstructed labour due to breech presentation
O64.1 [45534291]
O64.1 [45534291]
3.8e-01
-1.0e+50
-1.0e+50
1.0e+50
3.7e+00
1.3e+00
—
cases:0.56%
controls:0.38%
cases:0.00%
controls:0.10%
cases:0.00%
controls:0.02%
cases:0.21%
controls:0.00%
cases:0.70%
controls:0.02%
cases:0.39%
controls:0.10%
—
—
16
108
2845
28157
0
27
2861
28238
0
6
2861
28259
6
0
2855
28265
20
5
2840
28241
11
29
2817
27857
—
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
-5.6e-02
1.4e-02
9.8e-01
2.9e+00
1.1e+00
6.1e-02
1.1e-01
cases:8.67%
controls:9.12%
cases:6.08%
controls:6.00%
cases:2.45%
controls:0.93%
cases:0.80%
controls:0.04%
cases:2.87%
controls:1.01%
cases:6.58%
controls:6.21%
cases:15.59%
controls:14.15%
248
2578
2613
25687
174
1697
2687
26568
70
263
2791
28002
23
12
2838
28253
82
284
2778
27962
186
1733
2642
26153
415
3691
2247
22399
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
53292-9 [3041096]
1.1e-01
1.3e+00
1.9e+00
—
1.8e+00
1.2e-01
2.6e-01
cases:4.09%
controls:3.66%
cases:5.63%
controls:1.58%
cases:1.29%
controls:0.20%
—
—
cases:1.05%
controls:0.17%
cases:1.73%
controls:1.54%
cases:6.09%
controls:4.78%
117
1035
2744
27230
161
446
2700
27819
37
57
2824
28208
—
30
49
2830
28197
49
430
2779
27456
162
1247
2500
24843
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
-5.6e-02
9.8e-01
1.7e+00
—
1.7e+00
4.1e-01
6.0e-01
cases:1.82%
controls:1.92%
cases:1.92%
controls:0.73%
cases:0.59%
controls:0.11%
—
—
cases:0.45%
controls:0.08%
cases:0.92%
controls:0.61%
cases:3.12%
controls:1.74%
52
543
2809
27722
55
207
2806
28058
17
30
2844
28235
—
13
24
2847
28222
26
171
2802
27715
83
454
2579
25636
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
20454-5 [3014051]
-2.5e-02
1.2e+00
2.0e+00
—
1.7e+00
-1.5e-01
2.5e-02
cases:2.27%
controls:2.33%
cases:4.47%
controls:1.33%
cases:1.36%
controls:0.19%
—
—
cases:1.05%
controls:0.19%
cases:1.20%
controls:1.39%
cases:4.88%
controls:4.77%
65
658
2796
27607
128
377
2733
27888
39
53
2822
28212
—
30
55
2830
28191
34
387
2794
27499
130
1244
2532
24846
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
1.5e-01
4.7e-01
1.6e+00
—
2.3e+00
6.2e-01
4.7e-01
cases:2.62%
controls:2.26%
cases:1.43%
controls:0.90%
cases:0.56%
controls:0.12%
—
—
cases:1.01%
controls:0.11%
cases:1.66%
controls:0.90%
cases:4.62%
controls:2.93%
75
638
2786
27627
41
254
2820
28011
16
33
2845
28232
—
29
30
2831
28216
47
252
2781
27634
123
764
2539
25326
General health counselling
SPAT1312 [2001700413]
SPAT1312 [2001700413]
6.1e-03
5.8e-01
1.8e+00
—
1.9e+00
5.5e-01
1.8e-01
cases:4.93%
controls:4.90%
cases:2.59%
controls:1.46%
cases:1.08%
controls:0.17%
—
—
cases:0.84%
controls:0.12%
cases:2.19%
controls:1.28%
cases:5.07%
controls:4.25%
141
1385
2720
26880
74
413
2787
27852
31
49
2830
28216
—
24
35
2836
28211
62
357
2766
27529
135
1110
2527
24980
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
60026-2 [40763086]
4.1e-02
1.2e+00
1.9e+00
—
1.8e+00
-2.5e-02
1.8e-01
cases:5.07%
controls:4.88%
cases:7.13%
controls:2.18%
cases:1.71%
controls:0.27%
—
—
cases:1.36%
controls:0.24%
cases:2.12%
controls:2.17%
cases:7.96%
controls:6.75%
145
1378
2716
26887
204
615
2657
27650
49
77
2812
28188
—
39
67
2821
28179
60
606
2768
27280
212
1762
2450
24328
Glucose tolerance 2 hours panel - Serum or Plasma
72171-2 [43054914]
72171-2 [43054914]
9.2e-02
2.0e+00
2.0e+00
—
6.8e-01
5.4e-01
9.2e-01
cases:2.55%
controls:2.33%
cases:6.40%
controls:0.95%
cases:0.73%
controls:0.10%
—
—
cases:0.21%
controls:0.11%
cases:1.45%
controls:0.85%
cases:6.31%
controls:2.63%
73
659
2788
27606
183
269
2678
27996
21
29
2840
28236
—
6
30
2854
28216
41
237
2787
27649
168
685
2494
25405
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
O24.0 [45558213]
O24.0 [45558213]
-5.9e-01
9.8e-01
2.0e+00
—
1.8e+00
1.3e-02
-2.5e-01
cases:0.98%
controls:1.74%
cases:2.20%
controls:0.84%
cases:2.17%
controls:0.29%
—
—
cases:1.92%
controls:0.32%
cases:0.92%
controls:0.91%
cases:1.88%
controls:2.40%
28
493
2833
27772
63
238
2798
28027
62
83
2799
28182
—
55
90
2805
28156
26
253
2802
27633
50
625
2612
25465
Outlet vacuum delivery
MAE00 [2001306882]
MAE00 [2001306882]
-7.1e-04
—
—
—
3.9e+00
9.2e-01
-5.6e-01
cases:1.54%
controls:1.54%
—
—
—
—
—
—
cases:2.83%
controls:0.06%
cases:1.17%
controls:0.47%
cases:0.90%
controls:1.57%
44
435
2817
27830
—
—
—
81
17
2779
28229
33
130
2795
27756
24
409
2638
25681
Psychosocial counselling and guidance
SPAT1307 [2001700408]
SPAT1307 [2001700408]
-3.1e-02
1.2e+00
1.9e+00
—
8.1e-01
1.0e+00
6.9e-01
cases:1.54%
controls:1.58%
cases:1.08%
controls:0.33%
cases:0.45%
controls:0.07%
—
—
cases:0.17%
controls:0.08%
cases:0.95%
controls:0.35%
cases:1.99%
controls:1.01%
44
448
2817
27817
31
94
2830
28171
13
19
2848
28246
—
5
22
2855
28224
27
98
2801
27788
53
263
2609
25827
pH of Urine
2756-5 [3015736]
2756-5 [3015736]
3.7e-02
1.1e+00
1.8e+00
—
1.8e+00
-2.1e-01
6.0e-02
cases:4.68%
controls:4.52%
cases:6.33%
controls:2.18%
cases:1.71%
controls:0.28%
—
—
cases:1.68%
controls:0.29%
cases:1.91%
controls:2.35%
cases:7.51%
controls:7.11%
134
1278
2727
26987
181
615
2680
27650
49
80
2812
28185
—
48
82
2812
28164
54
654
2774
27232
200
1855
2462
24235
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
3.0e-01
9.7e-01
1.2e+00
—
1.8e+00
2.8e-01
4.4e-01
cases:7.10%
controls:5.37%
cases:4.37%
controls:1.70%
cases:0.73%
controls:0.22%
—
—
cases:0.98%
controls:0.17%
cases:2.16%
controls:1.65%
cases:8.83%
controls:5.89%
203
1517
2658
26748
125
480
2736
27785
21
63
2840
28202
—
28
47
2832
28199
61
459
2767
27427
235
1537
2427
24553
Home Visit
OMOP4822459 [581476]
OMOP4822459 [581476]
2.1e-01
-9.5e-01
7.6e-01
—
3.8e+00
1.4e+00
4.0e-01
cases:6.57%
controls:5.37%
cases:0.73%
controls:1.87%
cases:0.59%
controls:0.28%
—
—
cases:11.05%
controls:0.28%
cases:8.03%
controls:2.04%
cases:9.09%
controls:6.31%
188
1518
2673
26747
21
529
2840
27736
17
79
2844
28186
—
316
78
2544
28168
227
570
2601
27316
242
1646
2420
24444
Extensive ultrasound of fetal heart
FM1QE [2001306826]
FM1QE [2001306826]
—
2.9e+00
—
—
—
-1.0e+50
1.8e+00
—
—
cases:0.77%
controls:0.04%
—
—
—
—
—
—
cases:0.00%
controls:0.03%
cases:0.49%
controls:0.08%
—
22
12
2839
28253
—
—
—
0
7
2828
27879
13
22
2649
26068
Pain localized to other parts of lower abdomen
R10.3 [45534426]
R10.3 [45534426]
3.3e-01
1.2e+00
1.1e+00
—
1.6e+00
2.9e-01
4.2e-01
cases:6.22%
controls:4.55%
cases:5.24%
controls:1.57%
cases:0.63%
controls:0.22%
—
—
cases:0.98%
controls:0.20%
cases:2.12%
controls:1.60%
cases:7.36%
controls:4.99%
178
1286
2683
26979
150
445
2711
27820
18
61
2843
28204
—
28
57
2832
28189
60
446
2768
27440
196
1301
2466
24789
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
3.0e-02
1.1e+00
1.9e+00
—
1.6e+00
-5.7e-02
2.3e-01
cases:3.32%
controls:3.23%
cases:5.03%
controls:1.66%
cases:1.50%
controls:0.23%
—
—
cases:1.36%
controls:0.27%
cases:1.66%
controls:1.76%
cases:5.97%
controls:4.79%
95
912
2766
27353
144
469
2717
27796
43
66
2818
28199
—
39
77
2821
28169
47
490
2781
27396
159
1250
2503
24840
Ultrasound examination of uterus and parametria
LC2AE [2001306543]
LC2AE [2001306543]
9.0e-01
1.3e+00
—
—
1.7e+00
7.3e-01
2.9e-01
cases:4.51%
controls:1.89%
cases:2.87%
controls:0.82%
—
—
—
—
cases:0.45%
controls:0.08%
cases:1.34%
controls:0.65%
cases:3.27%
controls:2.46%
129
534
2732
27731
82
232
2779
28033
—
—
13
23
2847
28223
38
181
2790
27705
87
643
2575
25447
Other ultrasound examination during pregnancy
SPAT1189 [2001700290]
SPAT1189 [2001700290]
1.9e-01
2.1e+00
2.6e+00
—
1.3e+00
-6.3e-01
3.5e-01
cases:1.19%
controls:0.98%
cases:2.76%
controls:0.36%
cases:0.59%
controls:0.05%
—
—
cases:0.17%
controls:0.05%
cases:0.18%
controls:0.33%
cases:1.65%
controls:1.17%
34
278
2827
27987
79
102
2782
28163
17
13
2844
28252
—
5
13
2855
28233
5
92
2823
27794
44
305
2618
25785
metadoxine
A05BA09 [947756]
A05BA09 [947756]
—
3.4e+00
—
—
—
-1.0e+50
1.2e+00
—
—
cases:0.66%
controls:0.02%
—
—
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.53%
controls:0.16%
—
19
6
2842
28259
—
—
—
0
18
2828
27868
14
43
2648
26047
pyridoxine (vit B6); oral, parenteral
A11HA02 [21600843]
A11HA02 [21600843]
—
3.4e+00
—
—
—
-1.0e+50
1.2e+00
—
—
cases:0.66%
controls:0.02%
—
—
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.53%
controls:0.16%
—
19
6
2842
28259
—
—
—
0
18
2828
27868
14
43
2648
26047
Elevated level of transaminase and lactic acid dehydrogenase
274774002 [436238]
274774002 [436238]
—
—
—
—
—
2.7e+00
1.9e+00
—
—
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.03%
cases:0.75%
controls:0.11%
—
—
—
—
—
13
9
2815
27877
20
29
2642
26061
Headache
R51.80 [2000503603]
R51.80 [2000503603]
2.7e-01
6.2e-01
1.9e+00
—
2.0e+00
-1.2e-01
6.1e-01
cases:2.52%
controls:1.93%
cases:1.15%
controls:0.62%
cases:0.38%
controls:0.06%
—
—
cases:0.35%
controls:0.05%
cases:0.57%
controls:0.63%
cases:3.94%
controls:2.18%
72
545
2789
27720
33
176
2828
28089
11
16
2850
28249
—
10
13
2850
28233
16
177
2812
27709
105
570
2557
25520
Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
78445-4 [21492711]
78445-4 [21492711]
—
2.3e+00
—
1.0e+50
—
—
2.2e+00
—
—
cases:0.24%
controls:0.02%
—
—
cases:0.70%
controls:0.00%
—
—
—
—
cases:0.83%
controls:0.09%
—
7
7
2854
28258
—
20
0
2841
28265
—
—
22
23
2640
26067
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
7.1e-02
3.0e-01
1.4e+00
—
1.9e+00
6.5e-01
5.3e-01
cases:2.97%
controls:2.77%
cases:1.85%
controls:1.38%
cases:0.91%
controls:0.22%
—
—
cases:1.22%
controls:0.18%
cases:2.48%
controls:1.31%
cases:5.82%
controls:3.51%
85
784
2776
27481
53
389
2808
27876
26
63
2835
28202
—
35
50
2825
28196
70
366
2758
27520
155
917
2507
25173
Treatment of a patient needing special arrangements
WYA30 [2001310874]
WYA30 [2001310874]
3.1e-01
4.4e-01
-1.0e+50
1.0e+50
2.9e+00
1.0e+00
6.1e-01
cases:1.26%
controls:0.93%
cases:0.49%
controls:0.31%
cases:0.00%
controls:0.03%
cases:0.24%
controls:0.00%
cases:0.63%
controls:0.04%
cases:0.71%
controls:0.25%
cases:1.65%
controls:0.91%
36
262
2825
28003
14
89
2847
28176
0
9
2861
28256
7
0
2854
28265
18
10
2842
28236
20
70
2808
27816
44
237
2618
25853
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
-6.2e-02
8.6e-01
1.7e+00
—
1.5e+00
8.5e-02
3.8e-01
cases:2.17%
controls:2.30%
cases:2.38%
controls:1.02%
cases:0.66%
controls:0.12%
—
—
cases:0.56%
controls:0.13%
cases:1.03%
controls:0.94%
cases:3.98%
controls:2.76%
62
651
2799
27614
68
287
2793
27978
19
34
2842
28231
—
16
36
2844
28210
29
263
2799
27623
106
720
2556
25370
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
2.0e-01
-4.0e-01
1.2e+00
—
4.0e+00
4.0e-01
4.1e-01
cases:2.27%
controls:1.87%
cases:0.59%
controls:0.89%
cases:0.28%
controls:0.08%
—
—
cases:4.90%
controls:0.09%
cases:1.45%
controls:0.98%
cases:4.55%
controls:3.05%
65
528
2796
27737
17
251
2844
28014
8
23
2853
28242
—
140
26
2720
28220
41
273
2787
27613
121
796
2541
25294
Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
55869-2 [40758990]
55869-2 [40758990]
2.9e-01
2.6e+00
—
—
—
—
1.7e+00
cases:0.17%
controls:0.13%
cases:0.59%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.41%
controls:0.07%
5
37
2856
28228
17
12
2844
28253
—
—
—
—
11
19
2651
26071
Second degree perineal laceration during delivery
O70.1 [45572890]
O70.1 [45572890]
3.8e-01
—
—
1.0e+50
4.4e+00
8.5e-01
-6.3e-01
cases:1.15%
controls:0.79%
—
—
—
—
cases:0.63%
controls:0.00%
cases:1.92%
controls:0.02%
cases:0.67%
controls:0.29%
cases:0.60%
controls:1.13%
33
224
2828
28041
—
—
18
0
2843
28265
55
7
2805
28239
19
80
2809
27806
16
294
2646
25796
False labour at or after 37 completed weeks of gestation
O47.1 [45558317]
O47.1 [45558317]
4.1e-01
—
—
—
3.5e+00
8.8e-01
4.4e-01
cases:1.36%
controls:0.91%
—
—
—
—
—
—
cases:0.91%
controls:0.03%
cases:0.74%
controls:0.31%
cases:1.47%
controls:0.95%
39
258
2822
28007
—
—
—
26
8
2834
28238
21
86
2807
27800
39
247
2623
25843
Routine postpartum follow-up
Z39.2 [45547306]
Z39.2 [45547306]
2.7e-01
-2.1e+00
—
—
2.8e+00
2.6e+00
7.0e-01
cases:7.31%
controls:5.69%
cases:0.24%
controls:1.89%
—
—
—
—
cases:2.94%
controls:0.18%
cases:23.62%
controls:2.15%
cases:12.77%
controls:6.81%
209
1607
2652
26658
7
533
2854
27732
—
—
84
52
2776
28194
668
600
2160
27286
340
1776
2322
24314
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
-1.2e-01
7.6e-01
1.7e+00
—
1.5e+00
6.3e-02
3.7e-01
cases:2.69%
controls:3.03%
cases:2.59%
controls:1.22%
cases:0.77%
controls:0.14%
—
—
cases:0.70%
controls:0.16%
cases:1.31%
controls:1.23%
cases:4.88%
controls:3.42%
77
856
2784
27409
74
345
2787
27920
22
40
2839
28225
—
20
44
2840
28202
37
343
2791
27543
130
891
2532
25199
Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9838-4 [3003265]
9838-4 [3003265]
—
—
—
—
—
2.5e+00
1.9e+00
—
—
—
—
—
—
—
—
—
—
cases:0.21%
controls:0.02%
cases:0.49%
controls:0.08%
—
—
—
—
—
6
5
2822
27881
13
20
2649
26070
Vomiting of pregnancy, unspecified
O21.9 [45577562]
O21.9 [45577562]
8.9e-01
2.5e+00
1.8e+00
—
—
—
8.8e-01
cases:0.77%
controls:0.32%
cases:1.82%
controls:0.15%
cases:0.17%
controls:0.03%
—
—
—
—
—
—
cases:1.16%
controls:0.49%
22
90
2839
28175
52
41
2809
28224
5
8
2856
28257
—
—
—
31
127
2631
25963
Streptococcus agalactiae Ag [Presence] in Vaginal fluid
40784-1 [3042206]
40784-1 [3042206]
1.6e-01
—
2.0e+00
1.0e+50
4.3e+00
4.7e-01
3.3e-01
cases:0.80%
controls:0.69%
—
—
cases:0.17%
controls:0.02%
cases:1.19%
controls:0.00%
cases:2.52%
controls:0.04%
cases:0.64%
controls:0.40%
cases:2.18%
controls:1.58%
23
194
2838
28071
—
5
7
2856
28258
34
0
2827
28265
72
10
2788
28236
18
111
2810
27775
58
412
2604
25678
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
8.6e-02
-4.3e-01
-1.0e+50
1.0e+50
2.8e+00
1.0e+00
4.7e-01
cases:2.73%
controls:2.51%
cases:0.45%
controls:0.69%
cases:0.00%
controls:0.09%
cases:0.42%
controls:0.00%
cases:1.50%
controls:0.09%
cases:1.59%
controls:0.59%
cases:4.02%
controls:2.54%
78
709
2783
27556
13
196
2848
28069
0
26
2861
28239
12
0
2849
28265
43
26
2817
28220
45
165
2783
27721
107
663
2555
25427
Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]
6500B [2000405100]
6500B [2000405100]
-1.1e-01
—
-1.0e+50
—
3.6e+00
2.1e-02
6.4e-01
cases:4.58%
controls:5.07%
—
—
cases:0.00%
controls:0.06%
—
—
cases:2.73%
controls:0.07%
cases:0.92%
controls:0.90%
cases:3.04%
controls:1.63%
131
1432
2730
26833
—
0
18
2861
28247
—
78
21
2782
28225
26
251
2802
27635
81
425
2581
25665
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
-5.6e-02
8.4e-01
1.6e+00
—
1.5e+00
8.6e-02
4.0e-01
cases:2.52%
controls:2.66%
cases:2.69%
controls:1.18%
cases:0.70%
controls:0.15%
—
—
cases:0.66%
controls:0.16%
cases:1.20%
controls:1.10%
cases:4.66%
controls:3.19%
72
751
2789
27514
77
334
2784
27931
20
41
2841
28224
—
19
44
2841
28202
34
308
2794
27578
124
831
2538
25259
Person consulting for explanation of investigation findings
Z71.2 [45552100]
Z71.2 [45552100]
-1.3e-01
3.4e-01
1.9e+00
—
2.4e+00
5.4e-01
1.5e-01
cases:2.06%
controls:2.35%
cases:1.54%
controls:1.10%
cases:0.77%
controls:0.12%
—
—
cases:1.19%
controls:0.11%
cases:1.56%
controls:0.91%
cases:4.06%
controls:3.50%
59
664
2802
27601
44
312
2817
27953
22
34
2839
28231
—
34
32
2826
28214
44
254
2784
27632
108
912
2554
25178
Ultrasound examination of lower leg veins
PH2AE [2001309451]
PH2AE [2001309451]
5.2e-01
1.3e+00
—
—
2.9e+00
6.3e-01
5.2e-01
cases:0.63%
controls:0.38%
cases:0.49%
controls:0.13%
—
—
—
—
cases:0.31%
controls:0.02%
cases:0.28%
controls:0.15%
cases:0.79%
controls:0.47%
18
106
2843
28159
14
37
2847
28228
—
—
9
5
2851
28241
8
42
2820
27844
21
123
2641
25967
Treatment plan or consultation
WZC00 [2001310885]
WZC00 [2001310885]
1.2e-01
7.2e-01
1.8e+00
1.0e+50
1.6e+00
4.2e-02
2.8e-01
cases:3.98%
controls:3.56%
cases:2.31%
controls:1.13%
cases:0.91%
controls:0.15%
cases:0.21%
controls:0.00%
cases:0.77%
controls:0.15%
cases:1.24%
controls:1.19%
cases:5.26%
controls:4.02%
114
1007
2747
27258
66
320
2795
27945
26
41
2835
28224
6
0
2855
28265
22
43
2838
28203
35
331
2793
27555
140
1050
2522
25040
Calculus of bile duct without cholangitis or cholecystitis
K80.5 [45572234]
K80.5 [45572234]
9.1e-01
2.1e+00
—
—
—
2.3e+00
1.8e+00
cases:0.17%
controls:0.07%
cases:0.17%
controls:0.02%
—
—
—
—
—
—
cases:0.35%
controls:0.04%
cases:0.68%
controls:0.11%
5
20
2856
28245
5
6
2856
28259
—
—
—
10
10
2818
27876
18
28
2644
26062
doxylamine, combinations
R06AA59 [40254475]
R06AA59 [40254475]
—
2.9e+00
—
—
-1.0e+50
-1.0e+50
1.2e+00
—
—
cases:0.80%
controls:0.04%
—
—
—
—
cases:0.00%
controls:0.02%
cases:0.00%
controls:0.08%
cases:0.71%
controls:0.22%
—
23
12
2838
28253
—
—
0
6
2860
28240
0
22
2828
27864
19
57
2643
26033
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
-4.9e-02
8.0e-01
1.6e+00
—
1.3e+00
1.2e-02
4.0e-01
cases:2.20%
controls:2.31%
cases:2.24%
controls:1.02%
cases:0.59%
controls:0.12%
—
—
cases:0.52%
controls:0.14%
cases:0.95%
controls:0.94%
cases:3.94%
controls:2.68%
63
653
2798
27612
64
287
2797
27978
17
35
2844
28230
—
15
39
2845
28207
27
263
2801
27623
105
699
2557
25391
No procedures
SPAT1301 [2001700402]
SPAT1301 [2001700402]
1.4e-01
4.9e-01
1.5e+00
—
1.6e+00
6.1e-01
4.2e-01
cases:3.84%
controls:3.37%
cases:1.61%
controls:0.99%
cases:0.42%
controls:0.10%
—
—
cases:0.42%
controls:0.08%
cases:1.66%
controls:0.91%
cases:4.73%
controls:3.17%
110
953
2751
27312
46
279
2815
27986
12
27
2849
28238
—
12
24
2848
28222
47
255
2781
27631
126
826
2536
25264
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
T81.4 [45575538]
1.6e-01
—
—
—
2.4e+00
1.7e+00
-1.3e-01
cases:0.56%
controls:0.48%
—
—
—
—
—
—
cases:0.24%
controls:0.02%
cases:0.67%
controls:0.13%
cases:0.56%
controls:0.64%
16
135
2845
28130
—
—
—
7
6
2853
28240
19
36
2809
27850
15
168
2647
25922
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
3.1e-02
-9.3e-02
1.9e-01
2.9e+00
6.5e-01
-1.4e-01
3.4e-01
cases:81.34%
controls:80.86%
cases:64.91%
controls:66.99%
cases:27.82%
controls:24.17%
cases:15.62%
controls:1.06%
cases:37.90%
controls:24.15%
cases:65.95%
controls:68.98%
cases:94.85%
controls:92.91%
2327
22854
534
5411
1857
18936
1004
9329
796
6831
2065
21434
447
299
2414
27966
1084
6821
1776
21425
1865
19235
963
8651
2525
24241
137
1849
Structural ultrasound screening, weeks 18+0-21+6
SPAT1375 [2001700476]
SPAT1375 [2001700476]
-3.3e-01
2.9e+00
—
—
—
-1.0e+50
1.1e+00
cases:0.17%
controls:0.24%
cases:1.12%
controls:0.06%
—
—
—
—
—
—
cases:0.00%
controls:0.08%
cases:0.64%
controls:0.21%
5
69
2856
28196
32
17
2829
28248
—
—
—
0
23
2828
27863
17
56
2645
26034
Specific gravity of Urine by Refractometry
5810-7 [3019150]
5810-7 [3019150]
-1.9e-01
9.4e-01
1.6e+00
—
1.5e+00
-2.4e-01
1.2e-01
cases:2.20%
controls:2.64%
cases:3.29%
controls:1.31%
cases:0.84%
controls:0.17%
—
—
cases:0.66%
controls:0.16%
cases:1.17%
controls:1.48%
cases:4.96%
controls:4.41%
63
747
2798
27518
94
369
2767
27896
24
47
2837
28218
—
19
44
2841
28202
33
413
2795
27473
132
1150
2530
24940
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
3255-7 [3016407]
5.6e-01
—
—
—
4.0e+00
1.2e+00
2.1e-01
cases:0.49%
controls:0.28%
—
—
—
—
—
—
cases:0.98%
controls:0.02%
cases:0.28%
controls:0.08%
cases:0.56%
controls:0.46%
14
79
2847
28186
—
—
—
28
5
2832
28241
8
23
2820
27863
15
119
2647
25971
mesalazine; oral, rectal
A07EC02 [21600664]
A07EC02 [21600664]
8.8e-01
6.9e-01
8.1e-01
—
1.0e+00
7.0e-01
7.0e-01
cases:1.78%
controls:0.75%
cases:1.15%
controls:0.58%
cases:0.45%
controls:0.20%
—
—
cases:0.59%
controls:0.21%
cases:1.24%
controls:0.62%
cases:1.88%
controls:0.94%
51
211
2810
28054
33
164
2828
28101
13
57
2848
28208
—
17
60
2843
28186
35
173
2793
27713
50
245
2612
25845
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
1.2e-01
2.0e-01
7.1e-01
—
2.2e+00
7.6e-01
3.6e-01
cases:28.49%
controls:26.03%
cases:10.56%
controls:8.84%
cases:1.82%
controls:0.90%
—
—
cases:7.62%
controls:0.94%
cases:17.57%
controls:9.05%
cases:36.63%
controls:28.78%
815
7358
2046
20907
302
2499
2559
25766
52
255
2809
28010
—
218
265
2642
27981
497
2525
2331
25361
975
7510
1687
18580
Microscopic observation [Identifier] in Vaginal fluid by Gram stain
14361-0 [3000855]
14361-0 [3000855]
2.2e-02
1.7e+00
2.3e+00
—
—
4.5e-02
4.3e-01
cases:0.84%
controls:0.82%
cases:1.12%
controls:0.21%
cases:0.28%
controls:0.03%
—
—
—
—
cases:0.25%
controls:0.24%
cases:1.13%
controls:0.74%
24
232
2837
28033
32
60
2829
28205
8
8
2853
28257
—
—
7
66
2821
27820
30
192
2632
25898
Maternal care for (suspected) chromosomal abnormality in fetus
O35.1 [45606585]
O35.1 [45606585]
6.3e-01
3.2e+00
—
—
—
—
7.4e-01
cases:0.52%
controls:0.28%
cases:1.92%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.94%
controls:0.45%
15
79
2846
28186
55
23
2806
28242
—
—
—
—
25
117
2637
25973
vaginal ring with progestogen; vaginal
G02BB02 [715899]
G02BB02 [715899]
1.5e+00
2.4e+00
-1.0e+50
—
-1.0e+50
—
1.3e-01
cases:1.05%
controls:0.24%
cases:1.36%
controls:0.12%
cases:0.00%
controls:0.04%
—
—
cases:0.00%
controls:0.05%
—
—
cases:0.53%
controls:0.46%
30
69
2831
28196
39
34
2822
28231
0
11
2861
28254
—
0
15
2860
28231
—
14
120
2648
25970
Albumin [Mass/volume] in Urine
1754-1 [3012516]
1754-1 [3012516]
-1.5e-01
-1.4e-01
2.0e+00
—
2.5e+00
1.8e-01
-5.5e-01
cases:0.94%
controls:1.09%
cases:0.80%
controls:0.93%
cases:0.84%
controls:0.12%
—
—
cases:1.36%
controls:0.12%
cases:1.34%
controls:1.13%
cases:2.07%
controls:3.51%
27
309
2834
27956
23
262
2838
28003
24
33
2837
28232
—
39
33
2821
28213
38
314
2790
27572
55
917
2607
25173
Antepartum bleeding
W03 [2002001208]
W03 [2002001208]
1.4e+00
2.5e+00
—
—
—
—
3.6e-01
cases:0.45%
controls:0.12%
cases:0.49%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.30%
controls:0.21%
13
33
2848
28232
14
11
2847
28254
—
—
—
—
8
55
2654
26035
Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]
8095-2 [3007566]
4.6e-01
—
—
—
—
2.2e+00
1.7e+00
cases:0.28%
controls:0.18%
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.07%
cases:1.01%
controls:0.18%
8
50
2853
28215
—
—
—
—
17
19
2811
27867
27
48
2635
26042
metronidazole; oral, rectal
P01AB01 [21604857]
P01AB01 [21604857]
2.8e-01
4.5e-02
3.9e-02
—
2.7e+00
5.7e-01
3.5e-01
cases:9.47%
controls:7.36%
cases:2.24%
controls:2.14%
cases:0.21%
controls:0.20%
—
—
cases:2.59%
controls:0.18%
cases:3.71%
controls:2.14%
cases:11.16%
controls:8.14%
271
2081
2590
26184
64
605
2797
27660
6
57
2855
28208
—
74
50
2786
28196
105
598
2723
27288
297
2123
2365
23967
flucloxacillin; oral, parenteral
J01CF05 [21602857]
J01CF05 [21602857]
-1.8e-01
—
—
—
2.6e+00
1.3e+00
1.7e-01
cases:0.21%
controls:0.25%
—
—
—
—
—
—
cases:0.24%
controls:0.02%
cases:0.57%
controls:0.16%
cases:0.79%
controls:0.67%
6
71
2855
28194
—
—
—
7
5
2853
28241
16
45
2812
27841
21
174
2641
25916
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
7853-5 [3015635]
2.5e-01
2.0e+00
—
1.0e+50
—
—
1.9e+00
cases:0.45%
controls:0.35%
cases:0.52%
controls:0.07%
—
—
cases:1.71%
controls:0.00%
—
—
—
—
cases:1.88%
controls:0.28%
13
100
2848
28165
15
21
2846
28244
—
49
0
2812
28265
—
—
50
74
2612
26016
Mitochondria Ab [Titer] in Serum
20483-4 [3034770]
20483-4 [3034770]
6.4e-01
—
—
—
—
2.1e+00
1.7e+00
cases:0.31%
controls:0.17%
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.07%
cases:1.01%
controls:0.18%
9
47
2852
28218
—
—
—
—
16
19
2812
27867
27
47
2635
26043
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
2.7e-01
-4.8e-02
2.0e+00
—
1.8e+00
2.4e-01
3.0e-01
cases:1.92%
controls:1.47%
cases:0.38%
controls:0.40%
cases:0.56%
controls:0.07%
—
—
cases:0.35%
controls:0.06%
cases:0.60%
controls:0.47%
cases:2.44%
controls:1.82%
55
416
2806
27849
11
114
2850
28151
16
21
2845
28244
—
10
16
2850
28230
17
132
2811
27754
65
476
2597
25614
Pain localized to upper abdomen
R10.1 [45568111]
R10.1 [45568111]
2.9e-01
5.2e-01
2.3e+00
—
1.6e+00
9.1e-01
6.3e-01
cases:1.78%
controls:1.34%
cases:0.77%
controls:0.46%
cases:0.63%
controls:0.06%
—
—
cases:0.24%
controls:0.05%
cases:1.10%
controls:0.44%
cases:3.08%
controls:1.67%
51
378
2810
27887
22
130
2839
28135
18
18
2843
28247
—
7
14
2853
28232
31
124
2797
27762
82
436
2580
25654
Creatinine [Moles/volume] in Urine
14683-7 [3009508]
14683-7 [3009508]
-2.1e-01
-8.3e-02
1.7e+00
—
2.1e+00
-4.8e-02
-3.4e-01
cases:1.54%
controls:1.90%
cases:1.15%
controls:1.25%
cases:1.01%
controls:0.18%
—
—
cases:1.50%
controls:0.18%
cases:1.45%
controls:1.52%
cases:3.31%
controls:4.58%
44
536
2817
27729
33
354
2828
27911
29
52
2832
28213
—
43
52
2817
28194
41
424
2787
27462
88
1194
2574
24896
Periodic health check-up of children and adolescents
SPAT1315 [2001700416]
SPAT1315 [2001700416]
3.0e-02
1.2e+00
—
—
—
1.6e+00
9.5e-01
cases:0.77%
controls:0.75%
cases:0.52%
controls:0.16%
—
—
—
—
—
—
cases:0.67%
controls:0.13%
cases:1.35%
controls:0.53%
22
211
2839
28054
15
44
2846
28221
—
—
—
19
37
2809
27849
36
137
2626
25953
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
7.0e-02
1.3e+00
1.4e+00
—
1.0e+00
5.6e-02
2.3e-01
cases:5.35%
controls:5.01%
cases:8.00%
controls:2.26%
cases:1.15%
controls:0.28%
—
—
cases:0.80%
controls:0.29%
cases:2.44%
controls:2.31%
cases:8.90%
controls:7.22%
153
1415
2708
26850
229
638
2632
27627
33
78
2828
28187
—
23
82
2837
28164
69
644
2759
27242
237
1885
2425
24205
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
22246-3 [3017918]
3.8e-01
1.8e+00
—
1.0e+50
—
—
2.0e+00
cases:0.49%
controls:0.34%
cases:0.52%
controls:0.08%
—
—
cases:1.85%
controls:0.00%
—
—
—
—
cases:1.95%
controls:0.28%
14
95
2847
28170
15
24
2846
28241
—
53
0
2808
28265
—
—
52
73
2610
26017
Postpartum check-up
SPAT1380 [2001700480]
SPAT1380 [2001700480]
3.3e-01
—
—
—
6.0e-01
2.7e+00
7.5e-01
cases:5.14%
controls:3.76%
—
—
—
—
—
—
cases:0.24%
controls:0.13%
cases:14.60%
controls:1.15%
cases:7.40%
controls:3.64%
147
1062
2714
27203
—
—
—
7
38
2853
28208
413
320
2415
27566
197
949
2465
25141
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
O99.4 [45592316]
O99.4 [45592316]
—
2.4e+00
—
—
—
1.3e+00
1.4e+00
—
—
cases:0.35%
controls:0.03%
—
—
—
—
—
—
cases:0.18%
controls:0.05%
cases:0.41%
controls:0.11%
—
10
9
2851
28256
—
—
—
5
14
2823
27872
11
28
2651
26062
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
7852-7 [3010130]
3.0e-01
1.9e+00
—
1.0e+50
—
—
1.9e+00
cases:0.45%
controls:0.34%
cases:0.49%
controls:0.07%
—
—
cases:1.68%
controls:0.00%
—
—
—
—
cases:1.77%
controls:0.28%
13
95
2848
28170
14
21
2847
28244
—
48
0
2813
28265
—
—
47
73
2615
26017
Albumin/Creatinine [Ratio] in Urine
32294-1 [3020682]
32294-1 [3020682]
-2.7e-02
-1.1e-01
2.0e+00
—
2.3e+00
1.2e-01
-5.5e-01
cases:1.15%
controls:1.19%
cases:0.87%
controls:0.98%
cases:0.94%
controls:0.13%
—
—
cases:1.40%
controls:0.14%
cases:1.38%
controls:1.22%
cases:2.18%
controls:3.73%
33
335
2828
27930
25
276
2836
27989
27
38
2834
28227
—
40
39
2820
28207
39
341
2789
27545
58
974
2604
25116
Curettage of uterus after delivery or abortion
MBA03 [2001306930]
MBA03 [2001306930]
9.3e-01
6.3e-01
—
—
2.8e+00
8.8e-01
1.8e-01
cases:1.78%
controls:0.71%
cases:0.38%
controls:0.21%
—
—
—
—
cases:0.45%
controls:0.03%
cases:0.42%
controls:0.18%
cases:1.01%
controls:0.85%
51
200
2810
28065
11
58
2850
28207
—
—
13
8
2847
28238
12
49
2816
27837
27
221
2635
25869
Pregnancy, not (yet) confirmed
Z32.0 [45585821]
Z32.0 [45585821]
9.1e-01
2.0e+00
—
—
-1.0e+50
—
7.8e-01
cases:1.47%
controls:0.59%
cases:1.75%
controls:0.24%
—
—
—
—
cases:0.00%
controls:0.02%
—
—
cases:1.28%
controls:0.59%
42
168
2819
28097
50
69
2811
28196
—
—
0
5
2860
28241
—
34
154
2628
25936
ICSI
TLW14 [2001306785]
TLW14 [2001306785]
1.4e+00
2.3e+00
—
—
—
—
—
cases:0.45%
controls:0.12%
cases:0.52%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
13
33
2848
28232
15
15
2846
28250
—
—
—
—
—
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 [3007080]
31374-2 [3007080]
2.9e-01
1.7e+00
—
1.0e+50
—
—
1.9e+00
cases:0.42%
controls:0.31%
cases:0.42%
controls:0.07%
—
—
cases:1.71%
controls:0.00%
—
—
—
—
cases:1.80%
controls:0.27%
12
89
2849
28176
12
21
2849
28244
—
49
0
2812
28265
—
—
48
70
2614
26020
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
2.5e-01
3.0e-01
—
—
3.6e+00
4.1e-01
3.9e-01
cases:0.91%
controls:0.71%
cases:0.35%
controls:0.26%
—
—
—
—
cases:1.19%
controls:0.03%
cases:0.39%
controls:0.26%
cases:1.43%
controls:0.97%
26
200
2835
28065
10
73
2851
28192
—
—
34
9
2826
28237
11
72
2817
27814
38
253
2624
25837
Combined screening in early pregnancy
SPAT1373 [2001700474]
SPAT1373 [2001700474]
-2.1e-01
2.7e+00
—
—
—
—
9.4e-01
cases:0.38%
controls:0.47%
cases:1.99%
controls:0.14%
—
—
—
—
—
—
—
—
cases:0.94%
controls:0.37%
11
134
2850
28131
57
40
2804
28225
—
—
—
—
25
96
2637
25994
triptorelin; parenteral
L02AE04 [21603827]
L02AE04 [21603827]
1.4e+00
2.2e+00
-1.0e+50
—
-1.0e+50
—
1.9e-01
cases:1.08%
controls:0.28%
cases:1.15%
controls:0.13%
cases:0.00%
controls:0.02%
—
—
cases:0.00%
controls:0.02%
—
—
cases:0.49%
controls:0.40%
31
79
2830
28186
33
36
2828
28229
0
5
2861
28260
—
0
5
2860
28241
—
13
105
2649
25985
bromocriptine; oral
N04BC01 [21604473]
N04BC01 [21604473]
4.7e-01
6.5e-01
-1.0e+50
—
2.4e+00
1.1e+00
5.5e-01
cases:0.66%
controls:0.42%
cases:0.24%
controls:0.13%
cases:0.00%
controls:0.02%
—
—
cases:0.28%
controls:0.02%
cases:0.53%
controls:0.17%
cases:0.75%
controls:0.43%
19
118
2842
28147
7
36
2854
28229
0
7
2861
28258
—
8
7
2852
28239
15
48
2813
27838
20
113
2642
25977
bromocriptine; oral, parenteral
G02CB01 [21602458]
G02CB01 [21602458]
4.7e-01
6.5e-01
-1.0e+50
—
2.4e+00
1.1e+00
5.5e-01
cases:0.66%
controls:0.42%
cases:0.24%
controls:0.13%
cases:0.00%
controls:0.02%
—
—
cases:0.28%
controls:0.02%
cases:0.53%
controls:0.17%
cases:0.75%
controls:0.43%
19
118
2842
28147
7
36
2854
28229
0
7
2861
28258
—
8
7
2852
28239
15
48
2813
27838
20
113
2642
25977
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 [3007844]
5159-9 [3007844]
2.8e-01
1.6e+00
—
1.0e+50
—
—
1.9e+00
cases:0.42%
controls:0.32%
cases:0.38%
controls:0.08%
—
—
cases:1.78%
controls:0.00%
—
—
—
—
cases:1.84%
controls:0.27%
12
90
2849
28175
11
22
2850
28243
—
51
0
2810
28265
—
—
49
70
2613
26020
RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
35465-4 [3034603]
35465-4 [3034603]
2.8e-01
2.6e+00
1.8e+00
—
—
—
8.8e-01
cases:0.80%
controls:0.61%
cases:2.59%
controls:0.19%
cases:0.21%
controls:0.04%
—
—
—
—
—
—
cases:1.65%
controls:0.69%
23
172
2838
28093
74
54
2787
28211
6
10
2855
28255
—
—
—
44
181
2618
25909
Ectopic pregnancy, unspecified
O00.9 [45572743]
O00.9 [45572743]
1.3e+00
2.2e+00
—
—
—
—
4.9e-01
cases:0.77%
controls:0.22%
cases:0.45%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.41%
controls:0.25%
22
61
2839
28204
13
14
2848
28251
—
—
—
—
11
66
2651
26024
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
-4.2e-02
—
—
1.0e+50
3.0e+00
3.4e-01
5.1e-01
cases:1.19%
controls:1.24%
—
—
—
—
cases:0.42%
controls:0.00%
cases:0.56%
controls:0.03%
cases:0.57%
controls:0.40%
cases:2.25%
controls:1.37%
34
350
2827
27915
—
—
12
0
2849
28265
16
8
2844
28238
16
112
2812
27774
60
358
2602
25732
Nonpurulent mastitis associated with childbirth
O91.2 [45539211]
O91.2 [45539211]
6.2e-01
-1.0e+50
—
—
—
2.5e+00
9.5e-01
cases:0.42%
controls:0.23%
cases:0.00%
controls:0.06%
—
—
—
—
—
—
cases:0.85%
controls:0.07%
cases:0.75%
controls:0.29%
12
64
2849
28201
0
17
2861
28248
—
—
—
24
19
2804
27867
20
76
2642
26014
Delayed delivery after spontaneous or unspecified rupture of membranes
O75.6 [45582575]
O75.6 [45582575]
1.1e-01
-1.0e+50
—
—
3.5e+00
9.5e-01
1.3e-01
cases:0.56%
controls:0.50%
cases:0.00%
controls:0.14%
—
—
—
—
cases:1.01%
controls:0.03%
cases:0.39%
controls:0.15%
cases:0.56%
controls:0.49%
16
142
2845
28123
0
40
2861
28225
—
—
29
9
2831
28237
11
42
2817
27844
15
129
2647
25961
Fear of complications of pregnancy
W27 [2002001220]
W27 [2002001220]
1.1e+00
2.4e+00
—
—
—
-1.0e+50
6.9e-01
cases:0.73%
controls:0.25%
cases:0.87%
controls:0.08%
—
—
—
—
—
—
cases:0.00%
controls:0.08%
cases:0.49%
controls:0.25%
21
71
2840
28194
25
23
2836
28242
—
—
—
0
22
2828
27864
13
64
2649
26026
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
16933-4 [3021879]
4.8e-01
1.1e+00
—
—
1.9e+00
-8.9e-01
2.2e-01
cases:2.52%
controls:1.57%
cases:1.75%
controls:0.60%
—
—
—
—
cases:0.28%
controls:0.04%
cases:0.21%
controls:0.51%
cases:2.10%
controls:1.69%
72
444
2789
27821
50
171
2811
28094
—
—
8
12
2852
28234
6
143
2822
27743
56
441
2606
25649
ganirelix; parenteral
H01CC01 [21602720]
H01CC01 [21602720]
1.3e+00
2.1e+00
-1.0e+50
—
-1.0e+50
—
-4.5e-01
cases:2.06%
controls:0.56%
cases:1.85%
controls:0.23%
cases:0.00%
controls:0.03%
—
—
cases:0.00%
controls:0.02%
—
—
cases:0.53%
controls:0.82%
59
158
2802
28107
53
64
2808
28201
0
9
2861
28256
—
0
6
2860
28240
—
14
214
2648
25876
follitropin beta; parenteral
G03GA06 [21602604]
G03GA06 [21602604]
1.3e+00
2.1e+00
-1.0e+50
—
-1.0e+50
—
-6.5e-01
cases:2.13%
controls:0.57%
cases:1.82%
controls:0.23%
cases:0.00%
controls:0.04%
—
—
cases:0.00%
controls:0.05%
—
—
cases:0.49%
controls:0.93%
61
160
2800
28105
52
65
2809
28200
0
11
2861
28254
—
0
13
2860
28233
—
13
242
2649
25848
Pregnancy-related condition, unspecified
O26.9 [45558221]
O26.9 [45558221]
1.2e+00
3.4e+00
—
—
—
—
9.0e-01
cases:0.31%
controls:0.09%
cases:0.52%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.19%
controls:0.08%
9
26
2852
28239
15
5
2846
28260
—
—
—
—
5
20
2657
26070
Labour and delivery complicated by other evidence of fetal stress
O68.8 [45582566]
O68.8 [45582566]
2.9e-01
-1.0e+50
—
—
3.4e+00
—
—
cases:0.28%
controls:0.21%
cases:0.00%
controls:0.06%
—
—
—
—
cases:0.52%
controls:0.02%
—
—
—
—
8
59
2853
28206
0
17
2861
28248
—
—
15
5
2845
28241
—
—
Crohn disease of small intestine
K50.0 [45596324]
K50.0 [45596324]
1.2e+00
1.1e+00
1.6e+00
1.0e+50
2.1e+00
1.2e+00
1.0e+00
cases:0.49%
controls:0.14%
cases:0.31%
controls:0.11%
cases:0.21%
controls:0.04%
cases:0.21%
controls:0.00%
cases:0.21%
controls:0.02%
cases:0.32%
controls:0.09%
cases:0.49%
controls:0.18%
14
40
2847
28225
9
30
2852
28235
6
12
2855
28253
6
0
2855
28265
6
7
2854
28239
9
26
2819
27860
13
46
2649
26044
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
MA1AE [2001306827]
MA1AE [2001306827]
4.5e-01
2.4e+00
-1.0e+50
—
—
-3.3e-01
5.5e-01
cases:5.45%
controls:3.56%
cases:11.99%
controls:1.26%
cases:0.00%
controls:0.12%
—
—
—
—
cases:0.88%
controls:1.22%
cases:7.44%
controls:4.42%
156
1006
2705
27259
343
355
2518
27910
0
35
2861
28230
—
—
25
341
2803
27545
198
1154
2464
24936
Puerperal mastitis
W94 [2002001281]
W94 [2002001281]
9.4e-01
-1.0e+50
—
—
1.0e+50
2.4e+00
9.9e-01
cases:0.28%
controls:0.11%
cases:0.00%
controls:0.04%
—
—
—
—
cases:0.21%
controls:0.00%
cases:0.46%
controls:0.04%
cases:0.56%
controls:0.21%
8
31
2853
28234
0
10
2861
28255
—
—
6
0
2854
28246
13
12
2815
27874
15
55
2647
26035
Percutaneous or transvaginal puncture and recovery of oocyte
LAA10 [2001306406]
LAA10 [2001306406]
1.1e+00
2.2e+00
-1.0e+50
—
-1.0e+50
—
-4.5e-01
cases:1.82%
controls:0.60%
cases:2.13%
controls:0.23%
cases:0.00%
controls:0.03%
—
—
cases:0.00%
controls:0.03%
—
—
cases:0.41%
controls:0.65%
52
171
2809
28094
61
65
2800
28200
0
8
2861
28257
—
0
9
2860
28237
—
11
169
2651
25921
Maternal care for other specified fetal problems
O36.8 [45567946]
O36.8 [45567946]
3.0e-01
1.1e+00
3.3e+00
1.0e+50
—
1.2e+00
6.2e-01
cases:0.49%
controls:0.36%
cases:0.38%
controls:0.13%
cases:0.70%
controls:0.02%
cases:0.21%
controls:0.00%
—
—
cases:0.35%
controls:0.11%
cases:0.71%
controls:0.39%
14
103
2847
28162
11
37
2850
28228
20
7
2841
28258
6
0
2855
28265
—
10
30
2818
27856
19
101
2643
25989
Ultrasound screening of fetal nuchal translucency
MA2JE [2001306837]
MA2JE [2001306837]
2.3e-01
2.7e+00
-1.0e+50
—
—
-3.4e-01
6.6e-01
cases:4.12%
controls:3.32%
cases:13.39%
controls:1.05%
cases:0.00%
controls:0.09%
—
—
—
—
cases:0.64%
controls:0.89%
cases:6.54%
controls:3.49%
118
938
2743
27327
383
298
2478
27967
0
25
2861
28240
—
—
18
249
2810
27637
174
910
2488
25180
Combined first trimester screening
MA3AE [2001306839]
MA3AE [2001306839]
1.5e-01
2.6e+00
-1.0e+50
—
-1.0e+50
-8.7e-01
7.8e-01
cases:1.89%
controls:1.63%
cases:7.97%
controls:0.67%
cases:0.00%
controls:0.10%
—
—
cases:0.00%
controls:0.10%
cases:0.28%
controls:0.67%
cases:4.92%
controls:2.32%
54
462
2807
27803
228
189
2633
28076
0
27
2861
28238
—
0
28
2860
28218
8
187
2820
27699
131
605
2531
25485
Outcome of delivery
Z37 [45581024]
Z37 [45581024]
2.1e-01
-3.5e+00
-1.3e+00
—
6.0e+00
1.1e+00
8.2e-01
cases:32.61%
controls:28.11%
cases:0.28%
controls:8.11%
cases:0.17%
controls:0.67%
—
—
cases:75.17%
controls:0.74%
cases:21.00%
controls:8.24%
cases:44.18%
controls:25.76%
933
7945
1928
20320
8
2293
2853
25972
5
188
2856
28077
—
2150
210
710
28036
594
2299
2234
25587
1176
6722
1486
19368
Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
93769-8 [1002102]
93769-8 [1002102]
2.0e-01
2.5e+00
—
—
-1.0e+50
2.4e-01
7.9e-01
cases:1.82%
controls:1.50%
cases:6.78%
controls:0.57%
—
—
—
—
cases:0.00%
controls:0.08%
cases:0.53%
controls:0.42%
cases:3.57%
controls:1.65%
52
423
2809
27842
194
162
2667
28103
—
—
0
22
2860
28224
15
116
2813
27770
95
430
2567
25660
Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
32046-5 [3021584]
32046-5 [3021584]
2.3e-01
2.6e+00
—
—
-1.0e+50
-2.5e-01
7.4e-01
cases:5.21%
controls:4.19%
cases:18.63%
controls:1.70%
—
—
—
—
cases:0.00%
controls:0.16%
cases:1.13%
controls:1.44%
cases:9.43%
controls:4.73%
149
1183
2712
27082
533
481
2328
27784
—
—
0
44
2860
28202
32
402
2796
27484
251
1233
2411
24857
Parvovirus B19 IgG Ab [Titer] in Serum
25630-5 [3009550]
25630-5 [3009550]
3.5e-01
2.2e+00
—
—
—
—
1.1e+00
cases:0.28%
controls:0.20%
cases:0.35%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.64%
controls:0.22%
8
56
2853
28209
10
11
2851
28254
—
—
—
—
17
57
2645
26033
Care and examination immediately after delivery
Z39.0 [45556829]
Z39.0 [45556829]
1.3e+00
-1.0e+50
—
—
—
2.0e+00
6.2e-01
cases:0.66%
controls:0.19%
cases:0.00%
controls:0.03%
—
—
—
—
—
—
cases:0.57%
controls:0.08%
cases:0.41%
controls:0.22%
19
54
2842
28211
0
9
2861
28256
—
—
—
16
21
2812
27865
11
58
2651
26032
Emergency use of U07.1 | COVID-19, virus identified
U07.1 [45756093]
U07.1 [45756093]
-4.2e-02
2.3e-01
1.4e+00
—
1.8e+00
-7.2e-01
-2.0e-04
cases:1.40%
controls:1.46%
cases:0.94%
controls:0.75%
cases:0.38%
controls:0.09%
—
—
cases:0.42%
controls:0.07%
cases:0.39%
controls:0.79%
cases:2.67%
controls:2.67%
40
412
2821
27853
27
213
2834
28052
11
26
2850
28239
—
12
19
2848
28227
11
221
2817
27665
71
696
2591
25394
chorionic gonadotrophin; parenteral
G03GA01 [21602599]
G03GA01 [21602599]
1.2e+00
2.0e+00
-1.0e+50
—
-1.0e+50
—
-3.8e-01
cases:4.89%
controls:1.48%
cases:5.00%
controls:0.69%
cases:0.00%
controls:0.09%
—
—
cases:0.00%
controls:0.11%
—
—
cases:1.39%
controls:2.02%
140
419
2721
27846
143
194
2718
28071
0
25
2861
28240
—
0
31
2860
28215
—
37
528
2625
25562
choriogonadotropin alfa; parenteral
G03GA08 [21602606]
G03GA08 [21602606]
1.2e+00
2.0e+00
-1.0e+50
—
-1.0e+50
—
-3.8e-01
cases:4.89%
controls:1.48%
cases:5.00%
controls:0.69%
cases:0.00%
controls:0.09%
—
—
cases:0.00%
controls:0.11%
—
—
cases:1.39%
controls:2.02%
140
419
2721
27846
143
194
2718
28071
0
25
2861
28240
—
0
31
2860
28215
—
37
528
2625
25562
Female infertility associated with anovulation
N97.0 [45592162]
N97.0 [45592162]
1.1e+00
2.1e+00
-1.0e+50
—
-1.0e+50
—
-8.5e-02
cases:2.17%
controls:0.71%
cases:2.10%
controls:0.25%
cases:0.00%
controls:0.06%
—
—
cases:0.00%
controls:0.07%
—
—
cases:0.68%
controls:0.74%
62
201
2799
28064
60
72
2801
28193
0
16
2861
28249
—
0
21
2860
28225
—
18
192
2644
25898
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
JN1AE [2001305517]
1.7e-01
1.0e+00
—
1.0e+50
—
1.6e+00
1.6e+00
cases:0.56%
controls:0.47%
cases:0.38%
controls:0.14%
—
—
cases:3.32%
controls:0.00%
—
—
cases:0.71%
controls:0.14%
cases:2.14%
controls:0.43%
16
134
2845
28131
11
39
2850
28226
—
95
0
2766
28265
—
20
40
2808
27846
57
112
2605
25978
Chorion biopsy with ultrasound guidance
MA4AT [2001306860]
MA4AT [2001306860]
—
3.2e+00
—
—
—
—
6.7e-01
—
—
cases:0.42%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.30%
controls:0.15%
—
12
5
2849
28260
—
—
—
—
8
40
2654
26050
Polyhydramnios
O40 [45606611]
O40 [45606611]
—
5.3e-01
3.2e+00
1.0e+50
—
6.8e-01
4.6e-01
—
—
cases:0.17%
controls:0.10%
cases:0.42%
controls:0.02%
cases:0.56%
controls:0.00%
—
—
cases:0.21%
controls:0.11%
cases:0.64%
controls:0.40%
—
5
29
2856
28236
12
5
2849
28260
16
0
2845
28265
—
6
30
2822
27856
17
105
2645
25985
Maternal care for tumour of corpus uteri
O34.1 [45548752]
O34.1 [45548752]
—
3.2e+00
—
—
1.0e+50
—
—
—
—
cases:0.42%
controls:0.02%
—
—
—
—
cases:0.35%
controls:0.00%
—
—
—
—
—
12
5
2849
28260
—
—
10
0
2850
28246
—
—
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
6.3e-02
-5.3e-01
-1.0e+50
—
2.6e+00
7.1e-01
5.6e-01
cases:1.71%
controls:1.61%
cases:0.24%
controls:0.41%
cases:0.00%
controls:0.03%
—
—
cases:0.52%
controls:0.04%
cases:0.74%
controls:0.37%
cases:2.63%
controls:1.52%
49
455
2812
27810
7
117
2854
28148
0
9
2861
28256
—
15
11
2845
28235
21
102
2807
27784
70
397
2592
25693
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]
LC2BE [2001306544]
4.6e-01
1.0e+00
1.8e-01
—
9.0e-01
4.2e-01
3.5e-01
cases:10.49%
controls:6.89%
cases:6.89%
controls:2.55%
cases:0.45%
controls:0.38%
—
—
cases:0.77%
controls:0.32%
cases:3.85%
controls:2.56%
cases:11.08%
controls:8.09%
300
1948
2561
26317
197
722
2664
27543
13
107
2848
28158
—
22
89
2838
28157
109
715
2719
27171
295
2111
2367
23979
Repeated measurement of ovarian cyst
LA2HE [2001306399]
LA2HE [2001306399]
1.3e+00
1.9e+00
—
—
—
-1.0e+50
—
cases:0.59%
controls:0.16%
cases:0.31%
controls:0.05%
—
—
—
—
—
—
cases:0.00%
controls:0.04%
—
—
17
46
2844
28219
9
14
2852
28251
—
—
—
0
12
2828
27874
—
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
29953-7 [3037522]
-1.4e-01
-2.6e-01
—
—
2.6e+00
5.0e-01
5.4e-01
cases:1.01%
controls:1.16%
cases:0.31%
controls:0.41%
—
—
—
—
cases:0.38%
controls:0.03%
cases:0.74%
controls:0.45%
cases:2.63%
controls:1.56%
29
329
2832
27936
9
115
2852
28150
—
—
11
8
2849
28238
21
126
2807
27760
70
406
2592
25684
Compl labour/ delivery livebirth
W92 [2002001279]
W92 [2002001279]
-1.0e-01
—
-1.0e+50
—
—
2.5e+00
6.9e-01
cases:0.56%
controls:0.62%
—
—
cases:0.00%
controls:0.03%
—
—
—
—
cases:2.12%
controls:0.19%
cases:1.39%
controls:0.71%
16
175
2845
28090
—
0
8
2861
28257
—
—
60
52
2768
27834
37
184
2625
25906
Telephone prescription or other care instructions
WZB00 [2001310884]
WZB00 [2001310884]
2.8e-01
4.3e-01
1.4e+00
—
1.7e+00
3.6e-01
2.7e-01
cases:5.38%
controls:4.13%
cases:1.78%
controls:1.17%
cases:0.38%
controls:0.09%
—
—
cases:0.73%
controls:0.13%
cases:1.70%
controls:1.19%
cases:5.52%
controls:4.27%
154
1168
2707
27097
51
330
2810
27935
11
26
2850
28239
—
21
38
2839
28208
48
333
2780
27553
147
1113
2515
24977
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
2276-4 [3001122]
1.0e-01
8.4e-01
1.7e+00
2.3e+00
6.0e-01
3.0e-01
2.6e-01
cases:6.75%
controls:6.14%
cases:8.46%
controls:3.84%
cases:2.76%
controls:0.50%
cases:0.17%
controls:0.02%
cases:1.05%
controls:0.58%
cases:5.55%
controls:4.18%
cases:13.94%
controls:11.09%
193
1736
2668
26529
242
1085
2619
27180
79
141
2782
28124
5
5
2856
28260
30
163
2830
28083
157
1166
2671
26720
371
2894
2291
23196
Parvovirus B19 IgM Ab [Units/volume] in Serum
7984-8 [3026515]
7984-8 [3026515]
3.6e-01
2.0e+00
—
—
—
—
1.2e+00
cases:0.31%
controls:0.22%
cases:0.35%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.23%
9
62
2852
28203
10
14
2851
28251
—
—
—
—
19
59
2643
26031
nafarelin; nasal
H01CA02 [21602712]
H01CA02 [21602712]
1.2e+00
1.9e+00
-1.0e+50
—
-1.0e+50
—
-6.0e-01
cases:1.92%
controls:0.57%
cases:1.64%
controls:0.25%
cases:0.00%
controls:0.05%
—
—
cases:0.00%
controls:0.03%
—
—
cases:0.53%
controls:0.96%
55
162
2806
28103
47
72
2814
28193
0
13
2861
28252
—
0
8
2860
28238
—
14
250
2648
25840
Obesity, unspecified
E66.9 [45576460]
E66.9 [45576460]
8.1e-02
3.9e-01
—
—
3.1e+00
7.1e-01
5.4e-01
cases:0.31%
controls:0.29%
cases:0.24%
controls:0.17%
—
—
—
—
cases:0.38%
controls:0.02%
cases:0.21%
controls:0.10%
cases:0.60%
controls:0.35%
9
82
2852
28183
7
47
2854
28218
—
—
11
5
2849
28241
6
29
2822
27857
16
92
2646
25998
Pruritus
S02 [2002000967]
S02 [2002000967]
2.7e-01
1.7e+00
—
1.0e+50
—
—
1.4e+00
cases:0.31%
controls:0.24%
cases:0.31%
controls:0.06%
—
—
cases:0.35%
controls:0.00%
—
—
—
—
cases:0.98%
controls:0.24%
9
68
2852
28197
9
17
2852
28248
—
10
0
2851
28265
—
—
26
62
2636
26028
Female infertility associated with male factors
N97.4 [45606523]
N97.4 [45606523]
1.3e+00
1.8e+00
-1.0e+50
—
-1.0e+50
—
-7.6e-02
cases:1.78%
controls:0.49%
cases:1.29%
controls:0.22%
cases:0.00%
controls:0.06%
—
—
cases:0.00%
controls:0.06%
—
—
cases:0.53%
controls:0.57%
51
138
2810
28127
37
63
2824
28202
0
18
2861
28247
—
0
18
2860
28228
—
14
148
2648
25942
Prolonged pregnancy
O48 [45582557]
O48 [45582557]
1.6e-01
-1.0e+50
—
—
3.1e+00
-5.6e-01
6.2e-02
cases:1.12%
controls:0.95%
cases:0.00%
controls:0.27%
—
—
—
—
cases:0.45%
controls:0.02%
cases:0.18%
controls:0.31%
cases:1.05%
controls:0.99%
32
269
2829
27996
0
75
2861
28190
—
—
13
6
2847
28240
5
86
2823
27800
28
258
2634
25832
Fetal Trisomy 21 risk [Likelihood] Based on maternal age
49090-4 [3049207]
49090-4 [3049207]
2.3e-01
2.4e+00
—
—
-1.0e+50
-4.9e-01
6.1e-01
cases:2.87%
controls:2.30%
cases:9.68%
controls:0.92%
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.50%
controls:0.81%
cases:4.51%
controls:2.49%
82
650
2779
27615
277
260
2584
28005
—
—
0
16
2860
28230
14
225
2814
27661
120
650
2542
25440
Spontaneous abortion, Incomplete, without complication
O03.4 [45558185]
O03.4 [45558185]
1.2e+00
1.8e+00
—
—
—
—
7.2e-01
cases:1.36%
controls:0.40%
cases:0.73%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.98%
controls:0.48%
39
112
2822
28153
21
34
2840
28231
—
—
—
—
26
125
2636
25965
Mild hyperemesis gravidarum
O21.0 [45596924]
O21.0 [45596924]
7.4e-01
3.1e+00
—
—
—
—
7.9e-01
cases:0.35%
controls:0.17%
cases:1.12%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.56%
controls:0.26%
10
47
2851
28218
32
15
2829
28250
—
—
—
—
15
67
2647
26023
Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
25373-2 [3019145]
25373-2 [3019145]
3.1e-01
2.5e+00
—
—
-1.0e+50
-5.7e-01
5.9e-01
cases:3.22%
controls:2.38%
cases:10.31%
controls:0.97%
—
—
—
—
cases:0.00%
controls:0.07%
cases:0.50%
controls:0.87%
cases:4.77%
controls:2.69%
92
673
2769
27592
295
275
2566
27990
—
—
0
19
2860
28227
14
242
2814
27644
127
703
2535
25387
Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
76348-2 [46235831]
76348-2 [46235831]
2.3e-01
2.5e+00
—
—
-1.0e+50
-4.4e-01
5.8e-01
cases:2.87%
controls:2.30%
cases:10.00%
controls:0.93%
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.53%
controls:0.82%
cases:4.51%
controls:2.57%
82
650
2779
27615
286
263
2575
28002
—
—
0
17
2860
28229
15
228
2813
27658
120
671
2542
25419
Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
60477-7 [40763531]
60477-7 [40763531]
2.3e-01
2.5e+00
—
—
-1.0e+50
-4.4e-01
5.8e-01
cases:2.87%
controls:2.30%
cases:10.00%
controls:0.93%
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.53%
controls:0.82%
cases:4.51%
controls:2.57%
82
650
2779
27615
286
263
2575
28002
—
—
0
17
2860
28229
15
228
2813
27658
120
671
2542
25419
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
Z00.4 [45605094]
-1.0e-01
7.7e-01
5.0e-01
—
1.5e+00
7.8e-01
2.0e-01
cases:1.40%
controls:1.54%
cases:0.87%
controls:0.41%
cases:0.21%
controls:0.13%
—
—
cases:0.49%
controls:0.11%
cases:0.85%
controls:0.39%
cases:1.69%
controls:1.38%
40
436
2821
27829
25
115
2836
28150
6
36
2855
28229
—
14
31
2846
28215
24
109
2804
27777
45
361
2617
25729
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
966
938
14.46
307.65
6.3
1.5
10.22
4.45
umol/l
15.27
865
667
348
615
6.24
191.26
1.2
1.4
143.10
151.54
au/ml
0.59
133
145
359
660
6.02
189.39
1.2
1.3
14.08
19.58
u/ml
—
5
17
348
715
5.35
162.05
1.2
1.2
192.62
262.80
u/ml
7.09
280
466
156
224
7.28
103.72
1.2
1.2
83.33
88.09
—
6
11
781
4906
1.79
39.66
1.6
1.6
991.12
1011.33
mu/l
0.24
650
4111
1653
12762
1.63
37.93
5.5
5.4
9.77
9.45
umol/l
0.61
1567
12114
524
2985
1.91
36.08
2.6
2.4
6.33
5.95
umol/l
0.18
463
2519
201
828
2.53
31.28
1.5
1.3
85.45
123.64
titre
0.61
22
88
1281
9848
1.51
26.35
3.8
3.0
34.06
27.62
u/l
6.15
1224
9418
518
3245
1.71
25.25
1.5
1.5
—
—
—
0
0
390
2305
1.79
23.19
1.8
1.6
—
—
—
0
0
355
2077
1.80
21.78
2.0
1.8
—
—
—
0
0
2220
19453
1.49
21.46
8.2
7.2
79.54
71.97
u/l
14.25
2132
18628
3044
29047
2.83
20.60
13.0
9.7
32.88
23.73
u/l
43.23
3013
28513
367
2227
1.73
19.78
2.6
2.8
10.76
10.38
g/l
1.45
338
2102
411
2595
1.67
19.10
1.5
1.5
—
—
—
0
0
435
2791
1.65
18.99
1.6
1.5
67.12
61.02
ug/l
1.56
347
2334
299
1733
1.80
18.85
1.7
1.9
1.36
1.38
g/l
0.06
279
1637
1028
7950
1.44
18.75
2.5
2.5
64.05
56.10
u/l
0.83
976
7471
413
2627
1.66
18.63
1.6
1.5
1.22
1.14
ratio
0.83
253
1590
413
2634
1.65
18.43
1.6
1.5
1.16
1.22
ratio
0.61
256
1606
413
2634
1.65
18.43
1.6
1.5
0.93
0.95
ratio
0.64
254
1597
2111
18786
1.38
15.25
4.6
4.0
696.14
1232.36
e6/l
0.31
21
200
313
1948
1.67
15.24
3.1
4.1
222.72
227.71
u/l
0.33
300
1855
288
1772
1.69
14.63
1.6
1.5
61.70
60.08
ug/l
0.25
288
1772
1469
12493
1.33
13.56
9.9
9.3
0.00
0.00
e9/l
0.85
1214
10256
298
1888
1.64
13.51
2.4
2.3
0.23
0.23
g/l
0.08
281
1801
1051
8528
1.35
13.26
5.4
6.0
1.03
1.05
inr
3.07
864
7011
83
367
2.30
11.18
1.1
1.1
1.39
1.46
g/l
0.79
75
336
1751
15534
1.29
10.74
3.6
3.4
2.88
3.37
estimate
0.06
451
3226
220
1375
1.65
10.52
1.3
1.2
—
—
—
0
0
780
6256
1.33
10.11
4.1
3.3
98.94
99.17
%
0.11
756
6079
123
659
1.90
10.01
1.7
1.5
—
—
—
0
0
1753
15639
1.28
9.90
3.7
3.4
0.00
0.03
estimate
1.18
445
3171
2601
24468
1.38
9.81
4.3
3.9
—
—
—
0
0
1561
13755
1.27
9.66
2.9
2.6
—
—
estimate
—
0
0
123
668
1.88
9.61
2.2
1.9
1.09
1.34
g/l
2.11
106
582
2002
18189
1.28
9.59
3.7
3.4
57.99
65.19
ug/l
4.00
1929
17472
1170
10006
1.27
9.10
4.9
4.3
37.04
37.35
g/l
1.31
1115
9494
1720
15401
1.26
9.02
3.6
3.4
0.00
0.00
estimate
1.85
454
3214
1084
9228
1.27
8.65
3.0
2.7
0.03
0.07
estimate
0.75
393
2676
51
208
2.48
8.30
1.3
1.2
280.77
211.25
titre
0.21
13
40
2633
24967
1.35
8.22
14.9
13.6
13.32
13.30
%
0.29
2611
24673
783
6443
1.29
8.13
2.7
2.7
0.16
0.25
e6/l
3.25
556
4547
2297
21404
1.28
8.05
3.6
3.0
38.06
32.02
u/l
4.23
2204
20715
1593
14249
1.24
8.00
4.4
4.0
6.09
6.18
mmol/l
1.02
1435
12950
896
7515
1.27
7.95
1.5
1.4
2.10
2.09
g/l
0.04
605
5040
53
225
2.38
7.93
1.0
1.1
—
—
—
0
0
55
240
2.31
7.75
1.1
1.0
311.56
298.68
mg/l
0.39
48
224
951
8086
1.25
7.41
3.5
3.5
0.01
0.00
estimate
0.27
442
3095
884
7508
1.25
6.86
2.8
2.8
33.21
80.25
e6/l
1.40
642
5537
776
6496
1.26
6.83
1.4
1.3
8.47
7.86
u/ml
0.13
320
2855
56
263
2.15
6.67
1.4
1.3
1183.33
1035.56
titre
0.38
12
45
835
7070
1.25
6.62
1.4
1.4
24.26
24.41
iu/ml
0.01
246
2107
1028
8902
1.23
6.62
1.4
1.4
1.03
1.54
u/ml
1.92
315
2740
332
2486
1.38
6.59
2.6
2.3
36.26
36.84
u/l
0.06
298
2091
1518
13691
1.21
6.45
6.6
6.2
30.02
29.93
%
0.13
1462
13099
736
6161
1.25
6.43
2.2
2.0
294.94
293.20
umol/l
0.23
671
5665
115
696
1.68
6.33
1.8
1.6
7.64
7.58
mmol/l
0.11
108
669
1494
13505
1.20
6.05
6.5
6.0
56.21
56.37
%
0.27
1453
13002
2198
20613
1.22
6.05
4.6
4.1
9.52
9.19
mm/h
0.77
2113
19734
614
5090
1.26
5.77
2.4
2.4
9.15
9.02
e6/l
0.03
549
4573
1098
9680
1.21
5.71
1.8
1.8
—
—
—
0
0
1338
12017
1.20
5.69
3.4
3.2
0.06
0.24
estimate
0.45
384
2690
497
4028
1.28
5.64
2.0
2.3
14.81
14.78
umol/l
0.04
466
3778
454
3646
1.29
5.53
2.8
2.3
6277.65
6410.90
u/l
0.03
212
1493
137
903
1.54
5.36
2.6
2.4
4.02
3.61
g/l
2.47
124
849
796
6842
1.22
5.30
1.9
1.7
0.97
0.80
mg/l
1.47
601
5168
37
164
2.27
5.14
1.2
1.2
69.49
68.84
ug/l
0.02
37
164
256
1915
1.37
5.14
2.4
2.4
—
—
—
0
0
1625
14943
1.18
5.05
6.8
6.5
0.18
0.18
e9/l
0.20
1491
13510
198
1424
1.42
5.02
1.4
1.4
—
—
—
0
0
34
149
2.30
4.86
3.2
3.2
8.67
8.21
mg/l
0.14
27
116
62
342
1.83
4.79
1.4
1.2
—
—
—
0
0
816
7099
1.20
4.72
2.4
2.2
2.39
2.53
mg/l
1.40
723
6215
445
3634
1.26
4.72
2.1
2.3
2.50
2.49
g/l
0.15
410
3373
44
218
2.03
4.66
2.5
2.4
24.00
24.75
mg/l
0.05
31
148
2794
27102
1.29
4.60
6.1
5.8
1.63
1.70
mu/l
2.18
2696
26205
177
1269
1.42
4.59
1.8
1.9
0.04
0.01
estimate
0.29
69
482
2756
26699
1.27
4.50
10.6
10.4
139.65
139.62
mmol/l
0.34
2711
26175
598
5075
1.22
4.45
3.2
2.5
95.80
91.06
ug/g
0.17
479
4040
2547
24474
1.22
4.42
5.3
5.0
14.26
14.21
pmol/l
0.52
2428
23424
398
3240
1.26
4.33
2.1
2.4
24.38
24.13
%
0.14
375
3006
1603
14835
1.17
4.31
6.7
6.2
1.94
1.99
e9/l
1.47
1472
13513
1022
9130
1.18
4.30
2.8
2.6
0.42
0.06
0.81
12
110
368
2985
1.26
4.13
2.2
2.0
28.75
28.90
s
0.22
351
2895
85
538
1.60
4.05
4.8
3.4
917.93
384.86
u/ml
0.34
76
463
2755
26767
1.25
3.85
10.8
10.5
3.88
3.89
mmol/l
2.18
2707
26164
43
230
1.88
3.73
1.3
1.5
—
—
—
0
0
424
3537
1.23
3.71
2.4
2.5
5.41
4.88
e6/l
0.21
188
1561
1697
15894
1.15
3.58
8.5
9.0
3.82
3.94
e9/l
1.58
1510
14018
159
1173
1.37
3.56
2.0
2.3
2.92
3.69
iu/l
1.62
70
540
761
6736
1.17
3.48
2.1
1.9
—
—
—
0
0
50
289
1.74
3.41
1.1
1.2
—
1.11
—
0
10
324
2657
1.24
3.33
3.1
3.5
4.58
4.56
pmol/l
0.17
299
2418
168
2201
0.75
3.29
4.1
4.2
—
—
—
0
0
143
1056
1.37
3.21
2.2
2.6
1.02
1.02
ratio
0.68
125
908
91
628
1.46
3.01
1.7
1.5
6.33
6.78
mmol/l
1.41
78
578
2854
27953
1.24
2.93
12.5
11.3
17.03
18.42
mg/l
1.79
2348
22458
450
3878
1.19
2.82
2.4
2.4
2.21
1.00
e6/l
0.48
211
1906
207
1646
1.28
2.80
3.1
3.1
1.22
1.23
mmol/l
1.76
183
1414
8
222
0.36
2.77
6.0
14.6
680.88
6675.48
nmol/l
—
8
214
97
690
1.42
2.76
1.2
1.3
—
—
—
0
0
2518
24420
1.16
2.75
4.5
4.5
36.52
36.82
mmol/mol
1.34
2426
23530
2672
26039
1.18
2.72
10.3
9.5
94.09
93.53
ml/min/173m2
0.92
2467
23620
9
233
0.38
2.65
9.2
20.2
1179.33
5590.77
nmol/l
—
9
223
835
7580
1.14
2.62
2.5
2.5
17.98
36.30
ng/l
0.68
307
2970
1408
13208
1.12
2.55
2.7
2.5
75.30
73.95
nmol/l
1.17
1340
12586
6
11
5.46
2.54
1.0
1.0
—
—
—
0
0
165
1303
1.28
2.40
6.4
7.6
6.80
6.93
mmol/l
0.12
157
1267
24
125
1.93
2.35
2.0
1.5
1.76
6.20
u/l
2.78
17
105
52
339
1.54
2.32
2.1
1.6
—
—
—
0
0
273
2295
1.21
2.27
1.3
1.3
17.66
40.12
au/ml
2.69
11
136
289
2446
1.20
2.24
2.4
2.4
17.03
19.75
au/ml
0.41
30
366
14
60
2.34
2.21
1.1
1.1
—
—
—
0
0
193
1574
1.24
2.17
1.2
1.3
0.27
1.07
u/ml
1.77
12
120
152
1210
1.27
2.11
2.2
2.1
40.46
39.37
u/l
0.31
142
1137
1155
10810
1.11
2.07
5.4
5.7
1.22
1.22
mmol/l
0.12
1000
9416
1175
11017
1.11
2.02
1.8
1.8
1.19
1.32
mmol/l
7.54
1034
9824
660
5994
1.13
2.02
1.6
1.6
20.78
20.52
nmol/l
0.20
603
5429
2938
28987
1.23
1.98
13.2
12.4
65.21
65.58
umol/l
0.62
2923
28698
3090
30698
1.57
1.98
19.7
17.7
266.94
271.17
e9/l
3.71
3060
30334
702
6407
1.12
1.98
1.9
2.0
114.74
132.28
u/l
0.75
677
6145
125
980
1.29
1.98
1.2
1.3
60.59
39.55
u/ml
—
7
83
61
428
1.43
1.96
1.1
1.2
179.98
3189.51
pmol/l
—
9
38
1009
9401
1.11
1.95
5.2
5.2
1.22
1.22
mmol/l
0.15
964
8817
314
2714
1.17
1.94
1.4
1.3
194.13
185.88
u/ml
0.04
303
2539
9
33
2.73
1.93
1.0
1.3
—
—
—
0
0
3090
30703
1.56
1.92
19.6
17.6
89.91
90.18
fl
3.39
3082
30565
3090
30703
1.56
1.92
20.1
17.9
39.73
40.69
%
2.57
3081
30549
3090
30706
1.55
1.88
19.7
17.7
4.46
4.47
e12/l
1.19
3058
30314
3090
30707
1.55
1.86
19.7
17.7
6.68
6.69
e9/l
0.02
3058
30292
355
3112
1.16
1.84
1.6
1.8
—
—
—
0
0
193
2308
0.83
1.84
1.4
1.5
—
—
—
0
0
188
1562
1.22
1.81
2.1
2.1
7.16
6.85
iu/ml
0.05
46
380
31
191
1.63
1.81
2.4
1.5
—
—
—
0
0
604
5494
1.12
1.80
4.1
4.0
10.03
9.66
mg/mmol
0.08
377
3354
135
1086
1.25
1.76
1.3
1.3
7.40
5.92
u/ml
—
9
98
12
54
2.23
1.73
1.2
1.1
—
—
—
0
0
3090
30718
1.51
1.72
19.8
17.8
132.40
133.47
g/l
7.73
3081
30577
531
4809
1.13
1.71
1.7
1.6
16807153.46
38598138.32
pmol/l
0.60
476
4293
745
6882
1.11
1.68
3.8
3.3
7.78
7.72
mmol/l
0.12
657
6097
99
773
1.29
1.66
1.2
1.1
13.45
13.98
au/ml
0.04
33
229
179
1497
1.21
1.64
1.6
1.7
—
—
—
0
0
134
1088
1.24
1.64
1.3
1.4
6.86
10.23
u/ml
0.37
14
160
30
189
1.59
1.62
1.3
1.2
—
—
—
0
0
118
945
1.26
1.62
1.4
1.6
—
—
—
0
0
50
354
1.42
1.58
1.2
1.1
16.76
14.07
u/ml
0.30
26
172
1054
9927
1.09
1.58
1.8
1.8
100.80
99.25
pmol/l
0.49
569
5546
2602
25514
1.12
1.57
3.8
3.8
5.51
5.56
mmol/l
1.52
2475
24364
22
129
1.71
1.56
1.1
1.1
—
—
—
0
0
25
152
1.65
1.56
1.2
1.3
—
—
—
0
0
26
161
1.62
1.52
1.2
1.1
95.40
95.10
%
—
10
69
49
350
1.41
1.49
1.1
1.1
7.79
7.60
iu/ml
0.02
15
104
133
1092
1.23
1.49
1.5
1.6
—
—
—
0
0
107
858
1.26
1.48
12.1
9.5
16.36
16.08
%
0.52
101
822
15
80
1.88
1.44
1.3
3.0
11870.60
62.72
mg/l
—
10
57
377
3382
1.13
1.44
3.1
3.3
0.84
0.83
mmol/l
0.90
362
3221
5
16
3.13
1.44
1.0
1.2
—
—
—
0
0
144
1198
1.21
1.43
1.3
1.3
84.22
38.10
u/ml
—
6
74
106
855
1.25
1.41
1.3
1.3
1.23
4.13
u/ml
—
6
52
80
624
1.29
1.40
2.6
2.4
1.74
1.91
index
0.05
46
315
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
32
214
1.50
1.38
2.0
1.9
129.01
117.03
%
0.49
32
209
158
1333
1.20
1.36
1.5
1.6
0.24
0.28
mg/l
0.40
55
547
127
1049
1.22
1.36
1.2
1.2
4.50
4.32
0.09
29
185
24
151
1.59
1.34
1.7
1.8
2.42
2.81
mg/l
0.60
24
146
419
3802
1.12
1.33
2.5
2.5
289.96
429.03
ng/l
1.31
329
3059
23
144
1.60
1.32
1.3
1.8
28.61
30.67
umol/l
0.50
23
129
9
43
2.10
1.30
6.9
4.0
—
—
—
0
0
21
129
1.63
1.29
1.2
1.2
—
—
—
0
0
856
8055
1.09
1.28
2.2
2.2
—
—
—
0
0
5
18
2.78
1.28
1.8
1.4
—
—
—
0
0
38
268
1.42
1.27
1.2
1.2
—
—
—
0
0
130
1086
1.21
1.27
1.1
1.1
7.72
5.12
eliau/ml
0.15
19
178
113
931
1.22
1.26
1.8
2.4
51.45
70.55
ng/l
1.29
97
817
79
625
1.27
1.26
1.3
1.2
1.28
2.69
u/ml
2.87
29
230
6
25
2.40
1.24
1.0
1.1
—
—
—
0
0
38
271
1.41
1.21
1.2
1.2
—
—
—
0
0
22
140
1.58
1.20
1.0
1.1
—
—
—
0
0
8
38
2.11
1.18
1.0
1.1
—
—
—
0
0
24
157
1.53
1.17
1.2
1.1
99.80
97.74
%
—
10
68
0
33
0.00
1.16
0.0
1.0
—
—
—
0
0
0
34
0.00
1.16
0.0
1.0
—
—
—
0
0
62
482
1.29
1.15
1.1
1.3
—
—
—
0
0
71
563
1.27
1.14
1.4
1.5
—
—
—
0
0
395
3610
1.11
1.12
1.3
1.3
162.73
150.62
u/ml
0.24
161
1472
39
284
1.38
1.12
1.2
1.2
0.62
0.66
ratio
0.30
16
172
338
3065
1.12
1.11
2.0
2.2
369.94
375.43
nmol/l
0.22
318
2856
43
319
1.35
1.11
1.4
1.2
—
—
—
0
0
61
477
1.28
1.10
1.5
1.4
—
—
—
0
0
268
2401
1.13
1.09
4.3
5.3
1.05
1.05
mmol/l
0.17
257
2230
727
6844
1.08
1.08
3.4
3.3
1.02
1.47
kg/l
0.80
498
4432
44
330
1.34
1.07
1.4
1.2
—
—
—
0
0
189
2149
0.87
1.07
1.4
1.5
—
—
—
0
0
44
331
1.33
1.05
1.4
1.2
—
—
—
0
0
6
121
0.49
1.05
4.2
2.8
—
—
—
0
0
237
2115
1.13
1.04
1.4
1.7
—
—
—
0
0
42
316
1.33
1.01
1.4
1.2
—
—
—
0
0
1022
9765
1.07
1.01
1.6
1.6
—
—
—
0
0
35
256
1.37
1.00
1.3
1.4
—
—
—
0
0
91
755
1.21
1.00
1.2
1.3
—
—
—
0
0
16
250
0.64
1.00
1.4
1.5
0.42
0.50
e9/l
1.42
16
250
49
379
1.30
0.98
1.4
1.2
—
—
—
0
0
5
23
2.18
0.98
2.2
2.5
—
—
—
0
0
769
7286
1.07
0.96
2.2
2.1
—
—
—
0
0
83
686
1.22
0.96
1.4
1.3
320.27
323.05
ug/g
0.04
41
332
39
293
1.34
0.96
1.3
1.4
—
—
—
0
0
452
4195
1.09
0.95
1.3
1.3
26.18
25.48
iu/l
0.17
399
3630
74
606
1.23
0.94
1.4
1.2
1.97
4.45
u/ml
3.25
33
253
6
27
2.22
0.93
2.2
2.4
31.50
21.76
mg/l
—
6
27
44
339
1.30
0.92
1.4
1.2
—
—
—
0
0
129
1115
1.16
0.91
2.4
2.1
0.22
0.23
g/l
0.08
124
1055
41
313
1.31
0.91
1.3
1.4
—
—
—
0
0
39
296
1.32
0.91
1.3
1.4
—
—
—
0
0
39
296
1.32
0.91
1.3
1.4
—
—
—
0
0
126
1453
0.86
0.90
1.3
1.3
11.68
11.89
u/l
0.06
107
1200
41
314
1.31
0.90
1.3
1.4
—
—
—
0
0
127
1460
0.86
0.87
2.1
2.1
—
—
—
0
0
8
43
1.86
0.87
2.1
1.7
—
—
—
0
0
46
360
1.28
0.87
1.2
1.2
—
—
—
0
0
46
360
1.28
0.87
1.2
1.2
—
—
—
0
0
62
504
1.23
0.86
2.2
2.0
5.16
5.36
mmol/24h
0.25
57
469
27
195
1.39
0.86
1.1
1.2
—
—
—
0
0
56
692
0.81
0.86
1.2
1.2
—
—
—
0
0
10
167
0.60
0.85
1.8
2.2
—
—
—
0
0
15
96
1.57
0.84
1.0
1.1
—
—
—
0
0
70
579
1.21
0.83
1.2
1.1
1.91
2.95
0.53
22
125
41
320
1.28
0.80
1.3
1.4
—
—
—
0
0
127
1111
1.15
0.80
1.5
1.6
0.01
0.42
iu/ml
1.35
14
169
26
350
0.74
0.78
1.6
1.2
60.12
55.77
nmol/l
0.29
26
345
39
304
1.29
0.78
2.4
2.8
9.05
101.94
ug/min
3.59
30
205
77
649
1.19
0.77
4.0
5.1
1.75
1.70
%
0.10
71
609
24
174
1.38
0.76
1.8
1.8
1.79
1.93
umol/l
0.50
24
156
90
770
1.17
0.76
1.5
1.6
352.68
377.90
mu/l
0.27
71
610
21
149
1.41
0.75
1.1
1.1
—
—
—
0
0
13
83
1.57
0.75
1.2
1.7
—
8498.09
—
0
11
90
772
1.17
0.74
2.0
1.9
—
—
—
0
0
96
828
1.16
0.74
1.1
1.1
1.73
4.56
u/ml
2.31
44
341
168
1507
1.12
0.73
1.6
1.6
—
—
—
0
0
23
167
1.38
0.73
1.3
1.6
0.82
0.41
mmol/l
0.29
23
159
26
345
0.75
0.72
1.5
1.4
470.81
385.39
pmol/l
0.31
26
306
140
1244
1.13
0.72
2.4
2.3
67.31
67.83
g/l
0.44
132
1177
18
126
1.43
0.70
1.3
1.7
—
—
—
0
0
436
4102
1.07
0.69
1.6
1.7
1.36
1.32
%
0.54
382
3721
12
181
0.66
0.69
1.8
2.8
0.98
0.82
e9/l
0.83
12
175
166
1496
1.12
0.68
9.9
6.7
1.24
1.18
mmol/l
0.38
166
1464
10
61
1.64
0.68
1.1
1.1
1.01
1.25
mom
—
10
61
44
356
1.24
0.67
1.1
1.1
180.22
204.58
mg/l
1.17
38
320
53
438
1.21
0.67
1.9
1.7
14512.31
7263.54
e6/l
0.42
35
311
263
2429
1.09
0.67
1.6
1.6
370.70
302.89
mu/l
0.25
234
2166
35
276
1.27
0.66
1.1
1.1
1.08
1.05
ratio
0.82
30
225
32
250
1.28
0.65
1.2
1.6
—
—
—
0
0
224
2057
1.10
0.65
1.4
1.7
—
—
—
0
0
2513
25413
0.94
0.65
15.3
14.1
331.66
331.88
g/l
0.67
2499
25270
17
120
1.42
0.64
1.5
1.5
—
—
—
0
0
28
216
1.30
0.63
1.9
1.7
12.82
23.11
mg/l
1.38
11
89
235
2169
1.09
0.62
1.4
1.4
226.06
243.58
miu/ml
0.31
118
1132
10
63
1.59
0.61
2.8
2.6
0.63
0.62
mmol/l
—
10
63
18
245
0.73
0.61
1.4
1.2
9.44
9.30
mm/h
0.02
18
245
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
10
152
0.66
0.61
1.3
1.6
—
—
—
0
0
97
854
1.14
0.60
2.0
2.0
—
—
—
0
0
0
20
0.00
0.60
0.0
1.0
—
0.16
—
0
6
8
51
1.57
0.60
1.4
1.4
0.45
0.39
ug/l
—
8
41
8
53
1.51
0.58
1.0
1.1
—
—
—
0
0
859
8298
1.05
0.57
2.8
3.1
2.34
2.35
mmol/l
0.46
810
7807
44
365
1.21
0.56
1.1
1.1
42.54
34.10
mg/l
0.36
34
310
85
747
1.14
0.55
1.1
1.1
—
0.24
—
0
5
6
37
1.62
0.55
1.3
1.2
—
—
—
0
0
15
107
1.40
0.55
1.4
1.3
—
2520.00
—
0
5
37
304
1.22
0.53
4.6
8.1
105.84
105.41
mmol/l
0.17
32
273
15
203
0.74
0.51
1.1
1.6
—
—
—
0
0
9
136
0.66
0.51
3.2
2.3
1.93
1.01
ug/l
—
9
130
9
65
1.39
0.50
1.0
1.4
—
—
—
0
0
9
65
1.39
0.50
1.0
1.4
—
—
—
0
0
20
258
0.77
0.50
1.1
1.1
—
—
—
0
0
188
1742
1.08
0.49
1.1
1.1
0.58
0.61
ratio
0.31
27
175
28
226
1.24
0.48
1.7
1.7
50.33
47.36
%
0.13
18
127
7
47
1.49
0.47
1.1
1.4
—
—
—
0
0
128
1168
1.10
0.47
1.1
1.1
1.90
2.29
u/ml
0.20
70
583
124
1358
0.91
0.46
1.4
1.3
3.19
3.65
ug/l
0.55
116
1259
35
418
0.84
0.46
1.6
1.5
—
—
—
0
0
17
129
1.32
0.45
1.2
1.4
12.21
13.39
pmol/l
0.54
17
108
37
310
1.20
0.45
1.2
1.2
0.23
1.05
u/ml
2.21
19
149
98
884
1.11
0.45
1.1
1.1
0.84
4.67
u/ml
4.11
47
414
22
174
1.27
0.44
2.2
1.6
42.58
42.73
%
0.01
16
93
109
990
1.10
0.44
1.1
1.1
0.98
1.49
u/ml
0.53
52
470
90
997
0.90
0.43
1.6
1.8
10.69
5.00
ug/l
0.79
81
879
5
31
1.61
0.43
1.0
1.2
—
—
—
0
0
10
70
1.43
0.41
1.0
1.1
—
—
—
0
0
175
1632
1.08
0.41
1.9
1.7
3.09
4.25
mg/l
1.55
133
1176
0
17
0.00
0.40
0.0
5.9
—
10.90
—
0
17
81
729
1.11
0.40
1.3
1.4
986.23
6433.06
e6/l
0.52
60
569
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
8
60
1.33
0.40
1.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
0.30
—
0
5
49
427
1.15
0.40
1.2
1.5
—
3744.00
—
0
5
68
607
1.12
0.39
1.1
1.1
—
—
—
0
0
120
1106
1.09
0.38
1.4
1.4
23.79
24.54
u/l
0.09
95
918
236
2232
1.06
0.38
1.6
1.5
—
—
—
0
0
13
170
0.76
0.38
1.1
1.5
—
—
—
0
0
13
170
0.76
0.38
1.1
1.5
—
—
—
0
0
13
170
0.76
0.38
1.1
1.5
—
—
—
0
0
8
112
0.71
0.37
2.0
1.4
—
—
—
0
0
8
115
0.69
0.37
1.9
2.4
153.87
168.14
nmol/l
—
8
104
9
70
1.29
0.36
1.0
1.2
—
—
—
0
0
9
70
1.29
0.36
1.0
1.2
—
—
—
0
0
182
1935
0.94
0.36
2.0
2.3
80.29
79.93
ml/min/173m2
0.05
72
793
13
99
1.31
0.35
1.1
1.1
97.08
98.23
%
0.06
13
99
305
2915
1.05
0.35
1.7
1.6
1148.47
1182.71
nmol/l
0.29
248
2327
38
329
1.16
0.35
1.1
1.1
—
—
—
0
0
19
233
0.81
0.34
1.1
1.6
—
—
—
0
0
51
452
1.13
0.34
1.9
2.2
132.33
131.44
g/l
0.15
43
371
44
500
0.88
0.34
2.5
2.0
2.02
1.61
ug/l
0.15
35
456
73
663
1.10
0.33
1.8
1.9
—
—
—
0
0
47
530
0.89
0.33
1.9
2.5
24.38
24.62
mmol/l
0.37
41
493
26
219
1.19
0.33
1.5
1.2
—
—
—
0
0
91
986
0.92
0.31
15.9
9.1
1.14
1.34
%
1.37
91
980
84
772
1.09
0.31
2.3
2.2
10.39
10.67
mg/l
0.12
79
737
89
964
0.92
0.30
16.2
9.3
0.65
0.67
%
0.20
89
958
378
3647
1.04
0.30
2.9
2.8
277.08
341.33
ng/l
0.16
162
1743
266
2548
1.05
0.29
3.2
3.5
33.38
32.58
%
0.62
200
1968
178
1687
1.06
0.29
1.9
2.2
0.18
0.30
e6/l
1.11
166
1565
78
717
1.09
0.29
1.2
1.3
5.06
17.99
e6/l
2.24
52
530
8
109
0.73
0.29
2.0
2.3
14.55
15.76
umol/l
—
8
109
30
260
1.16
0.28
1.1
1.0
0.98
1.05
u/l
—
10
93
23
270
0.85
0.28
2.1
1.6
—
—
—
0
0
38
336
1.13
0.28
2.3
2.6
—
—
—
0
0
152
1437
1.06
0.28
1.6
1.7
7.78
10.43
u/ml
0.93
44
428
89
826
1.08
0.27
1.1
1.3
418.70
435.50
mg/l
0.17
84
798
16
131
1.22
0.27
1.1
1.1
—
—
—
0
0
8
65
1.23
0.27
1.3
2.1
42.91
42.28
g/l
—
8
65
49
542
0.90
0.27
1.5
1.6
—
—
—
0
0
8
66
1.21
0.26
1.0
1.2
—
—
—
0
0
14
113
1.24
0.26
1.1
1.0
16.57
33.63
iu/ml
1.28
14
113
234
2243
1.05
0.26
1.1
1.1
—
—
—
0
0
599
5849
1.03
0.26
1.8
2.0
—
—
—
0
0
35
310
1.13
0.26
1.3
1.2
0.17
0.21
nmol/l
0.31
27
220
80
742
1.08
0.25
1.1
1.1
0.05
0.30
u/ml
0.87
24
203
44
397
1.11
0.24
1.1
1.2
—
—
—
0
0
133
1260
1.06
0.24
2.0
2.8
4.82
4.71
kpa
0.19
128
1221
6
82
0.73
0.24
1.2
1.8
—
—
—
0
0
6
83
0.72
0.24
1.2
1.8
—
—
—
0
0
6
83
0.72
0.24
1.2
1.8
—
—
—
0
0
21
180
1.17
0.23
1.3
1.7
1.58
2.42
nmol/l
0.52
14
133
116
1096
1.06
0.23
1.5
1.6
—
—
—
0
0
2736
27252
1.03
0.22
4.3
4.3
2.84
2.89
mmol/l
3.39
2644
26319
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
4.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
26.87
—
0
12
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
8
103
0.78
0.21
1.0
1.0
—
—
—
0
0
8
103
0.78
0.21
2.0
1.4
—
—
—
0
0
18
154
1.17
0.21
1.1
1.4
72.90
87.48
nmol/24h
0.59
18
154
11
89
1.24
0.21
1.1
1.1
—
—
—
0
0
11
89
1.24
0.21
1.0
1.3
—
—
—
0
0
17
145
1.17
0.20
1.2
1.6
118.76
127.88
nmol/l
0.48
17
145
35
316
1.11
0.20
2.0
1.5
—
—
—
0
0
108
1024
1.06
0.20
1.1
1.1
3.54
5.29
u/ml
0.74
52
541
36
397
0.91
0.20
1.0
1.1
—
—
—
0
0
2723
27129
1.03
0.20
4.1
4.0
4.76
4.85
mmol/l
6.42
2637
26299
18
208
0.86
0.20
6.1
7.8
13.10
105.08
ug/l
0.61
11
140
6
49
1.22
0.20
1.0
1.1
1.20
1.19
mmol/l
—
6
49
9
112
0.80
0.20
1.9
1.4
—
—
—
0
0
9
112
0.80
0.20
4.0
4.1
—
—
—
0
0
24
270
0.89
0.19
1.1
1.1
1720.71
1552.60
miu/ml
0.39
24
270
6
53
1.13
0.18
1.8
1.7
15.45
64.77
u/l
—
6
47
25
280
0.89
0.18
1.2
1.6
—
—
—
0
0
13
109
1.19
0.18
1.4
1.6
121.62
80.08
ng/l
0.33
13
109
20
175
1.14
0.18
1.4
1.3
69.00
66.54
umol/l
0.26
20
175
17
147
1.16
0.18
1.7
3.0
723.53
1500.35
mg
1.38
17
147
17
147
1.16
0.18
1.2
1.4
153.17
145.00
mmol/24h
0.19
17
147
19
216
0.88
0.17
1.2
1.6
0.59
1.16
promille
1.28
14
173
157
1514
1.04
0.16
2.8
3.3
70.84
72.25
ng/l
0.10
147
1364
54
577
0.93
0.16
1.4
1.6
—
—
—
0
0
8
69
1.16
0.16
2.5
2.2
—
—
—
0
0
59
554
1.07
0.16
2.7
2.1
106.64
376.01
ug/l
1.14
48
492
2714
27056
1.02
0.16
4.0
4.0
1.54
1.55
mmol/l
0.16
2629
26135
8
71
1.13
0.16
1.1
1.1
—
—
—
0
0
11
92
1.20
0.16
1.0
1.3
—
—
—
0
0
29
318
0.91
0.15
1.4
1.6
—
—
—
0
0
10
119
0.84
0.15
3.5
2.2
1.76
1.57
nmol/l
—
10
99
9
79
1.14
0.15
1.1
1.1
—
—
—
0
0
28
307
0.91
0.15
1.6
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
38
352
1.08
0.14
3.2
3.8
0.39
0.35
iu/ml
0.37
19
178
21
232
0.90
0.13
1.5
2.3
—
—
—
0
0
403
3963
1.02
0.12
1.6
1.6
3.40
3.46
mmol/l
0.47
279
2606
132
1278
1.03
0.12
1.4
1.5
0.36
0.50
nmol/l
2.22
109
1034
31
287
1.08
0.12
1.8
2.1
18.60
20.11
nmol/l
0.40
31
278
56
531
1.06
0.12
1.4
1.3
—
—
—
0
0
101
973
1.04
0.12
1.1
1.1
1.03
0.99
u/ml
0.03
42
401
11
126
0.87
0.11
1.2
1.8
106.73
105.87
mmol/l
0.76
11
126
11
126
0.87
0.11
1.2
1.8
4.00
3.89
mmol/l
0.50
11
126
237
2321
1.02
0.11
2.8
2.5
25.37
33.66
u/ml
1.32
232
2251
147
1430
1.03
0.11
11.8
8.5
121.54
121.06
g/l
0.12
140
1399
420
4140
1.02
0.11
2.1
2.3
2.41
2.41
mmol/l
0.22
376
3720
24
260
0.92
0.11
1.3
1.3
—
47.00
—
0
9
5
45
1.11
0.09
1.2
1.1
—
—
—
0
0
107
1039
1.03
0.09
1.7
2.8
4.98
5.12
kpa
1.25
100
1007
11
97
1.13
0.09
1.1
6.0
—
379.50
—
0
14
48
502
0.96
0.08
1.0
1.2
2.33
21267.31
iu/ml
—
6
126
6
56
1.07
0.08
1.2
1.4
—
—
—
0
0
32
302
1.06
0.08
4.2
3.4
3.20
2.00
ratio
0.32
16
166
5
60
0.83
0.08
1.0
1.0
—
—
—
0
0
5
64
0.78
0.08
1.0
1.1
—
—
—
0
0
10
88
1.14
0.08
1.1
1.0
64.74
77.01
ug/l
—
10
75
45
470
0.96
0.08
1.4
1.4
—
—
—
0
0
6
71
0.84
0.07
1.2
1.3
5.52
5.52
mmol/l
—
6
71
8
76
1.05
0.07
1.1
1.1
—
—
—
0
0
35
367
0.95
0.07
2.4
1.3
696.00
423.45
titre
—
5
29
35
367
0.95
0.07
2.4
1.3
—
96.00
—
0
5
58
600
0.97
0.07
1.5
1.3
1.27
1.54
nmol/l
0.76
47
522
27
256
1.06
0.06
1.9
1.9
—
—
—
0
0
165
1624
1.02
0.06
5.1
3.9
33.57
35.86
ug/l
0.02
116
1152
13
119
1.09
0.06
1.4
1.3
5.55
6.04
mmol/l
0.73
13
111
147
1494
0.98
0.05
2.7
3.4
1.42
1.59
mmol/l
0.23
122
1306
48
464
1.04
0.05
3.3
3.5
27.44
21.10
mg/l
0.50
32
316
17
182
0.93
0.05
1.1
1.0
15.43
11.71
u/ml
—
10
133
56
576
0.97
0.05
1.4
1.4
55.42
35.65
nmol/l
0.45
48
522
11
120
0.92
0.05
2.2
1.7
—
—
—
0
0
11
120
0.92
0.05
1.2
1.8
1.21
1.20
mmol/l
0.98
11
120
169
1710
0.99
0.04
10.7
7.7
0.08
0.67
mmol/l
1.33
135
1360
12
111
1.08
0.04
1.1
1.1
—
—
—
0
0
45
438
1.03
0.03
2.0
3.0
0.87
0.86
nmol/l
0.03
36
385
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
141
1.06
0.03
1.2
1.1
—
—
—
0
0
86
874
0.98
0.03
1.7
2.7
1.05
1.36
mmol/l
0.51
51
632
25
240
1.04
0.03
1.6
1.5
—
—
—
0
0
19
181
1.05
0.03
2.2
2.6
10.40
15.69
index
—
10
114
67
658
1.02
0.03
1.1
1.1
1.75
3.59
eliau/ml
2.15
35
358
2550
25477
1.00
0.03
3.4
3.5
1.08
1.18
mmol/l
14.50
2469
24533
512
5098
1.01
0.03
1.8
1.8
3.19
3.28
ratio
1.02
390
3692
21
219
0.96
0.03
1.4
1.4
—
—
—
0
0
29
281
1.03
0.02
1.2
1.1
111.66
118.64
pmol/l
0.38
29
281
40
391
1.02
0.02
2.9
2.7
—
—
—
0
0
149
1479
1.01
0.02
11.3
8.2
96.57
96.57
%
0.00
141
1430
35
358
0.98
0.01
4.2
3.4
20.86
26.06
mg/l
0.82
30
314
46
452
1.02
0.01
1.3
1.1
—
—
—
0
0
172
1729
0.99
0.01
10.7
7.6
14.49
13.97
kpa
0.49
165
1668
88
888
0.99
0.01
4.7
7.0
24.30
24.18
mmol/l
0.15
80
847
172
1728
1.00
0.01
10.7
7.6
5.00
5.02
kpa
0.07
165
1669
10
99
1.01
0.00
1.1
1.1
4.08
6.33
u/ml
—
10
99
16
159
1.01
0.00
1.6
1.8
1.17
2.19
u/field
—
6
90
54
545
0.99
0.00
1.5
1.5
—
—
—
0
0
40
399
1.00
0.00
3.5
4.9
37.30
102.03
u/ml
—
9
136
80
805
0.99
0.00
1.2
1.1
—
—
—
0
0
11
114
0.96
0.00
1.1
1.6
—
—
—
0
0
11
114
0.96
0.00
1.1
1.6
—
—
—
0
0
11
114
0.96
0.00
1.1
1.6
—
—
—
0
0
11
114
0.96
0.00
1.1
1.6
—
—
—
0
0
14
144
0.97
0.00
2.5
1.4
4551.67
63302.56
e6/l
—
9
95
12
122
0.98
0.00
1.1
1.1
—
0.12
—
0
5
475
4751
1.00
0.00
1.6
1.9
—
—
—
0
0
17
172
0.99
0.00
1.2
1.3
—
—
u/ml
—
0
0
80
804
0.99
0.00
1.2
1.1
—
—
—
0
0
36
358
1.01
0.00
4.1
3.4
36.88
44.13
mg/l
0.24
31
315
176
1764
1.00
0.00
1.3
1.4
—
—
—
0
0
11
107
1.03
0.00
1.2
1.1
—
—
—
0
0
16
163
0.98
0.00
1.1
1.3
—
—
—
0
0
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
9
94
0.96
0.00
1.1
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
72
0.97
-0.00
1.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
5.00
—
0
6
5
55
0.91
-0.00
1.2
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
49.46
—
0
5
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
7
72
0.97
-0.00
1.0
1.1
—
—
—
0
0
6
67
0.90
-0.00
1.3
1.6
—
1.08
—
0
6
8
86
0.93
-0.00
1.4
1.7
8.23
8.02
ug/l
—
8
86
0
5
0.00
-0.00
0.0
1.0
—
19.20
—
0
5
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.77
—
0
6
0
7
0.00
-0.00
0.0
2.0
—
21.59
—
0
7
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
92.80
—
0
5
0
5
0.00
-0.00
0.0
5.2
—
—
—
0
0
6
68
0.88
-0.00
1.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
5.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: O15_ICP – Intrahepatic Cholestasis of Pregnancy (ICP)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).